@NP	A Comparative Study of Glial and Non-neural Cell Properties	1
@NP	A Comparative Study	1
@NP	Glial and Non-neural Cell Properties	24
@NP	Glial	24
@NP	Non-neural Cell Properties	34
@NP	Transplant-Mediated Repair	65
@NP	the Injured Spinal Cord ANDREW TOFT ,1,2 * MERCEDES TOME ,1,2 SUSAN C.	95
@NP	the	95
@NP	Spinal Cord ANDREW TOFT ,1,2 * MERCEDES TOME ,1,2 SUSAN C.	107
@NP	Spinal Cord ANDREW TOFT ,1,2	107
@NP	Spinal Cord ANDREW TOFT	107
@NP	,1,2	131
@NP	MERCEDES TOME ,1,2 SUSAN C.	137
@NP	MERCEDES TOME	137
@NP	,1,2 SUSAN C.	150
@NP	BARNETT ,2 AND JOHN S.	164
@NP	BARNETT	164
@NP	,2 AND JOHN S.	171
@NP	,2	171
@NP	JOHN S.	178
@NP	RIDDELL1 1Spinal Cord Group	186
@NP	RIDDELL1	186
@NP	1Spinal Cord Group	195
@NP	Institute	215
@NP	Neuroscience & Psychology	228
@NP	College of Medical	255
@NP	College	255
@NP	Medical	266
@NP	Veterinary and Life Sciences	275
@NP	Veterinary	275
@NP	Life Sciences	290
@NP	University of Glasgow	305
@NP	University	305
@NP	Glasgow	319
@NP	Glasgow	328
@NP	G12 8QQ	337
@NP	United Kingdom 2Glial Cell Biology Group	346
@NP	Institute of Infection , Immunity and Inflammation	388
@NP	Institute	388
@NP	Infection , Immunity and Inflammation	401
@NP	College of Medical	439
@NP	College	439
@NP	Medical	450
@NP	Veterinary and Life Sciences	459
@NP	Veterinary	459
@NP	Life Sciences	474
@NP	University of Glasgow	489
@NP	University	489
@NP	Glasgow	503
@NP	Glasgow	512
@NP	G12 8TA	521
@NP	United Kingdom ABSTRACT Cell transplantation	530
@NP	one strategy for encouraging regeneration	579
@NP	one strategy	579
@NP	encouraging regeneration	596
@NP	spinal cord injury and a range of cell types	627
@NP	spinal cord injury	627
@NP	a range of cell types	650
@NP	a range	650
@NP	cell types	661
@NP	their repair potential	699
@NP	variations in study design	732
@NP	variations	732
@NP	study design	746
@NP	determination of which cells are most effective	770
@NP	determination	770
@NP	cells	793
@NP	this study	822
@NP	we	833
@NP	a direct comparison	853
@NP	the regenerative and integrative properties	876
@NP	several cell preparations	923
@NP	transplantation into the lesioned rat spinal cord	959
@NP	transplantation	959
@NP	the lesioned rat spinal cord	980
@NP	Transplants	1010
@NP	olfactory ensheathing cells -LRB- OECs -RRB-	1045
@NP	olfactory ensheathing cells	1045
@NP	OECs	1074
@NP	ii	1085
@NP	fibroblast-like cells	1089
@NP	olfactory bulb -LRB- OBFB-L -RRB-	1117
@NP	olfactory bulb	1117
@NP	OBFB-L	1133
@NP	iii	1143
@NP	a 50:50 mixture	1148
@NP	-LRB- i -RRB- and -LRB- ii -RRB- -LRB- OEC/OBFB-L -RRB-	1167
@NP	-LRB- i -RRB-	1167
@NP	ii	1176
@NP	-LRB- OEC/OBFB-L -RRB-	1180
@NP	iv	1195
@NP	nasal mucosa -LRB- OM -RRB- , -LRB- v -RRB-	1211
@NP	nasal mucosa -LRB- OM -RRB-	1211
@NP	nasal mucosa	1211
@NP	OM	1225
@NP	v	1231
@NP	peripheral nerve Schwann cells -LRB- SCs -RRB- , -LRB- vi -RRB-	1243
@NP	peripheral nerve Schwann cells -LRB- SCs -RRB-	1243
@NP	peripheral nerve Schwann cells	1243
@NP	SCs	1275
@NP	vi	1282
@NP	peripheral nerve fibroblasts	1286
@NP	vii	1321
@NP	skin fibroblasts	1326
@NP	SF	1344
@NP	All transplants	1349
@NP	axonal regeneration	1375
@NP	OECs and SCs	1396
@NP	the greatest regeneration	1418
@NP	OBFB-like cells	1450
@NP	least efficient and mixed cell populations	1471
@NP	purified populations	1539
@NP	Tract-tracing experiments	1561
@NP	none of the cell types	1605
@NP	none	1605
@NP	the cell types	1613
@NP	regeneration	1637
@NP	the lesion	1657
@NP	all cell types	1678
@NP	cavity formation	1703
@NP	the extent of astrocytic hypertrophy	1721
@NP	the extent	1721
@NP	astrocytic hypertrophy	1735
@NP	GFAP immunoreactivity -LRB- IR -RRB-	1759
@NP	GFAP immunoreactivity	1759
@NP	IR	1782
@NP	the transplant/lesion site -RSB- differed markedly	1789
@NP	the transplant/lesion site	1789
@NP	OECs and SCs	1836
@NP	the least GFAP-IR	1870
@NP	fibroblasts and fibroblast-like cells	1889
@NP	fibroblasts	1889
@NP	fibroblast-like cells	1905
@NP	greater GFAP-IR	1939
@NP	hypertrophy surrounding transplants of OM	1961
@NP	hypertrophy	1961
@NP	transplants of OM	1985
@NP	transplants	1985
@NP	OM	2000
@NP	These differences in host-transplant reactivity	2023
@NP	These differences	2023
@NP	host-transplant reactivity	2044
@NP	cells	2103
@NP	normal spinal cord	2114
@NP	the cellular interaction	2139
@NP	injury	2186
@NP	purified glial cells	2200
@NP	advantages for transplant-mediated repair	2226
@NP	advantages	2226
@NP	transplant-mediated repair	2241
@NP	maximal support	2279
@NP	axonal regeneration	2299
@NP	a minimal astrocytic reaction around the transplant site	2324
@NP	a minimal astrocytic reaction	2324
@NP	the transplant site	2361
@NP	INTRODUCTION Spinal cord injury	2383
@NP	INTRODUCTION	2383
@NP	Spinal cord injury	2396
@NP	the loss of conduction in axonal pathways	2426
@NP	the loss	2426
@NP	conduction in axonal pathways	2438
@NP	conduction	2438
@NP	axonal pathways	2452
@NP	the spinal cord	2493
@NP	This	2510
@NP	permanent deficits of sensory , motor , and autonomic function	2524
@NP	permanent deficits	2524
@NP	sensory , motor , and autonomic function	2546
@NP	sensory	2546
@NP	motor	2555
@NP	autonomic function	2566
@NP	these axonal pathways	2608
@NP	The failure of axonal regeneration within the CNS	2649
@NP	The failure	2649
@NP	axonal regeneration within the CNS	2664
@NP	axonal regeneration	2664
@NP	the CNS	2691
@NP	the presence of inhibitory signals	2730
@NP	the presence	2730
@NP	inhibitory signals	2746
@NP	absence of stimulatory signals in the lesion environment	2769
@NP	absence	2769
@NP	stimulatory signals in the lesion environment	2780
@NP	stimulatory signals	2780
@NP	the lesion environment	2803
@NP	Fawcett , 2006 ; Fitch and Silver , 2008 ; Hollis and Tuszynski , 2011	2827
@NP	Fawcett	2827
@NP	2006 ; Fitch and Silver , 2008 ; Hollis and Tuszynski	2836
@NP	2006	2836
@NP	Fitch and Silver , 2008 ; Hollis and Tuszynski	2842
@NP	Fitch and Silver	2842
@NP	2008	2860
@NP	Hollis	2866
@NP	Tuszynski	2877
@NP	2011	2888
@NP	The use	2895
@NP	cell transplants for promoting axonal regeneration and spinal cord repair	2906
@NP	cell transplants	2906
@NP	axonal regeneration and spinal cord repair	2937
@NP	axonal regeneration	2937
@NP	spinal cord repair	2961
@NP	an active area of investigation for several decades	2989
@NP	an active area	2989
@NP	investigation for several decades	3007
@NP	investigation	3007
@NP	several decades	3025
@NP	recent advances in glial	3046
@NP	recent advances	3046
@NP	stem cell biology	3075
@NP	a proliferation of cell types with the potential	3106
@NP	a proliferation	3106
@NP	cell types with the potential	3125
@NP	cell types	3125
@NP	the potential	3141
@NP	repair	3166
@NP	Investigations	3174
@NP	stem cells	3213
@NP	varying origins	3227
@NP	Louro and Pearse , 2008 ; Nandoe Tewarie et al. , 2010 ; Tetzlaff et al. , 2011	3244
@NP	Louro and Pearse	3244
@NP	2008 ; Nandoe Tewarie et al. , 2010 ; Tetzlaff et al.	3262
@NP	2008	3262
@NP	Nandoe Tewarie et al. , 2010 ; Tetzlaff et al.	3268
@NP	Nandoe Tewarie	3268
@NP	et al. , 2010 ; Tetzlaff et al.	3283
@NP	et al. , 2010	3283
@NP	et al.	3283
@NP	2010	3291
@NP	Tetzlaff et al.	3297
@NP	Tetzlaff	3297
@NP	et al.	3306
@NP	2011	3314
@NP	cells from the peripheral nervous system -LSB- e.g.	3321
@NP	cells	3321
@NP	the peripheral nervous system -LSB- e.g.	3332
@NP	the peripheral nervous system	3332
@NP	e.g.	3363
@NP	Schwann cells	3369
@NP	SCs	3384
@NP	specialized glial cells	3440
@NP	the olfactory system where sensory neurons regenerate throughout life	3473
@NP	the olfactory system	3473
@NP	sensory neurons	3500
@NP	life	3538
@NP	Raisman and Li 2007 ; Barnett and Riddell 2007	3544
@NP	Raisman and Li 2007 ; Barnett and Riddell	3544
@NP	Raisman and Li 2007	3544
@NP	Raisman	3544
@NP	Li 2007	3556
@NP	Barnett and Riddell	3565
@NP	Barnett	3565
@NP	Riddell	3577
@NP	2007	3585
@NP	Fibroblasts obtained from various tissues	3592
@NP	Fibroblasts	3592
@NP	various tissues	3618
@NP	a cell scaffold	3681
@NP	axonal regeneration	3712
@NP	combination	3735
@NP	other therapies	3752
@NP	e.g. , neurotrophins , Grill et al. , 1997 ; Lu and Tuszynski , 2008	3769
@NP	e.g. , neurotrophins	3769
@NP	e.g.	3769
@NP	neurotrophins	3775
@NP	Grill et al.	3790
@NP	Grill	3790
@NP	et al.	3796
@NP	1997 ; Lu and Tuszynski , 2008	3804
@NP	1997	3804
@NP	Lu and Tuszynski , 2008	3810
@NP	Lu and Tuszynski	3810
@NP	2008	3828
@NP	they	3854
@NP	any identified intrinsic growth promoting properties	3864
@NP	any identified intrinsic growth	3864
@NP	properties	3906
@NP	there	3927
@NP	general agreement	3936
@NP	several cell types	3959
@NP	axonal regeneration	4004
@NP	the transplant environment	4031
@NP	some degree	4061
@NP	there	4074
@NP	varying and even contradictory reports of the extent of their repair potential	4084
@NP	varying	4084
@NP	even contradictory reports of the extent of their repair potential	4096
@NP	even contradictory reports	4096
@NP	the extent of their repair potential	4126
@NP	the extent	4126
@NP	their repair potential	4140
@NP	it	4167
@NP	cell type	4189
@NP	the best support for axonal regeneration	4208
@NP	the best support	4208
@NP	axonal regeneration	4229
@NP	A problem in making any such comparison	4250
@NP	A problem	4250
@NP	any such comparison	4270
@NP	the wide variation in study designs employed	4293
@NP	the wide variation	4293
@NP	study designs employed	4315
@NP	study designs	4315
@NP	Different lesion models	4339
@NP	regeneration of different systems of spinal cord fibers	4382
@NP	regeneration	4382
@NP	different systems of spinal cord fibers	4398
@NP	different systems	4398
@NP	spinal cord fibers	4419
@NP	Few studies	4457
@NP	the extent of regeneration of these different cell transplants	4492
@NP	the extent	4492
@NP	regeneration of these different cell transplants	4506
@NP	regeneration	4506
@NP	these different cell transplants	4522
@NP	the same experimental conditions	4561
@NP	The first aim of this study	4595
@NP	The first aim	4595
@NP	this study	4612
@NP	the ability of several candidate cell types	4648
@NP	the ability	4648
@NP	several candidate cell types	4663
@NP	axonal regeneration	4703
@NP	one cell type	4774
@NP	a greater potential than another	4792
@NP	a greater potential	4792
@NP	another	4817
@NP	The comparison	4826
@NP	cells that would be suitable for autologous transplantation	4870
@NP	cells	4870
@NP	autologous transplantation	4903
@NP	some reports	4934
@NP	mixtures of cells	4967
@NP	mixtures	4967
@NP	cells	4979
@NP	an advantage -LRB- Li et al. , 2005a -RRB-	4994
@NP	an advantage	4994
@NP	Li	5008
@NP	et al. , 2005a	5011
@NP	et al.	5011
@NP	2005a	5019
@NP	some cases	5033
@NP	transplantation	5045
@NP	complete tissues -LRB- e.g. , olfactory mucosa , Lu et al. , 2001 -RRB-	5064
@NP	complete tissues	5064
@NP	e.g. , olfactory mucosa	5082
@NP	e.g.	5082
@NP	olfactory mucosa	5088
@NP	Lu et al. , 2001	5106
@NP	Lu	5106
@NP	et al.	5109
@NP	2001	5117
@NP	we	5143
@NP	our choice	5158
@NP	cells , non-neural cells which may contaminate glial cell preparations	5172
@NP	cells	5172
@NP	non-neural cells which may contaminate glial cell preparations	5179
@NP	non-neural cells	5179
@NP	glial cell preparations	5218
@NP	cells	5243
@NP	glial cells in mixed cell transplants	5288
@NP	glial cells	5288
@NP	mixed cell transplants	5303
@NP	cells which would be contained in tissue transplants	5330
@NP	cells	5330
@NP	tissue transplants	5364
@NP	some cases	5387
@NP	mixtures of glial and non-neural cells	5399
@NP	mixtures	5399
@NP	glial and non-neural cells	5411
@NP	axonal regeneration	5472
@NP	candidate cells for transplant	5493
@NP	candidate cells	5493
@NP	transplant	5513
@NP	CNS repair	5533
@NP	the host spinal cord	5581
@NP	endogenous glial cells	5624
@NP	the glial scar	5673
@NP	there	5698
@NP	evidence	5707
@NP	olfactory ensheathing cells -LRB- OECs -RRB-	5721
@NP	olfactory ensheathing cells	5721
@NP	OECs	5750
@NP	more	5765
@NP	astrocytes than SCs	5785
@NP	astrocytes	5785
@NP	SCs	5801
@NP	spinal cord tissue	5847
@NP	Ghirnikar and Eng , 1994 ; Lakatos et al. , 2000 ; Santos-Silva et al. , 2007	5867
@NP	Ghirnikar and Eng	5867
@NP	1994 ; Lakatos et al. , 2000 ; Santos-Silva et al.	5886
@NP	1994	5886
@NP	Lakatos et al. , 2000 ; Santos-Silva et al.	5892
@NP	Lakatos	5892
@NP	et al. , 2000 ; Santos-Silva et al.	5900
@NP	et al. , 2000	5900
@NP	et al.	5900
@NP	2000	5908
@NP	Santos-Silva et al.	5914
@NP	Santos-Silva	5914
@NP	et al.	5927
@NP	2007	5935
@NP	little	5942
@NP	other candidate cell types	5964
@NP	A further aim of this study	5992
@NP	A further aim	5992
@NP	this study	6009
@NP	different candidates for cell transplantation	6052
@NP	different candidates	6052
@NP	cell transplantation	6077
@NP	the host spinal cord	6113
@NP	others	6154
@NP	Our study	6162
@NP	a diverse range of cell types	6183
@NP	a diverse range	6183
@NP	cell types	6202
@NP	substantial axonal regeneration	6239
@NP	none of those tested	6279
@NP	none	6279
@NP	those tested	6287
@NP	those	6287
@NP	regeneration	6308
@NP	the lesion	6328
@NP	we	6364
@NP	certain cell types	6382
@NP	marked astrocytosis	6408
@NP	the host spinal cord at the transplant site	6431
@NP	the host spinal cord	6431
@NP	the transplant site	6455
@NP	This	6476
@NP	cells that are potential contaminants of glial cell populations	6490
@NP	cells	6490
@NP	potential contaminants of glial cell populations	6505
@NP	potential contaminants	6505
@NP	glial cell populations	6531
@NP	Selection of the optimum cells for transplant	6555
@NP	Selection	6555
@NP	the optimum cells for transplant	6568
@NP	the optimum cells	6568
@NP	transplant	6590
@NP	repair of spinal cord injuries	6610
@NP	repair	6610
@NP	spinal cord injuries	6620
@NP	account	6668
@NP	the regenerative properties of candidate cells	6685
@NP	the regenerative properties	6685
@NP	candidate cells	6716
@NP	their ability to integrate favorably within the host neuropil	6741
@NP	the host neuropil	6785
@NP	MATERIALS AND METHODS Animals Fisher 344 rats	6804
@NP	MATERIALS	6804
@NP	METHODS Animals Fisher 344 rats	6818
@NP	METHODS Animals	6818
@NP	Fisher 344 rats	6834
@NP	Harlan	6851
@NP	Loughborough	6859
@NP	UK	6873
@NP	both cell preparation and transplantation	6891
@NP	both cell preparation	6891
@NP	transplantation	6917
@NP	Olfactory mucosa , olfactory bulbs and sciatic nerves	6934
@NP	Olfactory mucosa	6934
@NP	olfactory bulbs	6952
@NP	sciatic nerves	6972
@NP	postnatal day 7 -LRB- P7 -RRB- rats	7006
@NP	day 7	7016
@NP	P7	7023
@NP	transplants	7038
@NP	syngeneic adult male animals -LRB- 200 -- 250 g -RRB-	7068
@NP	syngeneic adult male animals	7068
@NP	200 -- 250 g	7098
@NP	200	7098
@NP	250 g	7102
@NP	All experimental procedures	7110
@NP	the Ethical Review Panel of the University of Glasgow	7155
@NP	the Ethical Review Panel	7155
@NP	the University of Glasgow	7183
@NP	the University	7183
@NP	Glasgow	7201
@NP	accordance with the UK Animals -LRB- Scientific Procedures -RRB-	7226
@NP	accordance	7226
@NP	the UK Animals -LRB- Scientific Procedures -RRB-	7242
@NP	the UK Animals	7242
@NP	Scientific Procedures	7258
@NP	Act 1986	7281
@NP	Cell Cultures Primary olfactory mucosal cell culture Olfactory mucosal cells	7291
@NP	Cell Cultures	7291
@NP	Primary olfactory mucosal cell culture Olfactory mucosal cells	7305
@NP	Tome	7409
@NP	et al. -LRB- 2009 -RRB-	7414
@NP	et al.	7414
@NP	2009	7422
@NP	olfactory bulbs	7438
@NP	the heads of postnatal day 7 -LRB- P7 -RRB- rats	7472
@NP	the heads	7472
@NP	postnatal day 7 -LRB- P7 -RRB- rats	7485
@NP	day 7	7495
@NP	P7	7502
@NP	The head	7512
@NP	each turbinate	7548
@NP	forceps	7578
@NP	cold Hank 's balanced salt solution -LRB- HBSS , Invitrogen , Paisley , UL -RRB-	7600
@NP	cold Hank 's balanced salt solution	7600
@NP	cold Hank 's	7600
@NP	HBSS	7636
@NP	Invitrogen	7642
@NP	Paisley , UL	7654
@NP	The olfactory mucosa	7668
@NP	the turbinate with forceps	7708
@NP	the turbinate	7708
@NP	forceps	7727
@NP	the microscope	7741
@NP	a scalpel	7784
@NP	The tissue obtained from 7 to 9 animals	7795
@NP	The tissue	7795
@NP	7 to 9 animals	7820
@NP	1.33 % collagenase -LRB- Sigma , Dorset , UK -RRB-	7861
@NP	1.33 % collagenase	7861
@NP	Sigma	7880
@NP	Dorset	7887
@NP	UK	7895
@NP	37 C in a 7 % CO2 incubator for 20 min	7902
@NP	37 C	7902
@NP	a 7 % CO2 incubator for 20 min	7910
@NP	a 7 % CO2 incubator	7910
@NP	20 min	7933
@NP	Soybean trypsin inhibitor and DNAse	7957
@NP	SD , 0.52 mg/mL soybean trypsin inhibitor	7994
@NP	SD	7994
@NP	0.52 mg/mL soybean trypsin inhibitor	7998
@NP	0.52 mg/mL	7998
@NP	soybean trypsin inhibitor	8009
@NP	0.04 mg/mL bovine pancreas DNAse	8036
@NP	0.04 mg/mL	8036
@NP	bovine pancreas DNAse	8047
@NP	3.0 mg/mL bovine serum albumin-fraction A	8070
@NP	3.0 mg/mL	8070
@NP	bovine serum albumin-fraction A	8080
@NP	L15 , Sigma	8115
@NP	L15	8115
@NP	Sigma	8120
@NP	cell clumping	8137
@NP	The cells	8152
@NP	several times	8199
@NP	a 10 µg/cm2 collagen-coated T25 flask -LRB- Greiner Bio-one -RRB-	8227
@NP	a 10 µg/cm2 collagen-coated T25 flask	8227
@NP	10 µg/cm2	8229
@NP	Greiner Bio-one	8266
@NP	DMEM/F12 -LRB- 1:1 , Invitrogen -RRB-	8288
@NP	DMEM/F12	8288
@NP	1:1	8298
@NP	Invitrogen	8303
@NP	EGF	8333
@NP	20 ng/mL , mouse epidermal growth factor , R&D systems , Abingdon , UK	8338
@NP	20 ng/mL , mouse epidermal growth factor , R&D systems	8338
@NP	Abingdon , UK	8392
@NP	FGF2 -LRB- 50 ng/mL Peprotech , London UK -RRB-	8407
@NP	FGF2	8407
@NP	50 ng/mL Peprotech , London UK	8413
@NP	50 ng/mL Peprotech	8413
@NP	London UK	8433
@NP	LIF	8448
@NP	103 units/mL , leukemia inhibitory factor , Chemicon International	8453
@NP	103 units/mL	8453
@NP	leukemia inhibitory factor	8467
@NP	Chemicon International	8495
@NP	8	8523
@NP	10 days before transplantation	8525
@NP	10 days	8525
@NP	transplantation	8540
@NP	The cultures	8557
@NP	37 °C in a 7 % CO2 incubator	8589
@NP	37 °C	8589
@NP	a 7 % CO2 incubator	8597
@NP	the medium	8620
@NP	every 2 -- 3 days	8643
@NP	every 2	8643
@NP	3 days	8651
@NP	OECs and SCs	8668
@NP	OECs and SCs	8681
@NP	P7 rat pups -LRB- Lakatos et al. , 2000 -RRB-	8737
@NP	P7 rat pups	8737
@NP	Lakatos	8750
@NP	et al. , 2000	8758
@NP	et al.	8758
@NP	2000	8766
@NP	PLL-coated flasks -LRB- 13.3 µg/mL ; Sigma -RRB-	8790
@NP	PLL-coated flasks	8790
@NP	13.3 µg/mL ; Sigma	8809
@NP	13.3 µg/mL	8809
@NP	Sigma	8821
@NP	SCs	9366
@NP	DMEM-FBS	9389
@NP	forskolin -LRB- 1026 M -RRB-	9409
@NP	forskolin	9409
@NP	1026 M	9420
@NP	heregulin beta-1 -LRB- Hrgb1 , 20 ng/mL ; R&D Systems -RRB-	9432
@NP	heregulin beta-1	9432
@NP	Hrgb1 , 20 ng/mL ; R&D Systems	9450
@NP	Hrgb1	9450
@NP	20 ng/mL ; R&D Systems	9457
@NP	20 ng/mL	9457
@NP	R&D Systems	9467
@NP	Fibroblast-like cells	9481
@NP	olfactory bulbs	9508
@NP	Fibroblast-like cells	9524
@NP	olfactory bulbs of P7 rats	9565
@NP	olfactory bulbs	9565
@NP	P7 rats	9584
@NP	methods	9598
@NP	those	9615
@NP	Li	9629
@NP	et al. -LRB- 2003 -RRB-	9632
@NP	et al.	9632
@NP	2003	9640
@NP	The olfactory bulbs	9647
@NP	the preparation of cell suspension	9729
@NP	the preparation	9729
@NP	cell suspension	9748
@NP	purified OECs	9768
@NP	dissociation and treatment with SD	9789
@NP	dissociation and treatment	9789
@NP	SD	9821
@NP	the cells	9824
@NP	12,000 rpm	9854
@NP	25 cm3 tissue culture flasks containing DMEM-FBS	9881
@NP	25 cm3 tissue culture flasks	9881
@NP	DMEM-FBS	9921
@NP	Cells	9931
@NP	three times a week	9946
@NP	three times	9946
@NP	a week	9958
@NP	time , usually 3 -- 4 weeks	9999
@NP	time	9999
@NP	3	10013
@NP	4 weeks	10015
@NP	fibroblast-like cells	10023
@NP	the major cell type in the cultures	10054
@NP	the major cell type	10054
@NP	the cultures	10077
@NP	lack of p75NTR expression and expression of thy1 .1	10105
@NP	lack	10105
@NP	p75NTR expression and expression	10113
@NP	thy1 .1	10149
@NP	muscle actin -LRB- SMA -RRB- -LRB- Fig. 1 -RRB-	10167
@NP	muscle actin -LRB- SMA -RRB-	10167
@NP	muscle actin	10167
@NP	SMA	10181
@NP	Fig. 1	10187
@NP	Peripheral nerve fibroblasts Peripheral nerve fibroblast -LRB- PNFB -RRB-	10196
@NP	Peripheral nerve fibroblasts Peripheral nerve fibroblast	10196
@NP	Peripheral nerve fibroblasts	10196
@NP	Peripheral nerve fibroblast	10225
@NP	PNFB	10254
@NP	a similar method	10277
@NP	that described by Keyvan-Fouladi et al -LRB- 2003 , 2005 -RRB-	10297
@NP	that	10297
@NP	Keyvan-Fouladi	10315
@NP	et al -LRB- 2003 , 2005 -RRB-	10330
@NP	et al	10330
@NP	2003	10337
@NP	2005	10343
@NP	The initial stages of this process	10350
@NP	The initial stages	10350
@NP	this process	10372
@NP	the preparation	10400
@NP	SCs	10419
@NP	peripheral nerve , but whereas fibroblasts are removed from the SC cultures	10428
@NP	peripheral nerve	10428
@NP	fibroblasts	10458
@NP	the SC	10487
@NP	they	10509
@NP	The sciatic nerves of P7 rats	10540
@NP	The sciatic nerves	10540
@NP	P7 rats	10562
@NP	collagenase -LRB- 1.33 % -RRB-	10606
@NP	collagenase	10606
@NP	1.33 %	10619
@NP	15 min followed by trypsin -LRB- 0.25 % Sigma -RRB- for 15 min	10630
@NP	15 min	10630
@NP	trypsin -LRB- 0.25 % Sigma -RRB- for 15 min	10649
@NP	trypsin -LRB- 0.25 % Sigma -RRB-	10649
@NP	trypsin	10649
@NP	0.25 % Sigma	10658
@NP	0.25 %	10658
@NP	Sigma	10664
@NP	15 min	10675
@NP	dissociation and treatment with SD	10689
@NP	dissociation and treatment	10689
@NP	SD	10721
@NP	the cells	10724
@NP	12,000 rpm	10754
@NP	25 cm3 tissue culture flasks containing 10 % DMEM-FBS	10781
@NP	25 cm3 tissue culture flasks	10781
@NP	10 % DMEM-FBS	10821
@NP	Cells	10835
@NP	three times a week	10850
@NP	three times	10850
@NP	a week	10862
@NP	time	10903
@NP	the non purified olfactory bulb cells	10916
@NP	the non	10916
@NP	olfactory bulb cells	10933
@NP	fibroblast-like cells	10955
@NP	the major cell type	10984
@NP	the cultures	11007
@NP	lack of p75NTR expression and expression of thy1 .1 and SMA -LRB- Fig. 1 -RRB-	11035
@NP	lack	11035
@NP	p75NTR expression and expression	11043
@NP	thy1 .1 and SMA -LRB- Fig. 1 -RRB-	11079
@NP	thy1 .1 and SMA	11079
@NP	Fig. 1	11095
@NP	Skin fibroblasts Skin fibroblasts -LRB- SFs -RRB-	11104
@NP	Skin fibroblasts Skin fibroblasts	11104
@NP	Skin fibroblasts	11104
@NP	Skin fibroblasts	11121
@NP	SFs	11139
@NP	fromP7 Fischer rats using a protocol modified from Tuszynski et al. , 1996	11158
@NP	fromP7 Fischer rats	11158
@NP	a protocol modified from Tuszynski	11184
@NP	a protocol	11184
@NP	Tuszynski	11209
@NP	et al. , 1996	11219
@NP	et al.	11219
@NP	1996	11227
@NP	skin biopsies measuring 10 3 10 mm3 in size	11242
@NP	skin biopsies	11242
@NP	10 3 10 mm3 in size	11266
@NP	10 3 10 mm3	11266
@NP	size	11281
@NP	the abdominal region	11305
@NP	The biopsies	11327
@NP	131mm3 pieces	11363
@NP	the surface of PLL-coated wells of a 24 well dish	11390
@NP	the surface	11390
@NP	PLL-coated wells of a 24 well dish	11405
@NP	PLL-coated wells	11405
@NP	a 24 well dish	11425
@NP	DMEMFBS	11456
@NP	a week	11471
@NP	fibroblasts	11478
@NP	fromthe explant	11499
@NP	cellswere	11519
@NP	culture	11559
@NP	Characterization of cell cultures	11568
@NP	Characterization	11568
@NP	cell cultures	11588
@NP	passage	11605
@NP	an aliquot of cells	11614
@NP	an aliquot	11614
@NP	cells	11628
@NP	PLL coated coverslips	11650
@NP	the same optimal culture conditions	11678
@NP	cells	11730
@NP	markers that characterize the various cell types	11760
@NP	markers	11760
@NP	the various cell types	11786
@NP	Preparation for transplantation	11810
@NP	Preparation	11810
@NP	transplantation	11826
@NP	the day of cell transplantation	11845
@NP	the day	11845
@NP	cell transplantation	11856
@NP	the various cell types	11878
@NP	the flask	11923
@NP	centrifugation	11958
@NP	300g	11976
@NP	5 min	11985
@NP	Cells	11992
@NP	ice	12011
@NP	transplantation	12021
@NP	immunocytochemical characterization of the transplanted cells	12042
@NP	immunocytochemical characterization	12042
@NP	the transplanted cells	12081
@NP	a sample of each cell culture	12105
@NP	a sample	12105
@NP	each cell culture	12117
@NP	PLL coated coverslips	12151
@NP	olfactory mucosal cells	12184
@NP	10 µg/cm2 collagen I-coated coverslips	12231
@NP	10 µg/cm2 collagen	12231
@NP	I-coated coverslips	12250
@NP	Immunocytochemisty Characterization and assessment	12271
@NP	the purity of cell cultures	12325
@NP	the purity	12325
@NP	cell cultures	12339
@NP	cells plated on PLL coated coverslips	12372
@NP	cells	12372
@NP	PLL coated coverslips	12388
@NP	The same methods and panel of markers	12411
@NP	The same methods	12411
@NP	panel of markers	12432
@NP	panel	12432
@NP	markers	12441
@NP	label cells prepared at passage and at the time of transplantation	12461
@NP	label cells	12461
@NP	passage	12485
@NP	the time of transplantation	12500
@NP	the time	12500
@NP	transplantation	12512
@NP	The primary antibody	12926
@NP	the appropriate fluorochrome-conjugated secondary antibody	12963
@NP	methanol for 20 min	13035
@NP	methanol	13035
@NP	20 min	13048
@NP	220 C.	13058
@NP	several washes	13071
@NP	the intracellular-antigen antibodies	13087
@NP	their appropriate secondary antibodies	13147
@NP	Primary antibodies	13187
@NP	60 min and secondary antibodies for 30 min	13221
@NP	60 min and secondary antibodies	13221
@NP	30 min	13257
@NP	room temperature -LRB- RT -RRB-	13272
@NP	room temperature	13272
@NP	RT	13290
@NP	Secondary antibodies	13295
@NP	fluorescein or rhodamine	13335
@NP	Southern Biotechniques	13361
@NP	Cambridge Biosciences	13385
@NP	1:100	13420
@NP	HBSS	13427
@NP	5 %	13443
@NP	donor calf serum -LRB- AutogenBioclear , UK -RRB-	13446
@NP	donor calf serum	13446
@NP	AutogenBioclear	13464
@NP	UK	13481
@NP	Hepes -LRB- Gibco , Invitrogen -RRB-	13490
@NP	Hepes	13490
@NP	Gibco	13497
@NP	Invitrogen	13504
@NP	staining solution	13529
@NP	the antibody stocks and wash between incubations	13557
@NP	the antibody stocks and wash	13557
@NP	incubations	13594
@NP	Cells on coverslips	13607
@NP	Cells	13607
@NP	coverslips	13616
@NP	VectaShield -LRB- Vector laboratories , Peterborough , UK -RRB-	13643
@NP	VectaShield	13643
@NP	Vector laboratories	13656
@NP	Peterborough	13677
@NP	UK	13691
@NP	2-phenylindole-dihydrochloride -LRB- DAPI -RRB-	13721
@NP	2-phenylindole-dihydrochloride	13721
@NP	DAPI	13753
@NP	nuclei	13772
@NP	Image Analysis Immunofluorescence images of the different cell type cultures	13780
@NP	Image Analysis Immunofluorescence images	13780
@NP	the different cell type cultures	13824
@NP	a Zeiss Axioskop 50B epifluorescence microscope	13874
@NP	a CCD camera -LRB- Princeton Instruments -RRB-	13936
@NP	a CCD camera	13936
@NP	Princeton Instruments	13950
@NP	Metamorph 6.1 software -LRB- Molecular Devices Ltd , Berkshire , UK -RRB-	13977
@NP	Metamorph 6.1 software	13977
@NP	Molecular Devices Ltd , Berkshire , UK	14001
@NP	Cell type quantification	14040
@NP	all cell cultures	14084
@NP	each experiment	14106
@NP	a minimum of two coverslips	14123
@NP	a minimum	14123
@NP	two coverslips	14136
@NP	each cell marker	14169
@NP	a minimum of 400 DAPI labeled nuclei counted per coverslip	14191
@NP	a minimum	14191
@NP	400 DAPI labeled nuclei counted per coverslip	14204
@NP	400 DAPI	14204
@NP	nuclei counted per coverslip	14221
@NP	nuclei	14221
@NP	coverslip	14240
@NP	Data for each marker	14251
@NP	Data	14251
@NP	each marker	14260
@NP	4 to 5 separate experiments	14290
@NP	Lesioning and Cell Transplantation Thirty-three adult male Fischer 344 rats	14319
@NP	Lesioning and Cell	14319
@NP	Thirty-three adult male Fischer 344 rats	14354
@NP	a bilateral dorsal column lesion	14413
@NP	a wire knife device	14452
@NP	David Kopf Instruments	14473
@NP	Tujunga	14497
@NP	Toft	14531
@NP	et al. , 2007	14536
@NP	et al.	14536
@NP	2007	14544
@NP	animals	14560
@NP	halothane and the L3/4	14592
@NP	halothane	14592
@NP	the L3/4	14606
@NP	spinal segmental border exposed by laminectomy	14615
@NP	spinal segmental border	14615
@NP	laminectomy	14650
@NP	The wire knife	14663
@NP	the left dorsal root entry zone	14696
@NP	an arc encompassing the dorsal columns	14747
@NP	an arc	14747
@NP	the dorsal columns	14767
@NP	a glass rod	14805
@NP	the surface of the cord	14827
@NP	the surface	14827
@NP	the cord	14842
@NP	the dorsal columns	14868
@NP	the same operation	14891
@NP	animals	14915
@NP	dextran amine	14942
@NP	BDA	14957
@NP	tract tracer	14962
@NP	regeneration	15005
@NP	the left L3 dorsal root	15031
@NP	order	15066
@NP	the possibility	15081
@NP	tracer being transported along anastomosing afferent fibers in adjacent roots	15100
@NP	tracer	15100
@NP	afferent fibers	15144
@NP	adjacent roots	15163
@NP	Cells	15179
@NP	the gap	15208
@NP	the wire knife	15227
@NP	injection	15273
@NP	a cell suspension as described previously -LRB- Toft et al. , 2007 -RRB-	15286
@NP	a cell suspension	15286
@NP	Toft	15329
@NP	et al. , 2007	15334
@NP	et al.	15334
@NP	2007	15342
@NP	cell suspensions	15358
@NP	a glass pipette	15395
@NP	a fine beveled tip -LRB- inside diameter 60 -- 70 µm -RRB-	15416
@NP	a fine beveled tip	15416
@NP	diameter 60 -- 70 µm	15443
@NP	diameter 60	15443
@NP	70 µm	15455
@NP	The pipette	15463
@NP	the lesion	15493
@NP	small slits in the dura either side of the central vein	15512
@NP	small slits	15512
@NP	the dura either side of the central vein	15527
@NP	the dura	15527
@NP	either side of the central vein	15536
@NP	either side	15536
@NP	the central vein	15551
@NP	Cell suspensions	15569
@NP	approximately 100,000	15602
@NP	cells/µL	15624
@NP	brief pressure pulses	15659
@NP	Picoinjector	15682
@NP	WPI	15696
@NP	Sarasota	15701
@NP	the course	15716
@NP	several minutes , during which the pipette was gradually raised to the surface	15730
@NP	several minutes	15730
@NP	the pipette	15760
@NP	the surface	15796
@NP	cells	15812
@NP	the lesion	15849
@NP	The lesion site	15861
@NP	10-0	15894
@NP	Ethicon	15900
@NP	Johnson and Johnson	15909
@NP	surgical sutures	15930
@NP	the dura	15956
@NP	Wounds	15966
@NP	layers and animals	15988
@NP	an analgesic -LRB- Vetergesic , Alstoe , UK ; 0.06 mg , s.c. -RRB-	16026
@NP	an analgesic	16026
@NP	Vetergesic , Alstoe	16040
@NP	Vetergesic	16040
@NP	Alstoe	16052
@NP	UK ; 0.06 mg , s.c.	16060
@NP	UK	16060
@NP	0.06 mg , s.c.	16064
@NP	0.06 mg	16064
@NP	s.c.	16073
@NP	Intercellular Interaction in Nonlesioned Cord	16080
@NP	Intercellular Interaction	16080
@NP	Nonlesioned Cord	16109
@NP	addition to the dorsal column lesioned animals	16129
@NP	addition	16129
@NP	the dorsal column lesioned animals	16141
@NP	cells	16177
@NP	the spinal cords of 11 normal uninjured animals	16207
@NP	the spinal cords	16207
@NP	11 normal uninjured animals	16227
@NP	the direct interaction between the transplanted cells and the host astrocytes	16266
@NP	the direct interaction	16266
@NP	the transplanted cells and the host astrocytes	16297
@NP	the transplanted cells	16297
@NP	the host astrocytes	16324
@NP	Animals	16345
@NP	halothane	16377
@NP	the fourth lumbar spinal segment	16391
@NP	laminectomy	16435
@NP	the T13/L1 vertebral junction	16450
@NP	Cells	16481
@NP	pressure	16492
@NP	beveled glass pipettes -LRB- inner tip diameter 60 -- 70 µm -RRB-	16518
@NP	beveled glass pipettes	16518
@NP	inner tip diameter	16542
@NP	60 -- 70 µm	16561
@NP	60	16561
@NP	70 µm	16564
@NP	Pipettes	16572
@NP	approximately 1 lL of a thick cell suspension -LRB- ca. 100,000 cells/lL -RRB-	16598
@NP	approximately 1 lL	16598
@NP	a thick cell suspension -LRB- ca. 100,000 cells/lL -RRB-	16620
@NP	a thick cell suspension	16620
@NP	ca. 100,000 cells/lL	16645
@NP	ca.	16645
@NP	100,000 cells/lL	16649
@NP	the left	16685
@NP	dorsal columns	16707
@NP	These sites	16723
@NP	the surface central vein	16764
@NP	the left and right sides of the cord	16792
@NP	the left and right sides	16792
@NP	the cord	16820
@NP	an angle of 25 ° -LRB- pipette tip pointing medially -RRB-	16836
@NP	an angle	16836
@NP	25 °	16848
@NP	pipette tip pointing medially	16853
@NP	pipette tip	16853
@NP	Wounds	16885
@NP	layers and animals	16907
@NP	an analgesic -LRB- Vetergesic , Alstoe , UK ; 0.06 mg , s.c. -RRB-	16949
@NP	an analgesic	16949
@NP	Vetergesic , Alstoe	16963
@NP	Vetergesic	16963
@NP	Alstoe	16975
@NP	UK ; 0.06 mg , s.c.	16983
@NP	UK	16983
@NP	0.06 mg , s.c.	16987
@NP	0.06 mg	16987
@NP	s.c.	16996
@NP	Tract Tracing	17003
@NP	12 animals	17020
@NP	regeneration of ascending dorsal column axons	17032
@NP	regeneration	17032
@NP	dorsal column axons	17058
@NP	tract-tracing	17097
@NP	BDA -LRB- 10,000 MW , product no	17116
@NP	BDA	17116
@NP	10,000 MW	17121
@NP	product	17132
@NP	no	17140
@NP	D-1956	17144
@NP	Invitrogen	17152
@NP	2 weeks	17173
@NP	perfusion	17188
@NP	The left L4 and L5 spinal nerves	17211
@NP	The left L4	17211
@NP	L5 spinal nerves	17227
@NP	the level of the iliac crest	17260
@NP	the level	17260
@NP	the iliac crest	17273
@NP	surgical anaesthesia	17295
@NP	Each nerve	17317
@NP	pressure	17332
@NP	Picoinjector ,	17351
@NP	fine beveled glass pipettes -LRB- tip 40 -- 50 µm internal diameter -RRB-	17384
@NP	fine beveled glass pipettes	17384
@NP	tip 40	17413
@NP	50 µm internal diameter	17420
@NP	50 µm	17420
@NP	internal diameter	17426
@NP	3	17450
@NP	4 lL	17452
@NP	a solution	17460
@NP	20 % BDA in 0.1 M phosphate buffer -LRB- PB -RRB- , with 2 % fast green	17474
@NP	20 % BDA	17474
@NP	0.1 M phosphate buffer -LRB- PB -RRB- , with 2 % fast green	17485
@NP	0.1 M phosphate buffer	17485
@NP	PB	17509
@NP	2 % fast green	17519
@NP	2 %	17519
@NP	spillage of the tracer	17554
@NP	spillage	17554
@NP	the tracer	17566
@NP	injection	17585
@NP	wounds	17596
@NP	layers and analgesia administered as above	17618
@NP	layers and analgesia	17618
@NP	Histological Processing of Spinal Cord	17662
@NP	Histological Processing	17662
@NP	Spinal Cord	17689
@NP	survival periods	17707
@NP	10 days -LRB- cell injections into normal cord -RRB-	17727
@NP	cell injections into normal cord	17736
@NP	cell injections	17736
@NP	normal cord	17757
@NP	6 weeks -LRB- cell transplants into lesioned cord -RRB-	17773
@NP	cell transplants into lesioned cord	17782
@NP	cell transplants	17782
@NP	lesioned cord	17804
@NP	animals	17820
@NP	intraperitoneal sodium pentobarbital	17859
@NP	Euthatal , Vericore , UK ; 200 mg/mL	17897
@NP	Euthatal , Vericore , UK	17897
@NP	200 mg/mL	17921
@NP	the left ventricle	17953
@NP	mammalian Ringer 's solution	17977
@NP	mammalian Ringer 's	17977
@NP	0.1 % lidocaine	18017
@NP	4 % paraformaldehyde	18067
@NP	0.1 M PF , pH 7.4	18090
@NP	0.1 M PF	18090
@NP	pH 7.4	18100
@NP	A block of tissue encompassing the lesion/transplant or injection sites	18108
@NP	A block	18108
@NP	tissue encompassing the lesion/transplant or injection sites	18119
@NP	tissue	18119
@NP	the lesion/transplant or injection sites	18139
@NP	post-fixed overnight in the same fixative	18196
@NP	post-fixed overnight	18196
@NP	the same fixative	18220
@NP	30 % sucrose	18243
@NP	70 µm sections encompassing the lesion/injection sites	18256
@NP	70 µm sections	18256
@NP	the lesion/injection sites	18284
@NP	a freezing microtome	18323
@NP	30 min	18376
@NP	50 % ethanol	18386
@NP	10 min in 0.3 M phosphatebuffered saline -LRB- PBS -RRB-	18414
@NP	10 min	18414
@NP	0.3 M phosphatebuffered saline -LRB- PBS -RRB-	18424
@NP	0.3 M	18424
@NP	saline -LRB- PBS -RRB-	18448
@NP	saline	18448
@NP	PBS	18456
@NP	Sections	18462
@NP	72 h	18495
@NP	4 C in different combinations of the following primary antibodies	18503
@NP	4 C	18503
@NP	different combinations of the following primary antibodies	18510
@NP	different combinations	18510
@NP	the following primary antibodies	18536
@NP	sheep anti-GFP -LRB- Biogenesis ; 1:1,000 -RRB-	18570
@NP	sheep anti-GFP	18570
@NP	Biogenesis ; 1:1,000	18586
@NP	Biogenesis	18586
@NP	1:1,000	18598
@NP	mouse anti-GFAP -LRB- Sigma , UK ; 1:1,000 -RRB-	18608
@NP	mouse anti-GFAP	18608
@NP	Sigma , UK ; 1:1,000	18625
@NP	Sigma , UK	18625
@NP	1:1,000	18636
@NP	rabbit anti-GFAP -LRB- DAKO ; 1:1,000 -RRB-	18646
@NP	rabbit anti-GFAP	18646
@NP	DAKO ; 1:1,000	18664
@NP	DAKO	18664
@NP	1:1,000	18670
@NP	mouse/rabbit anti-NF200 -LRB- 1:1,000 , Sigma -RRB-	18680
@NP	mouse/rabbit anti-NF200	18680
@NP	1:1,000	18705
@NP	Sigma	18714
@NP	mouse anti-nestin -LRB- 1:400 , DSHB , IOWA -RRB-	18722
@NP	mouse anti-nestin	18722
@NP	1:400	18741
@NP	DSHB	18748
@NP	IOWA	18754
@NP	goat anti-P0 -LRB- 1:100 Santa-Cruz -RRB-	18761
@NP	goat anti-P0	18761
@NP	1:100 Santa-Cruz	18775
@NP	1:100	18775
@NP	Santa-Cruz	18781
@NP	rabbit anti-neurofascin -LRB- 1:400 , gift from Prof.	18797
@NP	rabbit anti-neurofascin -LRB- 1:400 , gift	18797
@NP	rabbit anti-neurofascin	18797
@NP	1:400	18822
@NP	gift	18829
@NP	Prof.	18839
@NP	P.	18845
@NP	Brophy , University of Edinburgh , UK -RRB- .	18848
@NP	Brophy , University of Edinburgh , UK -RRB-	18848
@NP	Brophy	18848
@NP	University of Edinburgh , UK -RRB-	18856
@NP	University of Edinburgh	18856
@NP	University	18856
@NP	Edinburgh	18870
@NP	UK	18881
@NP	addition	18889
@NP	tissue where BDA tracer was to be detected	18902
@NP	tissue	18902
@NP	BDA tracer	18915
@NP	streptavidin	18946
@NP	dichloratriazinylamino fluorescein -LRB- DTAF ; 1:1,000 , Jackson -RRB-	18973
@NP	dichloratriazinylamino fluorescein	18973
@NP	DTAF ; 1:1,000 , Jackson	19009
@NP	DTAF	19009
@NP	1:1,000 , Jackson	19015
@NP	1:1,000	19015
@NP	Jackson	19024
@NP	place of one of the antibodies in the primary antibody cocktail	19052
@NP	place	19052
@NP	one of the antibodies in the primary antibody cocktail	19061
@NP	one	19061
@NP	the antibodies in the primary antibody cocktail	19068
@NP	the antibodies	19068
@NP	the primary antibody cocktail	19086
@NP	Sections	19117
@NP	fluorophore	19157
@NP	species-specific donkey IgG secondary antibodies for 4 h	19181
@NP	species-specific donkey IgG secondary antibodies	19181
@NP	4 h	19234
@NP	room temperature	19241
@NP	All antibodies	19259
@NP	PBS	19290
@NP	0.3 % triton X-100	19299
@NP	Sections	19318
@NP	plain glass slides	19345
@NP	VectaShield -LRB- Vector laboratories -RRB-	19370
@NP	VectaShield	19370
@NP	Vector laboratories	19383
@NP	220 °C	19418
@NP	Epifluorescence and Confocal Microscopy Sections	19425
@NP	low power	19501
@NP	a Nikon Eclipse E600 epifluorescence microscope	19517
@NP	Lesion morphology , co-expression of various markers	19566
@NP	Lesion morphology	19566
@NP	co-expression of various markers	19585
@NP	co-expression	19585
@NP	various markers	19602
@NP	evidence of regenerating and myelinated axons	19622
@NP	evidence	19622
@NP	regenerating and myelinated axons	19634
@NP	regenerating	19634
@NP	myelinated axons	19651
@NP	sections	19689
@NP	the tissue	19741
@NP	5 µm -LRB- 43 -RRB-	19755
@NP	43	19761
@NP	2 µm -LRB- 203 -RRB-	19766
@NP	203	19772
@NP	0.5 µm -LRB- 603 , oil immersion -RRB-	19781
@NP	603	19789
@NP	oil immersion	19794
@NP	intervals using a Bio-Rad MRC1024 confocal system	19809
@NP	intervals	19809
@NP	a Bio-Rad MRC1024 confocal system	19825
@NP	The resulting Z-series '	19860
@NP	projections	19888
@NP	these confocal image stacks	19903
@NP	Confocal Assistant software , Todd Clark Brelje , University of Minnesota	19945
@NP	Confocal Assistant software	19945
@NP	Todd Clark Brelje	19974
@NP	University of Minnesota	19993
@NP	University	19993
@NP	Minnesota	20007
@NP	notable features such as marker co-expression	20036
@NP	notable features	20036
@NP	marker co-expression	20061
@NP	axons	20102
@NP	the cell transplant	20116
@NP	the lesion site	20139
@NP	the dorsal column lesion	20178
@NP	Images selected for illustration	20204
@NP	Images	20204
@NP	illustration	20224
@NP	Adobe Photoshop CS2	20254
@NP	publication	20292
@NP	Quantification of Length of Lesion Site	20305
@NP	Quantification	20305
@NP	Length of Lesion Site	20323
@NP	Length	20323
@NP	Lesion Site	20333
@NP	the rostro-caudal extent of the lesion environment	20366
@NP	the rostro-caudal extent	20366
@NP	the lesion environment	20394
@NP	different cell preparations	20431
@NP	the lesion site	20477
@NP	we	20493
@NP	the extent of the lesion perimeter	20505
@NP	the extent	20505
@NP	the lesion perimeter	20519
@NP	6 weeks	20540
@NP	lesioning and transplantation	20554
@NP	GFAP expression	20585
@NP	the glial scar	20609
@NP	the perimeter of the transplanted lesion	20631
@NP	the perimeter	20631
@NP	the transplanted lesion	20648
@NP	GFAP immunolabeling	20673
@NP	the section	20724
@NP	each animal	20741
@NP	the greatest distance between rostral and caudal lesion perimeters	20761
@NP	the greatest distance	20761
@NP	rostral and caudal lesion perimeters	20791
@NP	GFAP immunoreactivity -LRB- IR -RRB-	20829
@NP	GFAP immunoreactivity	20829
@NP	IR	20852
@NP	a Nikon Eclipse E600 epifluorescence microscope	20879
@NP	a digital camera -LRB- Axiocam , Zeiss -RRB- and Zeiss Axiovision v3 .0 software	20939
@NP	a digital camera -LRB- Axiocam , Zeiss -RRB-	20939
@NP	a digital camera	20939
@NP	Axiocam	20957
@NP	Zeiss	20966
@NP	Zeiss Axiovision v3 .0 software	20977
@NP	Zeiss Axiovision	20977
@NP	v3 .0 software	20994
@NP	Digital images	21009
@NP	ImageJ software -LRB- NIH Image , Rasband , W.S. , ImageJ , U.	21041
@NP	ImageJ software -LRB- NIH Image , Rasband , W.S.	21041
@NP	ImageJ software	21041
@NP	NIH Image	21058
@NP	Rasband , W.S.	21069
@NP	ImageJ , U.	21084
@NP	S.	21095
@NP	National Institutes	21098
@NP	Health , Bethesda , Maryland , USA	21121
@NP	http://rsb.info.nih.gov/ij/	21154
@NP	1997 -- 2007	21183
@NP	the distance between the rostral and caudal perimeters of the glial reaction	21205
@NP	the distance between the rostral	21205
@NP	the distance	21205
@NP	the rostral	21226
@NP	caudal perimeters of the glial reaction	21242
@NP	caudal perimeters	21242
@NP	the glial reaction	21263
@NP	Statistical analyses	21283
@NP	GraphPad Prism	21325
@NP	v4 .03	21340
@NP	One-way ANOVA with Tukey-Kramer	21347
@NP	One-way ANOVA	21347
@NP	Tukey-Kramer	21366
@NP	hoc testing was used to test for significant differences between lesion lengths	21384
@NP	hoc	21384
@NP	testing	21388
@NP	significant differences between lesion lengths	21417
@NP	significant differences	21417
@NP	lesion lengths	21449
@NP	Quantification	21465
@NP	Density of Regenerating Axons Regeneration into each cell transplant	21483
@NP	Density	21483
@NP	Axons Regeneration	21507
@NP	each cell transplant	21531
@NP	6 weeks	21573
@NP	the density of neurofilament positive axons	21596
@NP	the density	21596
@NP	neurofilament positive axons	21611
@NP	confocal image stacks of transplant sites	21643
@NP	confocal image stacks	21643
@NP	transplant sites	21668
@NP	ImageJ software	21691
@NP	The volume of lesion	21708
@NP	The volume	21708
@NP	lesion	21722
@NP	transplant site	21730
@NP	GFAP IR	21770
@NP	a border	21788
@NP	a contour line	21809
@NP	the `` Freehand selections '' tool	21840
@NP	The area within this contour	21874
@NP	The area	21874
@NP	this contour	21890
@NP	the number of sections within the image	21921
@NP	the number	21921
@NP	sections within the image	21935
@NP	sections	21935
@NP	the image	21951
@NP	the z-depth between each zsection within the	21971
@NP	the z-depth	21971
@NP	each zsection within the	21991
@NP	each zsection	21991
@NP	a volume in µm3	22032
@NP	a volume	22032
@NP	µm3	22044
@NP	The density of neurofilament axons	22049
@NP	The density	22049
@NP	neurofilament axons	22064
@NP	the ImageJ	22116
@NP	Threshold '' and `` Skeletonize ''	22129
@NP	Threshold	22129
@NP	Skeletonize	22147
@NP	tools to convert stacks of labeled axons into stacks of 1 pixel thick profiles	22161
@NP	stacks of labeled axons into stacks of 1 pixel thick profiles	22178
@NP	stacks	22178
@NP	axons	22196
@NP	stacks of 1 pixel thick profiles	22207
@NP	stacks	22207
@NP	1 pixel thick profiles	22217
@NP	Quantification of the total length of profiles within each	22241
@NP	Quantification	22241
@NP	the total length of profiles within each	22259
@NP	the total length	22259
@NP	profiles within each	22279
@NP	profiles	22279
@NP	each	22295
@NP	the `` Analyze Particles '' function	22330
@NP	Particles	22344
@NP	The density of axon in-growth	22366
@NP	The density	22366
@NP	axon in-growth	22381
@NP	the total length	22414
@NP	neurofilament positive axons in µm , per µm3 of transplant site	22434
@NP	neurofilament positive axons	22434
@NP	µm	22466
@NP	µm3 of transplant site	22474
@NP	µm3	22474
@NP	transplant site	22481
@NP	Significant differences	22498
@NP	one-way ANOVA	22541
@NP	Tukey	22560
@NP	Kramer post hoc testing	22566
@NP	RESULTS	22592
@NP	1	22606
@NP	Immunocytochemical Characterization of Cell Preparations Fig. 1 .	22609
@NP	Immunocytochemical Characterization of Cell Preparations	22609
@NP	Immunocytochemical Characterization	22609
@NP	Cell Preparations	22648
@NP	Fig. 1	22667
@NP	Fig.	22667
@NP	1	22672
@NP	Immunocytochemical labeling of cell cultures .	22675
@NP	Immunocytochemical labeling	22675
@NP	cell cultures	22706
@NP	Antigenic profile	22721
@NP	quantification of marker positive cells/DAPI nuclei	22743
@NP	quantification	22743
@NP	marker positive cells/DAPI nuclei	22761
@NP	the types of cells	22800
@NP	the types	22800
@NP	cells	22813
@NP	transplantation	22828
@NP	-LRB- A -- C -RRB- OECs from p7 olfactory bulb .	22845
@NP	-LRB- A -- C -RRB- OECs from p7 olfactory bulb	22845
@NP	-LRB- A -- C -RRB- OECs	22845
@NP	A -- C	22846
@NP	A	22846
@NP	C	22848
@NP	p7 olfactory bulb	22861
@NP	-LRB- D -- F -RRB- SCs from p7 sciatic nerve .	22880
@NP	-LRB- D -- F -RRB- SCs from p7 sciatic nerve	22880
@NP	-LRB- D -- F -RRB- SCs	22880
@NP	D -- F	22881
@NP	D	22881
@NP	F	22883
@NP	p7 sciatic nerve	22895
@NP	-LRB- G -RRB-	22913
@NP	fibroblast-like cells from p7 olfactory bulb , -LRB- H -RRB-	22917
@NP	fibroblast-like cells	22917
@NP	p7 olfactory bulb , -LRB- H -RRB-	22944
@NP	p7 olfactory bulb	22944
@NP	H	22964
@NP	PNFB-like cells from P7 sciatic nerve , -LRB- I -RRB-	22967
@NP	PNFB-like cells	22967
@NP	P7 sciatic nerve , -LRB- I -RRB-	22988
@NP	P7 sciatic nerve	22988
@NP	I	23007
@NP	fibroblast-like cells from abdominal skin , -LRB- J -- L -RRB-	23010
@NP	fibroblast-like cells	23010
@NP	abdominal skin , -LRB- J -- L -RRB-	23037
@NP	abdominal skin	23037
@NP	J -- L	23054
@NP	J	23054
@NP	L	23056
@NP	mixed cells from p7 olfactory mucosa	23059
@NP	mixed cells	23059
@NP	p7 olfactory mucosa	23076
@NP	Scale bar 10 µm -LRB- A -- C , G , I , L , and K -RRB-	23097
@NP	Scale	23097
@NP	10 µm -LRB- A -- C , G , I , L , and K -RRB-	23107
@NP	10 µm	23107
@NP	A -- C , G , I , L , and K	23114
@NP	C , G , I , L , and K	23116
@NP	C	23116
@NP	G	23119
@NP	I	23122
@NP	L	23125
@NP	K	23132
@NP	scale bar 25 µm -LRB- D -- F , H , and J -RRB-	23135
@NP	scale bar	23135
@NP	25 µm -LRB- D -- F , H , and J -RRB-	23145
@NP	D -- F , H , and J	23152
@NP	D	23152
@NP	F , H , and J	23154
@NP	OEC , OECs	23168
@NP	OEC	23168
@NP	OECs	23173
@NP	OBFB-L , olfactory bulb fibroblast-like cells	23179
@NP	OBFB-L	23179
@NP	olfactory bulb fibroblast-like cells	23187
@NP	OM , mixed olfactory mucosa cells	23225
@NP	OM	23225
@NP	mixed olfactory mucosa cells	23229
@NP	SC , Schwann cells	23259
@NP	SC	23259
@NP	Schwann cells	23263
@NP	PNFB , peripheral nerve fibroblast	23278
@NP	PNFB	23278
@NP	peripheral nerve fibroblast	23284
@NP	SF , skin fibroblasts	23313
@NP	SF	23313
@NP	skin fibroblasts	23317
@NP	Fn	23335
@NP	Fibronectin	23339
@NP	SMA	23353
@NP	Thy1 -LRB- Thymocyte differentiation antigen 1.1 -RRB-	23358
@NP	Thy1	23358
@NP	Thymocyte differentiation antigen 1.1	23364
@NP	Thymocyte differentiation antigen	23364
@NP	1.1	23398
@NP	TUJ-1 -LRB- b III tubulin -RRB-	23407
@NP	TUJ-1	23407
@NP	b III tubulin	23414
@NP	-LSB- Color figure	23430
@NP	the online issue , which is available at wileyonlinelibrary.com	23461
@NP	the online issue	23461
@NP	wileyonlinelibrary.com	23501
@NP	Fig. 2 .	23527
@NP	Fig.	23527
@NP	2	23532
@NP	Axonal regeneration into transplanted cells	23535
@NP	Axonal regeneration	23535
@NP	transplanted cells	23560
@NP	anti-neurofilament	23594
@NP	Panels	23614
@NP	A -- G show montages	23621
@NP	G show	23623
@NP	several confocal images of representative sagittal sections	23650
@NP	several confocal images	23650
@NP	representative sagittal sections	23677
@NP	the lesion sites of animals	23715
@NP	the lesion sites	23715
@NP	animals	23735
@NP	each cell preparation	23761
@NP	Neurofilament-200 labeling -LRB- red -RRB-	23784
@NP	Neurofilament-200 labeling	23784
@NP	red	23812
@NP	regenerating axons	23836
@NP	GFAP staining -LRB- blue -RRB-	23861
@NP	GFAP staining	23861
@NP	blue	23876
@NP	the glial scar delineating the lesion/graft site	23890
@NP	the glial scar	23890
@NP	the lesion/graft site	23917
@NP	regeneration	23952
@NP	each transplant	23968
@NP	the density of neurofilamentlabeled axons	23985
@NP	the density	23985
@NP	neurofilamentlabeled axons	24000
@NP	µm of axon per µm3 transplant site	24028
@NP	µm	24028
@NP	axon	24034
@NP	µm3 transplant site	24043
@NP	confocal image stacks	24080
@NP	Quantification	24107
@NP	the density	24125
@NP	neurofilament positive axons	24140
@NP	each transplant	24172
@NP	Scatter plots	24189
@NP	mean 6 SD	24208
@NP	Oneway ANOVA with Tukey-Kramer post	24219
@NP	Oneway ANOVA	24219
@NP	Tukey-Kramer post	24237
@NP	hoc testing showed significant differences between OECs and OBFB-L	24255
@NP	hoc	24255
@NP	testing	24259
@NP	significant differences between OECs and OBFB-L	24274
@NP	significant differences	24274
@NP	OECs and OBFB-L	24306
@NP	P < 0.001 , *** -RRB-	24323
@NP	P	24323
@NP	0.001 , ***	24327
@NP	0.001	24327
@NP	***	24334
@NP	OEC/OBFB-L -LRB- P < 0.01 , ** -RRB- , and SF -LRB- P < 0.05 , * -RRB-	24340
@NP	OEC/OBFB-L -LRB- P < 0.01 , ** -RRB-	24340
@NP	OEC/OBFB-L	24340
@NP	P < 0.01 , **	24352
@NP	P	24352
@NP	< 0.01 , **	24354
@NP	<	24354
@NP	0.01 , **	24356
@NP	0.01	24356
@NP	SF -LRB- P < 0.05 , * -RRB-	24371
@NP	SF	24371
@NP	P < 0.05 , *	24375
@NP	P	24375
@NP	< 0.05 , *	24377
@NP	<	24377
@NP	0.05 , *	24379
@NP	0.05	24379
@NP	significant differences between SCs and OBFB-L transplants -LRB- P < 0.05 , *	24392
@NP	significant differences	24392
@NP	SCs and OBFB-L transplants -LRB- P < 0.05 , *	24424
@NP	SCs	24424
@NP	OBFB-L transplants -LRB- P < 0.05	24432
@NP	OBFB-L transplants	24432
@NP	P < 0.05	24452
@NP	P <	24452
@NP	P	24452
@NP	0.05	24456
@NP	-LRB- A -- G -RRB- scale	24466
@NP	A -- G	24467
@NP	A	24467
@NP	G	24469
@NP	500 µm	24484
@NP	OECs , OECs	24492
@NP	OECs	24492
@NP	OECs	24498
@NP	OBFB-L , olfactory bulb fibroblast-like cells	24504
@NP	OBFB-L	24504
@NP	olfactory bulb fibroblast-like cells	24512
@NP	OM , mixed olfactory mucosa cells	24550
@NP	OM	24550
@NP	mixed olfactory mucosa cells	24554
@NP	SCs , Schwann cells	24584
@NP	SCs	24584
@NP	Schwann cells	24589
@NP	PNFB , peripheral nerve fibroblasts	24604
@NP	PNFB	24604
@NP	peripheral nerve fibroblasts	24610
@NP	SF , skin fibroblasts	24640
@NP	SF	24640
@NP	skin fibroblasts	24644
@NP	-LSB- Color figure	24662
@NP	the online issue , which is available at wileyonlinelibrary.com	24693
@NP	the online issue	24693
@NP	wileyonlinelibrary.com	24733
@NP	Fig. 3 .	24759
@NP	Fig.	24759
@NP	3	24764
@NP	Axonal regeneration	24767
@NP	tract tracing	24802
@NP	tract	24802
@NP	Confocal image montages of representative sagittal sections from animals	24817
@NP	Confocal image montages	24817
@NP	representative sagittal sections from animals	24844
@NP	representative sagittal sections	24844
@NP	animals	24882
@NP	different cell preparations	24908
@NP	BDA tract tracer	24937
@NP	the L4 and L5 spinal nerves	24972
@NP	the L4	24972
@NP	L5 spinal nerves	24983
@NP	dorsal column axons	25032
@NP	A -- D	25054
@NP	A	25054
@NP	D	25056
@NP	OEC , SC , PNFB and OM transplants	25059
@NP	regeneration of ascending dorsal column axons but regenerating axons	25102
@NP	regeneration	25102
@NP	dorsal column axons	25128
@NP	axons	25165
@NP	the transplant within the lesion site	25188
@NP	the transplant	25188
@NP	the lesion site	25210
@NP	The lesion boundary	25227
@NP	GFAP immunostaining for the astrocytic scar -LRB- blue -RRB-	25266
@NP	GFAP immunostaining	25266
@NP	the astrocytic scar -LRB- blue -RRB-	25290
@NP	the astrocytic scar	25290
@NP	blue	25311
@NP	BDA-labeled axons regenerating into the lesion site	25321
@NP	BDA-labeled axons	25321
@NP	the lesion site	25357
@NP	The boxed areas	25393
@NP	The	25393
@NP	areas	25403
@NP	high power -LRB- 360 -RRB- insets in each panel	25422
@NP	high power -LRB- 360 -RRB- insets	25422
@NP	360	25434
@NP	each panel	25449
@NP	Scale bar A , 1 mm .	25461
@NP	Scale bar A	25461
@NP	1 mm	25474
@NP	Scale	25480
@NP	A inset , 25 µm	25490
@NP	A inset	25490
@NP	25 µm	25499
@NP	-LSB- Color figure	25506
@NP	the online issue , which is available at wileyonlinelibrary.com	25537
@NP	the online issue	25537
@NP	wileyonlinelibrary.com	25577
@NP	Fig. 4 .	25603
@NP	Fig.	25603
@NP	4	25608
@NP	Differences in the rostro-caudal extent of lesions	25611
@NP	Differences	25611
@NP	the rostro-caudal extent of lesions	25626
@NP	the rostro-caudal extent	25626
@NP	lesions	25654
@NP	different cell types A -- G , Confocal micrographs	25680
@NP	different cell types	25680
@NP	G , Confocal micrographs	25703
@NP	G	25703
@NP	Confocal micrographs	25706
@NP	the typical rostro-caudal extent of lesions assessed using GFAP immunolabeling	25737
@NP	the typical rostro-caudal extent	25737
@NP	lesions assessed using GFAP immunolabeling	25773
@NP	lesions	25773
@NP	GFAP immunolabeling	25796
@NP	The lesion morphology	25817
@NP	different cell preparations	25864
@NP	the mean lesion length	25905
@NP	the section	25929
@NP	each animal that showed the maximum rostro-caudal extent of the lesion	25946
@NP	each animal	25946
@NP	the maximum rostro-caudal extent of the lesion	25970
@NP	the maximum rostro-caudal extent	25970
@NP	the lesion	26006
@NP	the mean values	26035
@NP	6 SD reported in H.	26051
@NP	6 SD	26051
@NP	H.	26068
@NP	OECs -LRB- A -RRB- and SCs -LRB- E -RRB-	26071
@NP	OECs -LRB- A -RRB-	26071
@NP	OECs	26071
@NP	A	26077
@NP	SCs -LRB- E -RRB-	26084
@NP	SCs	26084
@NP	E	26089
@NP	narrow lesions	26109
@NP	preparations that contained a mixture of cells	26130
@NP	preparations	26130
@NP	a mixture of cells	26158
@NP	a mixture	26158
@NP	cells	26171
@NP	fibroblasts	26188
@NP	longer lesions	26213
@NP	Scale	26694
@NP	500 µm	26706
@NP	Fig. 5 .	26715
@NP	Fig.	26715
@NP	5	26720
@NP	Glial cell reaction to transplanted cells in nonlesioned cord .	26723
@NP	Glial cell reaction	26723
@NP	transplanted cells in nonlesioned cord	26746
@NP	transplanted cells	26746
@NP	nonlesioned cord	26768
@NP	The various cell preparations	26786
@NP	nonlesioned cord and sections	26835
@NP	antibodies	26878
@NP	GFAP -LRB- blue -RRB- and nestin -LRB- red -RRB-	26892
@NP	GFAP	26892
@NP	blue	26898
@NP	nestin	26908
@NP	red	26916
@NP	the induced glial reaction	26931
@NP	-LRB- D -- F -RRB- OECs and reactive astrocyte processes	26959
@NP	-LRB- D -- F -RRB- OECs	26959
@NP	D -- F	26960
@NP	D	26960
@NP	F	26962
@NP	reactive astrocyte processes	26974
@NP	the injected area	27022
@NP	-LRB- G -- I -RRB- SCs	27041
@NP	G -- I	27042
@NP	G	27042
@NP	I	27044
@NP	less interaction of this sort	27058
@NP	less interaction	27058
@NP	this sort	27078
@NP	the astrocytic tissue	27125
@NP	Mixed cell preparations and those containing fibroblasts	27148
@NP	Mixed cell preparations	27148
@NP	those containing fibroblasts	27176
@NP	those	27176
@NP	fibroblasts	27193
@NP	a more pronounced glial reaction	27213
@NP	PNFB -LRB- J -- L -RRB- , OM -LRB- M -- O -RRB- , and OBFB-L -LRB- P -- R -RRB-	27247
@NP	PNFB -LRB- J -- L -RRB-	27247
@NP	PNFB	27247
@NP	J -- L	27253
@NP	J	27253
@NP	L	27255
@NP	OM -LRB- M -- O -RRB-	27259
@NP	OM	27259
@NP	M -- O	27263
@NP	M	27263
@NP	O	27265
@NP	OBFB-L -LRB- P -- R -RRB-	27273
@NP	OBFB-L	27273
@NP	P -- R	27281
@NP	P	27281
@NP	R	27283
@NP	transplants	27286
@NP	intense GFAP and nestin staining	27310
@NP	processes that radiated around the transplanted cell bolus	27348
@NP	processes	27348
@NP	the transplanted cell bolus	27379
@NP	Spinal cord	27408
@NP	comparable volumes of culture medium	27434
@NP	comparable volumes	27434
@NP	culture medium	27456
@NP	A -- C	27472
@NP	A	27472
@NP	C	27474
@NP	a mild glial reaction	27484
@NP	the narrow injection track	27513
@NP	the patterns of reactivity seen above	27556
@NP	the patterns	27556
@NP	reactivity seen above	27572
@NP	reactivity	27572
@NP	the transplanted cells	27613
@NP	Scale	27637
@NP	A , 400 µm -LRB- applicable to A , D , G , J , M , and P -RRB-	27647
@NP	A	27647
@NP	400 µm -LRB- applicable to A , D , G , J , M , and P -RRB-	27650
@NP	applicable to A , D , G , J , M , and P	27658
@NP	applicable to A	27658
@NP	D , G , J , M , and P	27675
@NP	Scale	27695
@NP	B , 100 µm -LRB- applicable to B&C , E&F , H&I , K&L , N&O , and Q&R -RRB-	27705
@NP	B	27705
@NP	100 µm -LRB- applicable to B&C , E&F , H&I , K&L , N&O , and Q&R -RRB-	27708
@NP	B&C , E&F , H&I , K&L , N&O , and Q&R	27730
@NP	B&C , E&F , H&I , K&L , N&O ,	27730
@NP	Q&R	27759
@NP	-LSB- Color figure	27765
@NP	the online issue , which is available at wileyonlinelibrary.com	27796
@NP	the online issue	27796
@NP	wileyonlinelibrary.com	27836
@NP	Fig. 6 .	27862
@NP	Fig.	27862
@NP	6	27867
@NP	Regenerating axons	27870
@NP	markers of nodal architecture	27916
@NP	markers	27916
@NP	nodal architecture	27927
@NP	Transplants	27947
@NP	OECs -LRB- A -RRB-	27962
@NP	OECs	27962
@NP	A	27968
@NP	SCs -LRB- B -RRB-	27972
@NP	SCs	27972
@NP	B	27977
@NP	PNFBs -LRB- C -RRB-	27981
@NP	PNFBs	27981
@NP	C	27988
@NP	olfactory mucosa -LRB- D -RRB-	27996
@NP	olfactory mucosa	27996
@NP	D	28014
@NP	immunostaining for P0 -LRB- peripheral - type myelin ,	28037
@NP	immunostaining for P0 -LRB- peripheral - type myelin	28037
@NP	immunostaining	28037
@NP	P0 -LRB- peripheral -	28056
@NP	P0	28056
@NP	peripheral	28060
@NP	Many regenerating axons -LRB- neurofilament , red -RRB-	28087
@NP	Many regenerating axons	28087
@NP	neurofilament , red	28112
@NP	neurofilament	28112
@NP	red	28127
@NP	the transplants , enwrapped by P0 -LRB- green , arrows -RRB-	28157
@NP	the transplants	28157
@NP	P0 -LRB- green , arrows -RRB-	28187
@NP	P0	28187
@NP	green , arrows	28191
@NP	green	28191
@NP	arrows	28198
@NP	High power -LRB- 360 oil immersion -RRB- confocal images -LRB- E and F -RRB-	28207
@NP	High power -LRB- 360 oil immersion -RRB- confocal images	28207
@NP	High power	28207
@NP	360 oil immersion	28219
@NP	confocal images	28238
@NP	E and F	28255
@NP	E	28255
@NP	F	28261
@NP	paranodal neurofascin labeling	28271
@NP	red	28303
@NP	neurofilament-positive regenerating axons -LRB- NF200 blue -RRB-	28311
@NP	neurofilament-positive regenerating axons	28311
@NP	NF200 blue	28354
@NP	GFP-infected -LRB- green -RRB- OEC -LRB- E -RRB-	28373
@NP	GFP-infected -LRB- green -RRB- OEC	28373
@NP	E	28399
@NP	SC -LRB- F -RRB- transplants	28406
@NP	SC	28406
@NP	F	28410
@NP	transplants	28413
@NP	normal paranodal architecture -LRB- arrows -RRB-	28437
@NP	normal paranodal architecture	28437
@NP	arrows	28468
@NP	Scale	28477
@NP	A , 100 µm -LRB- applicable to A -- D -RRB-	28487
@NP	A	28487
@NP	100 µm -LRB- applicable to A -- D -RRB-	28490
@NP	A -- D	28512
@NP	D	28514
@NP	Scale	28518
@NP	E , 20 µm -LRB- applicable to E , F -RRB-	28528
@NP	E	28528
@NP	20 µm -LRB- applicable to E , F -RRB-	28531
@NP	E , F	28552
@NP	E	28552
@NP	F	28555
@NP	-LSB- Color figure	28559
@NP	the online issue , which is available at wileyonlinelibrary.com	28590
@NP	the online issue	28590
@NP	wileyonlinelibrary.com	28630
@NP	Cell Cultures A panel of markers	28656
@NP	Cell Cultures A panel	28656
@NP	Cell Cultures	28656
@NP	A panel	28670
@NP	markers	28681
@NP	the transplanted cells	28714
@NP	Quantitative results	28738
@NP	Table 1	28772
@NP	examples of immunolabeled cells	28784
@NP	examples	28784
@NP	immunolabeled cells	28796
@NP	Figure 1	28829
@NP	purification OECs and SCs	28845
@NP	97 % pure as defined by expression of the low affinity nerve	28891
@NP	97 % pure	28891
@NP	expression of the low affinity nerve	28914
@NP	expression	28914
@NP	the low affinity nerve	28928
@NP	growth factor receptor -LRB- p75NTR ; Barnett et al. , 1993 -RRB-	28951
@NP	growth factor receptor	28951
@NP	p75NTR ; Barnett et al. , 1993	28975
@NP	p75NTR	28975
@NP	Barnett et al. , 1993	28983
@NP	Barnett	28983
@NP	et al. , 1993	28991
@NP	et al.	28991
@NP	1993	28999
@NP	These cell types	29006
@NP	high levels	29038
@NP	nestin	29053
@NP	a marker	29061
@NP	a wide range	29083
@NP	cell types	29099
@NP	stem cells	29121
@NP	neuroepithelial cells	29133
@NP	glial cells -LRB- Gilyarov , 2008 ; Bramanti et al. , 2010 -RRB-	29159
@NP	glial cells	29159
@NP	Gilyarov , 2008 ; Bramanti et al. , 2010	29172
@NP	Gilyarov	29172
@NP	2008 ; Bramanti et al.	29182
@NP	2008	29182
@NP	Bramanti et al.	29188
@NP	Bramanti	29188
@NP	et al.	29197
@NP	2010	29205
@NP	a reactive cell status -LRB- Lin et al. , 1995 ; Tamango and Schiffer 2006 -RRB-	29231
@NP	a reactive cell status	29231
@NP	Lin et al. , 1995 ; Tamango and Schiffer 2006	29255
@NP	Lin	29255
@NP	et al. , 1995 ; Tamango and Schiffer 2006	29259
@NP	et al.	29259
@NP	1995	29267
@NP	Tamango	29273
@NP	Schiffer 2006	29285
@NP	addition	29304
@NP	we	29314
@NP	the antibody TUJ-1	29322
@NP	Covance	29346
@NP	neuron specific class III b-tubulin	29386
@NP	neuron specific class	29386
@NP	III b-tubulin	29408
@NP	bIII	29423
@NP	b-tubulin found in glial cells	29466
@NP	b-tubulin	29466
@NP	glial cells	29485
@NP	our hands	29510
@NP	a proportion of both OECs and SCs	29520
@NP	a proportion	29520
@NP	both OECs and SCs	29536
@NP	this marker	29576
@NP	these cell cultures	29592
@NP	96 % pure -LRB- p75NTR positive -RRB-	29622
@NP	96 % pure	29622
@NP	96 %	29622
@NP	pure	29626
@NP	p75NTR	29632
@NP	50 % of cells in each case	29659
@NP	50 %	29659
@NP	cells in each case	29666
@NP	cells	29666
@NP	each case	29675
@NP	TUJ-1 positive	29690
@NP	TUJ-1	29690
@NP	this	29706
@NP	TUJ-1	29724
@NP	both OECs and SCs	29746
@NP	This	29765
@NP	reports	29795
@NP	TUJ-1	29808
@NP	neurons	29833
@NP	a component of the mitotic spindle in multiple cell types	29848
@NP	a component	29848
@NP	the mitotic spindle in multiple cell types	29863
@NP	the mitotic spindle	29863
@NP	multiple cell types	29886
@NP	human SFs and certain cancer cells -LRB- Jouhilahti et al. , 2008 -RRB-	29917
@NP	human SFs	29917
@NP	certain cancer cells -LRB- Jouhilahti et al. , 2008 -RRB-	29931
@NP	certain cancer cells	29931
@NP	Jouhilahti	29953
@NP	et al. , 2008	29964
@NP	et al.	29964
@NP	2008	29972
@NP	Both SCs and OECs	29979
@NP	high levels of fibronectin	30007
@NP	high levels	30007
@NP	fibronectin	30022
@NP	The fibroblast-like cells from peripheral nerve , olfactory bulb and skin	30035
@NP	The fibroblast-like cells	30035
@NP	peripheral nerve , olfactory bulb and skin	30066
@NP	peripheral nerve	30066
@NP	olfactory bulb	30084
@NP	skin	30103
@NP	markers typical of connective tissue , including SMA , thy1 .1 and fibronectin	30118
@NP	markers	30118
@NP	connective tissue	30137
@NP	SMA , thy1 .1 and fibronectin	30166
@NP	SMA	30166
@NP	thy1 .1	30171
@NP	fibronectin	30182
@NP	the cells obtained from these tissues	30204
@NP	the cells	30204
@NP	these tissues	30228
@NP	one another	30276
@NP	the percentage of cells expressing the various antigens	30289
@NP	the percentage	30289
@NP	cells expressing the various antigens	30307
@NP	cells	30307
@NP	the various antigens	30324
@NP	Cells isolated from the skin	30355
@NP	Cells	30355
@NP	the skin	30375
@NP	a positive control for typical fibroblasts	30397
@NP	a positive control	30397
@NP	typical fibroblasts	30420
@NP	These cells	30441
@NP	fibronectin	30463
@NP	100 %	30476
@NP	high levels of thy1 .1 -LRB- 75 % -RRB- and TUJ-1 -LRB- 59 % -RRB-	30486
@NP	high levels	30486
@NP	thy1 .1 -LRB- 75 % -RRB- and TUJ-1 -LRB- 59 % -RRB-	30501
@NP	thy1 .1	30501
@NP	75 %	30509
@NP	TUJ-1	30518
@NP	59 %	30525
@NP	A proportion of these cells -LRB- 36 % -RRB-	30531
@NP	A proportion	30531
@NP	these cells -LRB- 36 % -RRB-	30547
@NP	these cells	30547
@NP	36 %	30560
@NP	SMA	30580
@NP	3 %	30593
@NP	nestin	30606
@NP	PNFBs	30614
@NP	a similar antigenic profile to SFs but with some quantitative differences	30624
@NP	a similar antigenic profile	30624
@NP	SFs	30655
@NP	some quantitative differences	30668
@NP	contrast	30702
@NP	the fibroblast-like cells isolated from the olfactory bulb	30712
@NP	the fibroblast-like cells	30712
@NP	the olfactory bulb	30752
@NP	a dramatically different antigenic profile	30778
@NP	particular a higher proportion	30825
@NP	cells	30859
@NP	nestin -LRB- 77 % -RRB- and SMA -LRB- 66 % -RRB-	30875
@NP	nestin -LRB- 77 % -RRB-	30875
@NP	nestin	30875
@NP	77 %	30883
@NP	SMA -LRB- 66 % -RRB-	30892
@NP	SMA	30892
@NP	66 %	30897
@NP	many fewer expressed Thy1 .1	30906
@NP	many fewer	30906
@NP	Thy1 .1	30927
@NP	4 %	30935
@NP	These data	30940
@NP	these cells	30959
@NP	typical fibroblasts	30979
@NP	Cultures generated from the olfactory mucosa	31000
@NP	Cultures	31000
@NP	the olfactory mucosa	31024
@NP	a mixed population of cells	31055
@NP	a mixed population	31055
@NP	cells	31077
@NP	the connective tissue	31088
@NP	the lamina propria as well as OECs	31113
@NP	the lamina propria	31113
@NP	OECs	31143
@NP	12 %	31149
@NP	Toft et al. , 2012	31154
@NP	Toft	31154
@NP	et al.	31159
@NP	2012	31167
@NP	It	31174
@NP	10 days in culture	31200
@NP	10 days	31200
@NP	culture	31211
@NP	any neurons	31219
@NP	some olfactory epithelial cells	31255
@NP	the culture	31303
@NP	the 3 %	31337
@NP	nuclei not labeled with any of the panel of antibodies	31347
@NP	nuclei	31347
@NP	any of the panel of antibodies	31371
@NP	any	31371
@NP	the panel of antibodies	31378
@NP	the panel	31378
@NP	antibodies	31391
@NP	Schwob	31403
@NP	et al. , 2002	31410
@NP	et al.	31410
@NP	2002	31418
@NP	Density of Axonal Regeneration	31425
@NP	Density	31425
@NP	Axonal Regeneration	31436
@NP	Different Transplants Regeneration	31463
@NP	spinal cord axons into transplants of each cell type	31501
@NP	spinal cord axons	31501
@NP	transplants of each cell type	31524
@NP	transplants	31524
@NP	each cell type	31539
@NP	6 weeks	31575
@NP	the density of neurofilament positive axons	31598
@NP	the density	31598
@NP	neurofilament positive axons	31613
@NP	confocal image stacks obtained from the transplant sites	31645
@NP	confocal image stacks	31645
@NP	the transplant sites	31681
@NP	Figure 2A	31703
@NP	G shows	31713
@NP	confocal microscope images	31721
@NP	typical sections	31751
@NP	dorsal column lesions	31776
@NP	the different cell types	31816
@NP	the axonal marker neurofilament-200	31864
@NP	Neurofilament	31916
@NP	positive fibers	31930
@NP	transplants of all of the cell types	31988
@NP	transplants	31988
@NP	all of the cell types	32003
@NP	all	32003
@NP	the cell types	32010
@NP	each	32051
@NP	axonal regeneration	32065
@NP	some degree	32088
@NP	the density of axonal regeneration	32110
@NP	the density	32110
@NP	axonal regeneration	32125
@NP	the transplants	32160
@NP	the quantitative analysis in Figure 2H	32193
@NP	the quantitative analysis	32193
@NP	Figure 2H	32222
@NP	Transplants of OECs	32233
@NP	Transplants	32233
@NP	OECs	32248
@NP	the greatest axonal density and therefore regeneration	32263
@NP	the greatest axonal density	32263
@NP	regeneration	32305
@NP	transplants	32322
@NP	SCs and even PNFBs and SFs	32337
@NP	SCs	32337
@NP	even PNFBs and SFs	32345
@NP	cell types supporting axonal regeneration	32393
@NP	cell types	32393
@NP	axonal regeneration	32415
@NP	substantial numbers of axons	32446
@NP	substantial numbers	32446
@NP	axons	32469
@NP	OBFB-like cells	32476
@NP	significantly fewer regenerating axons	32502
@NP	all other cell types tested	32546
@NP	all other cell types	32546
@NP	OECs	32580
@NP	the OBFB-L cells	32601
@NP	regeneration	32619
@NP	the cell mixture	32650
@NP	OECs	32697
@NP	Extent	32709
@NP	Axonal Regeneration	32719
@NP	Different Transplants	32752
@NP	in-growing axons detected within the transplants	32790
@NP	in-growing axons	32790
@NP	the transplants	32823
@NP	the lesion , tract tracing studies	32858
@NP	the lesion	32858
@NP	tract tracing studies	32870
@NP	tract	32870
@NP	studies	32884
@NP	a subset of animals	32910
@NP	a subset	32910
@NP	animals	32922
@NP	these experiments	32934
@NP	BDA	32953
@NP	the L4 and L5 spinal nerves	32975
@NP	the L4	32975
@NP	L5 spinal nerves	32986
@NP	dorsal column fibers	33022
@NP	Examples	33044
@NP	BDA labeled fibers in animals transplanted with OECs , SCs , PNFB and OM	33056
@NP	BDA	33056
@NP	fibers	33068
@NP	animals transplanted with OECs , SCs , PNFB and OM	33078
@NP	animals	33078
@NP	OECs , SCs , PNFB and OM	33104
@NP	Figure 3	33140
@NP	dorsal column fibers	33172
@NP	all cell types	33207
@NP	primary afferent fibers	33243
@NP	those regenerating in the transplants	33277
@NP	those	33277
@NP	the transplants	33299
@NP	axons	33316
@NP	the transplanted lesion in any of the animals	33344
@NP	the transplanted lesion	33344
@NP	any of the animals	33371
@NP	any	33371
@NP	the animals	33378
@NP	Extent	33391
@NP	Glial Scar Wire knife lesioning of the white matter of the dorsal columns	33401
@NP	Glial Scar Wire knife lesioning	33401
@NP	the white matter of the dorsal columns	33436
@NP	the white matter	33436
@NP	the dorsal columns	33456
@NP	a gap that develops over several weeks into a fluid filled cavity	33483
@NP	a gap	33483
@NP	several weeks	33508
@NP	a fluid filled cavity	33527
@NP	a fluid	33527
@NP	cavity	33542
@NP	the absence of a cell transplant	33553
@NP	the absence	33553
@NP	a cell transplant	33568
@NP	this gap or cavity	33587
@NP	time -LRB- Toft et al. , 2007 -RRB-	33635
@NP	time	33635
@NP	Toft	33641
@NP	et al. , 2007	33646
@NP	et al.	33646
@NP	2007	33654
@NP	All of the various cell types	33661
@NP	All	33661
@NP	the various cell types	33668
@NP	the gap created by lesioning	33698
@NP	the gap	33698
@NP	the development of cavities	33741
@NP	the development	33741
@NP	cavities	33760
@NP	there	33779
@NP	a marked difference	33789
@NP	the rostro-caudal extent	33812
@NP	the lesion site as defined by GFAP immunolabeling of the glial scar	33840
@NP	the lesion site as	33840
@NP	GFAP immunolabeling of the glial scar	33870
@NP	GFAP immunolabeling	33870
@NP	the glial scar	33893
@NP	Confocal microscope images	33909
@NP	the typical appearance of GFAP immunolabeling	33949
@NP	the typical appearance	33949
@NP	GFAP immunolabeling	33975
@NP	lesions transplanted with different cell types taken at the same magnification	33998
@NP	lesions	33998
@NP	different cell types taken at the same magnification	34024
@NP	different cell types	34024
@NP	the same magnification	34054
@NP	Figure 4	34090
@NP	the length of the cell-filled injury site	34105
@NP	the length	34105
@NP	the cell-filled injury site	34119
@NP	OECs and SCs	34163
@NP	the smallest lesion sites -LRB- ca. 1.2 mm in length at 6 weeks -RRB-	34185
@NP	the smallest lesion sites	34185
@NP	ca. 1.2 mm in length at 6 weeks	34212
@NP	ca.	34212
@NP	1.2 mm in length at 6 weeks	34216
@NP	1.2 mm	34216
@NP	length at 6 weeks	34226
@NP	length	34226
@NP	6 weeks	34236
@NP	transplants containing fibroblasts	34252
@NP	transplants	34252
@NP	fibroblasts	34275
@NP	more extensive lesion environments -LRB- 1.5 -- 2.1 mm -RRB-	34299
@NP	more extensive lesion environments	34299
@NP	1.5 -- 2.1 mm	34335
@NP	1.5	34335
@NP	2.1 mm	34339
@NP	transplanted OM	34351
@NP	the most extensive injury sites -LRB- 2.5 mm rostro-caudally -RRB-	34376
@NP	the most extensive injury sites	34376
@NP	2.5 mm	34409
@NP	Glial Cell Reaction	34434
@NP	Cells	34470
@NP	Non-lesioned Cord	34479
@NP	the reaction of host astrocytes	34520
@NP	the reaction	34520
@NP	host astrocytes	34536
@NP	transplanted cells	34555
@NP	small injections of cells	34575
@NP	small injections	34575
@NP	cells	34595
@NP	the normal spinal cord	34616
@NP	immunolabeling for GFAP and nestin	34643
@NP	immunolabeling	34643
@NP	GFAP and nestin	34662
@NP	the processes of reactive astrocytes	34692
@NP	the processes	34692
@NP	reactive astrocytes	34709
@NP	tissue sections	34743
@NP	the transplant site	34764
@NP	10 days	34790
@NP	Figure	34799
@NP	5 shows typical comparable sections of the injection sites	34806
@NP	5 shows typical comparable sections	34806
@NP	5 shows	34806
@NP	the injection sites	34845
@NP	different animals	34870
@NP	nestin -LRB- red -RRB- and GFAP -LRB- blue -RRB-	34908
@NP	nestin	34908
@NP	red	34916
@NP	GFAP	34925
@NP	blue	34931
@NP	Injection with medium	34938
@NP	Injection	34938
@NP	medium	34953
@NP	a minimal glial reaction	34975
@NP	the narrow profile of an injection pipette track	35005
@NP	the narrow profile	35005
@NP	an injection pipette track	35027
@NP	Injection with cells	35055
@NP	Injection	35055
@NP	cells	35070
@NP	a glial reaction , the extent of which varied with cell type	35085
@NP	a glial reaction	35085
@NP	cell type	35135
@NP	our previous reports	35162
@NP	Lakatos	35184
@NP	et al. , 2000 ; Santos-Silva et al. , 2007	35192
@NP	et al.	35192
@NP	2000 ; Santos-Silva et al.	35200
@NP	2000	35200
@NP	Santos-Silva et al.	35206
@NP	Santos-Silva	35206
@NP	et al.	35219
@NP	2007	35227
@NP	relatively low amounts of astrocytic hypertrophy	35247
@NP	relatively low amounts	35247
@NP	astrocytic hypertrophy	35273
@NP	there	35300
@NP	clear mingling of astrocytes with the central bolus of injected cells	35310
@NP	clear mingling	35310
@NP	astrocytes with the central bolus of injected cells	35328
@NP	astrocytes	35328
@NP	the central bolus of injected cells	35344
@NP	the central bolus	35344
@NP	injected cells	35365
@NP	SCinduced astrocytic hypertrophy	35387
@NP	extent	35435
@NP	astrocytes	35446
@NP	the central cell bolus	35484
@NP	There	35508
@NP	very little mingling between astrocytes and the PNFB and OM grafts	35523
@NP	very little mingling	35523
@NP	astrocytes and the PNFB and OM grafts	35552
@NP	astrocytes	35552
@NP	the PNFB and OM grafts	35567
@NP	These cells	35591
@NP	a more extensive pattern of hypertrophy	35617
@NP	a more extensive pattern	35617
@NP	hypertrophy	35645
@NP	the central cell bolus	35682
@NP	Those cells	35706
@NP	larger GFAP	35734
@NP	immunoreactive injury sites	35746
@NP	the most marked astrocytic response	35800
@NP	nestin IR and this	35850
@NP	nestin IR	35850
@NP	this	35864
@NP	the fibroblast-like cell grafts -LRB- Fig. 5J -- R -RRB-	35901
@NP	the fibroblast-like cell grafts	35901
@NP	Fig. 5J -- R	35934
@NP	Fig. 5J	35934
@NP	R	35942
@NP	Interaction of	35946
@NP	Interaction	35946
@NP	Cells	35974
@NP	Axons	35998
@NP	some transplants	36007
@NP	we	36025
@NP	the ability of OECs and SCs engineered to express GFP to interact with axons	36037
@NP	the ability	36037
@NP	OECs and SCs engineered to express GFP to interact with axons	36052
@NP	OECs and SCs	36052
@NP	GFP	36087
@NP	axons	36108
@NP	Both cell types	36115
@NP	axons	36168
@NP	myelination of fibers -LRB- Fig. 6A -- C -RRB- in both cell transplants	36210
@NP	myelination	36210
@NP	fibers -LRB- Fig. 6A -- C -RRB- in both cell transplants	36225
@NP	fibers -LRB- Fig. 6A -- C -RRB-	36225
@NP	fibers	36225
@NP	Fig. 6A -- C	36233
@NP	Fig. 6A	36233
@NP	C	36241
@NP	both cell transplants	36247
@NP	the correct formation of the paranodal protein	36274
@NP	the correct formation	36274
@NP	the paranodal protein	36299
@NP	neurofascin -LRB- Fig. 6E , F -RRB-	36321
@NP	neurofascin	36321
@NP	Fig. 6E , F	36334
@NP	Fig. 6E	36334
@NP	F	36342
@NP	P0 labeling around nerve fibers	36360
@NP	P0	36360
@NP	nerve fibers	36379
@NP	PNFB transplants	36409
@NP	some myelination of regenerating fibers	36442
@NP	some myelination	36442
@NP	regenerating fibers	36462
@NP	transplants	36504
@NP	cells which do not have a myelinating phenotype -LRB- Fig. 6C , D -RRB-	36519
@NP	cells	36519
@NP	a myelinating phenotype -LRB- Fig. 6C , D -RRB-	36543
@NP	a myelinating phenotype	36543
@NP	Fig. 6C , D	36568
@NP	Fig. 6C	36568
@NP	D	36576
@NP	DISCUSSION Rationale for Cells Included in the Study Cell transplantation	36581
@NP	DISCUSSION Rationale	36581
@NP	Cells Included in the Study Cell transplantation	36606
@NP	Cells	36606
@NP	the Study Cell transplantation	36624
@NP	a potential means	36658
@NP	effecting CNS repair	36679
@NP	Murray and Fischer , 2001 ; Barnett and Riddell 2007 ; Tetzlaff et al. , 2011	36701
@NP	Murray and Fischer	36701
@NP	2001 ; Barnett and Riddell 2007 ; Tetzlaff et al.	36721
@NP	2001	36721
@NP	Barnett and Riddell 2007 ; Tetzlaff et al.	36727
@NP	Barnett and Riddell 2007	36727
@NP	Barnett	36727
@NP	Riddell 2007	36739
@NP	Tetzlaff et al.	36753
@NP	Tetzlaff	36753
@NP	et al.	36762
@NP	2011	36770
@NP	Autologous transplantation of differentiated cell types	36777
@NP	Autologous transplantation	36777
@NP	cell types	36822
@NP	one strategy for sourcing cells	36836
@NP	one strategy	36836
@NP	sourcing cells	36853
@NP	the advantage	36883
@NP	the cell engineering and immunosuppression	36909
@NP	some stem cell sources	36978
@NP	this investigation	37005
@NP	we	37025
@NP	the axonal growth	37042
@NP	properties	37071
@NP	a range	37085
@NP	non-neural cell types	37140
@NP	each	37163
@NP	animal models of spinal cord injury repair	37206
@NP	animal models	37206
@NP	spinal cord injury repair	37223
@NP	the same model	37290
@NP	The cells tested	37306
@NP	The cells	37306
@NP	glial cells	37331
@NP	SCs and OECs	37344
@NP	SCs	37344
@NP	OECs	37352
@NP	axonal regeneration	37396
@NP	These	37417
@NP	fibroblastlike cells	37447
@NP	some	37469
@NP	glial cells in situ	37514
@NP	glial cells	37514
@NP	situ	37529
@NP	PNFBs in the case of SCs and fibroblast - like cells from olfactory bulb	37535
@NP	PNFBs	37535
@NP	the case of SCs and fibroblast	37544
@NP	the case	37544
@NP	SCs and fibroblast	37556
@NP	cells from olfactory bulb	37581
@NP	cells	37581
@NP	olfactory bulb	37592
@NP	most previous studies	37612
@NP	these cells	37635
@NP	undesirable contaminants	37668
@NP	purified glial cell cultures and the culture process employed	37696
@NP	purified glial cell cultures	37696
@NP	the culture process employed	37729
@NP	the culture process	37729
@NP	their presence -LRB- Barnett and Roskams , 2008 -RRB-	37798
@NP	their presence	37798
@NP	Barnett and Roskams	37814
@NP	2008	37835
@NP	This methodology	37842
@NP	the assumption	37874
@NP	glial cells	37894
@NP	properties that will optimize regeneration	37911
@NP	properties	37911
@NP	regeneration	37941
@NP	transplants of purified glial cells	37963
@NP	transplants	37963
@NP	purified glial cells	37978
@NP	regeneration	38012
@NP	fibroblast-like cells	38050
@NP	this	38095
@NP	views	38145
@NP	example	38176
@NP	one group	38185
@NP	cell preparations	38207
@NP	a mixture of olfactory bulb OECs and fibroblastlike cells	38238
@NP	a mixture	38238
@NP	olfactory bulb OECs and fibroblastlike cells	38251
@NP	olfactory bulb OECs	38251
@NP	fibroblastlike cells	38275
@NP	optimal reparative properties	38301
@NP	axonal regeneration -LRB- Raisman and Li , 2007 -RRB-	38345
@NP	axonal regeneration	38345
@NP	Raisman and Li , 2007	38366
@NP	Raisman	38366
@NP	Li , 2007	38378
@NP	Li	38378
@NP	2007	38382
@NP	addition	38392
@NP	some groups	38402
@NP	nondissociated tissue	38440
@NP	cells	38483
@NP	example	38494
@NP	olfactory lamina propria	38503
@NP	some rat studies	38553
@NP	these	38574
@NP	the basis	38590
@NP	clinical trials	38604
@NP	autologous transplantation	38630
@NP	these tissues in spinal cord injured patients	38660
@NP	these tissues in spinal cord	38660
@NP	these tissues	38660
@NP	spinal cord	38677
@NP	Lima et al. , 2010 ; Mackay - Sim and St John. , 2011	38707
@NP	Lima	38707
@NP	et al. , 2010 ; Mackay - Sim and St John. , 2011	38712
@NP	et al.	38712
@NP	2010	38720
@NP	Mackay	38726
@NP	Sim	38734
@NP	St John. , 2011	38742
@NP	St John.	38742
@NP	2011	38752
@NP	These	38759
@NP	complex tissues	38769
@NP	many diverse cell types -LRB- Lindsay et al. , 2010 -RRB-	38796
@NP	many diverse cell types	38796
@NP	Lindsay	38821
@NP	et al. , 2010	38829
@NP	et al.	38829
@NP	2010	38837
@NP	there	38847
@NP	contamination	38875
@NP	cells from the adjacent olfactory epithelium	38894
@NP	cells	38894
@NP	the adjacent olfactory epithelium	38905
@NP	the effect these cells	38949
@NP	the effect	38949
@NP	these cells	38960
@NP	transplanted into the spinal cord	38986
@NP	transplanted	38986
@NP	the spinal cord	39004
@NP	this study	39052
@NP	we	39064
@NP	some of these issues	39084
@NP	some	39084
@NP	these issues	39092
@NP	key properties of different cells	39118
@NP	key properties	39118
@NP	different cells	39136
@NP	identical conditions	39176
@NP	Axonal regeneration	39198
@NP	We	39218
@NP	the ability of the cell transplants	39244
@NP	the ability	39244
@NP	the cell transplants	39259
@NP	axonal regeneration	39291
@NP	We	39312
@NP	this	39319
@NP	the density of axons	39339
@NP	the density	39339
@NP	axons	39354
@NP	the cells transplanted into the gap created by a wire-knife injury	39367
@NP	the cells	39367
@NP	the gap created by a wire-knife injury	39395
@NP	the gap	39395
@NP	a wire-knife injury	39414
@NP	these axons	39443
@NP	regenerating axons	39490
@NP	We	39510
@NP	the transplants	39527
@NP	the injury	39565
@NP	we	39584
@NP	the intrinsic growth support	39606
@NP	the cells	39640
@NP	growing axons	39670
@NP	the complication	39693
@NP	different cell types	39715
@NP	the glial scar	39749
@NP	the transplant-host interface in different ways	39767
@NP	the transplant-host interface	39767
@NP	different ways	39800
@NP	the number of fibers able to enter the graft	39851
@NP	the number	39851
@NP	fibers able to enter the graft	39865
@NP	fibers	39865
@NP	the graft	39886
@NP	we	39923
@NP	axons	39940
@NP	the transplant	39966
@NP	the glial scar	39988
@NP	the effects	40031
@NP	interactions	40046
@NP	transplanted and host cells	40067
@NP	a factor affecting the numbers of axons within the graft	40098
@NP	a factor	40098
@NP	the numbers of axons within the graft	40117
@NP	the numbers	40117
@NP	axons within the graft	40132
@NP	axons	40132
@NP	the graft	40145
@NP	A notable finding of the current investigation	40156
@NP	A notable finding	40156
@NP	the current investigation	40177
@NP	all of the cell types and cell mixtures tested	40211
@NP	all	40211
@NP	the cell types and cell mixtures tested	40218
@NP	the cell types and cell mixtures	40218
@NP	some degree of axonal regeneration	40266
@NP	some degree	40266
@NP	axonal regeneration	40281
@NP	the presence	40318
@NP	numerous neurofilament immunolabeled fibers	40334
@NP	the transplanted cells	40398
@NP	OECs versus SCs	40422
@NP	all cell transplants tested , supported axonal regeneration ,	40447
@NP	all cell transplants	40447
@NP	axonal regeneration	40486
@NP	populations of glial cells	40516
@NP	populations	40516
@NP	glial cells	40531
@NP	the highest density of axons	40556
@NP	the highest density	40556
@NP	axons	40579
@NP	transplants	40592
@NP	OECs	40610
@NP	a higher density	40634
@NP	SCs	40656
@NP	this difference	40668
@NP	The reparative potential of both OECs and SCs	40705
@NP	The reparative potential	40705
@NP	both OECs and SCs	40733
@NP	detail	40771
@NP	it	40788
@NP	both cell types	40816
@NP	axonal regeneration	40840
@NP	there	40861
@NP	surprisingly few direct comparisons	40877
@NP	the same experimental conditions	40919
@NP	Takami et al. -LRB- 2002 -RRB-	40953
@NP	Takami et al.	40953
@NP	Takami	40953
@NP	et al.	40960
@NP	2002	40968
@NP	SCs	40983
@NP	OECs	41000
@NP	the olfactory bulb	41010
@NP	a moderate contusion injury in which transplants were performed after 1 week	41032
@NP	a moderate contusion injury	41032
@NP	transplants	41069
@NP	1	41102
@NP	week	41104
@NP	Estimations of the numbers of myelinated axons within the transplant	41110
@NP	Estimations	41110
@NP	the numbers of myelinated axons within the transplant	41125
@NP	the numbers	41125
@NP	myelinated axons within the transplant	41140
@NP	myelinated axons	41140
@NP	the transplant	41164
@NP	toluidine blue semithin sections	41195
@NP	the injury / transplant site	41233
@NP	the injury	41233
@NP	transplant site	41245
@NP	Both SC and OEC transplant sites	41262
@NP	more than twice	41305
@NP	many fibers	41324
@NP	nontransplanted controls	41339
@NP	SC transplants supporting more than OEC transplants	41370
@NP	SC transplants	41370
@NP	more	41396
@NP	OEC transplants	41406
@NP	a contusion injury	41435
@NP	it	41454
@NP	sparing and regeneration of fibers at the injury site	41496
@NP	sparing and regeneration	41496
@NP	fibers at the injury site	41524
@NP	fibers	41524
@NP	the injury site	41534
@NP	a subsequent study	41564
@NP	the same model	41586
@NP	transplantation	41607
@NP	the same 1 week time point -LRB- Pearse et al. , 2007 -RRB-	41626
@NP	the same 1 week time point	41626
@NP	Pearse	41654
@NP	et al. , 2007	41661
@NP	et al.	41661
@NP	2007	41669
@NP	OEC survival	41687
@NP	that of SCs	41721
@NP	that	41721
@NP	SCs	41729
@NP	4 % of transplanted cells remaining 3 weeks post-transplantation	41744
@NP	4 %	41744
@NP	transplanted cells remaining 3 weeks post-transplantation	41750
@NP	transplanted cells	41750
@NP	3 weeks	41779
@NP	differences in cell survival	41817
@NP	differences	41817
@NP	cell survival	41832
@NP	the comparison of regeneration	41866
@NP	the comparison	41866
@NP	regeneration	41884
@NP	this model	41909
@NP	the only other direct comparison	41924
@NP	our knowledge , SCs and a 50:50 OEC/fibroblast	41972
@NP	our knowledge	41972
@NP	SCs	41987
@NP	a 50:50 OEC/fibroblast	41995
@NP	cell mixture prepared from Fischer	42024
@NP	cell mixture	42024
@NP	Fischer	42051
@NP	rats	42059
@NP	a dorsal column crush model in immunosuppressed Sprague-Dawley rats	42087
@NP	a dorsal column crush model	42087
@NP	immunosuppressed Sprague-Dawley rats	42118
@NP	Both transplants	42156
@NP	similar numbers of GAP-43 positive immunolabeling	42194
@NP	similar numbers	42194
@NP	GAP-43 positive immunolabeling	42213
@NP	Many of these profiles	42245
@NP	Many	42245
@NP	these profiles	42253
@NP	co-localized neurofilament though these were not quantified	42268
@NP	co-localized neurofilament	42268
@NP	these	42302
@NP	Andrews and Stelzner	42329
@NP	2007	42351
@NP	this very limited information	42364
@NP	some of the technical complications involved in previous studies	42398
@NP	some	42398
@NP	the technical complications involved in previous studies	42406
@NP	the technical complications	42406
@NP	previous studies	42446
@NP	our findings	42464
@NP	the clearest indication	42485
@NP	transplants of OECs from the olfactory bulb support axonal regeneration at least	42518
@NP	transplants	42518
@NP	OECs from the olfactory bulb support axonal regeneration at least	42533
@NP	OECs	42533
@NP	the olfactory bulb support axonal regeneration at least	42543
@NP	the olfactory bulb support axonal regeneration	42543
@NP	SC transplants	42650
@NP	OECs versus OEC and fibroblast-like cell mixtures	42675
@NP	OECs	42675
@NP	OEC and fibroblast-like cell mixtures	42687
@NP	Most groups studying OECs	42725
@NP	Most groups	42725
@NP	OECs	42746
@NP	some form of purification step in their culture procedures	42758
@NP	some form	42758
@NP	purification step in their culture procedures	42771
@NP	purification step	42771
@NP	their culture procedures	42792
@NP	highly enriched cultures of OECs -LRB- Barnett and Roskams , 2008 -RRB-	42851
@NP	highly enriched cultures	42851
@NP	OECs -LRB- Barnett and Roskams , 2008 -RRB-	42879
@NP	OECs	42879
@NP	Barnett and Roskams	42885
@NP	2008	42906
@NP	one group -LRB- Li et al. , 2003 -RRB-	42922
@NP	Li	42933
@NP	et al. , 2003	42936
@NP	et al.	42936
@NP	2003	42944
@NP	transplant mixtures of OECs -LRB- approximately 50 % of cells -RRB-	42960
@NP	transplant mixtures	42960
@NP	OECs -LRB- approximately 50 % of cells -RRB-	42983
@NP	OECs	42983
@NP	approximately 50 % of cells	42989
@NP	approximately 50 %	42989
@NP	cells	43010
@NP	fibroblast	43031
@NP	cells from the olfactory bulb	43047
@NP	cells	43047
@NP	the olfactory bulb	43058
@NP	OECs and the fibroblastlike cells	43078
@NP	OECs	43078
@NP	the fibroblastlike cells	43087
@NP	growing axons	43142
@NP	olfactory receptor neurons	43159
@NP	the olfactory bulb -LRB- Li et al. , 2005a , b -RRB-	43194
@NP	the olfactory bulb	43194
@NP	Li	43214
@NP	et al. , 2005a , b	43217
@NP	et al.	43217
@NP	2005a	43225
@NP	b	43231
@NP	it	43238
@NP	these cells	43275
@NP	a pathway	43292
@NP	regenerating fibers	43314
@NP	Raisman and Li , 2007	43346
@NP	Raisman	43346
@NP	Li , 2007	43358
@NP	Li	43358
@NP	2007	43362
@NP	This group	43369
@NP	the collaboration of both cells types	43403
@NP	the collaboration	43403
@NP	cells types	43429
@NP	successful axonal regeneration	43457
@NP	corticospinal fibers	43492
@NP	the transplanted lesion	43521
@NP	Other groups	43546
@NP	report that corticospinal fibers	43569
@NP	report	43569
@NP	corticospinal fibers	43581
@NP	transplants	43637
@NP	olfactory bulb OECs	43652
@NP	Ruitenberg	43673
@NP	et al. , 2005	43684
@NP	et al.	43684
@NP	2005	43692
@NP	lamina propria OECs	43701
@NP	Lu	43722
@NP	et al. , 2006	43725
@NP	et al.	43725
@NP	2006	43733
@NP	We	43740
@NP	regeneration	43772
@NP	dorsal column fibers	43798
@NP	transplantation of purified OECs and cell mixtures	43825
@NP	transplantation	43825
@NP	purified OECs and cell mixtures	43844
@NP	the olfactory bulb	43890
@NP	both	43919
@NP	regeneration	43934
@NP	the transplant	43954
@NP	regeneration	43987
@NP	the graft -LRB- Toft et al. , 2007 -RRB-	44007
@NP	the graft	44007
@NP	Toft	44018
@NP	et al. , 2007	44023
@NP	et al.	44023
@NP	2007	44031
@NP	the current study	44041
@NP	we	44059
@NP	the density of axonal regeneration	44076
@NP	the density	44076
@NP	axonal regeneration	44091
@NP	transplants of purified OECs	44118
@NP	transplants	44118
@NP	purified OECs	44133
@NP	transplants	44155
@NP	the cells	44170
@NP	the Raisman group	44186
@NP	their `` OEC transplants ''	44215
@NP	a 50:50 mixture of OECs with the fibroblast-like cells	44248
@NP	a 50:50 mixture	44248
@NP	OECs with the fibroblast-like cells	44267
@NP	OECs	44267
@NP	the fibroblast-like cells	44277
@NP	Our findings	44304
@NP	purified OECs	44327
@NP	the most axonal growth	44349
@NP	fibroblast-like cells	44381
@NP	significantly less regeneration	44417
@NP	OECs	44457
@NP	the fibroblast	44465
@NP	cells	44485
@NP	support	44500
@NP	axonal regeneration	44512
@NP	the same extent as OECs	44543
@NP	the same extent	44543
@NP	OECs	44562
@NP	regeneration within the cell mixture	44581
@NP	regeneration	44581
@NP	the cell mixture	44601
@NP	that within transplants of purified OECs	44650
@NP	that	44650
@NP	transplants of purified OECs	44662
@NP	transplants	44662
@NP	purified OECs	44677
@NP	This	44692
@NP	support for axonal regeneration	44711
@NP	support	44711
@NP	axonal regeneration	44723
@NP	purification of OECs obtained from the olfactory bulb	44759
@NP	purification	44759
@NP	OECs obtained from the olfactory bulb	44775
@NP	OECs	44775
@NP	the olfactory bulb	44794
@NP	Reasons for the variation in findings between different groups	44814
@NP	Reasons	44814
@NP	the variation in findings between different groups	44826
@NP	the variation	44826
@NP	findings between different groups	44843
@NP	findings	44843
@NP	different groups	44860
@NP	Several studies	44892
@NP	the age of OECs in culture	44924
@NP	the age	44924
@NP	OECs in culture	44935
@NP	OECs	44935
@NP	culture	44943
@NP	a factor	44954
@NP	their pro-regenerative properties	44983
@NP	Franssen	45018
@NP	et al. , 2008 ; Llamus ı et al. , 2011	45027
@NP	et al.	45027
@NP	2008 ; Llamus ı et al.	45035
@NP	2008	45035
@NP	Llamus ı et al.	45041
@NP	Llamus ı	45041
@NP	et al.	45050
@NP	2011	45058
@NP	a recent in vivo study	45068
@NP	recent	45070
@NP	this idea , at least	45100
@NP	this idea	45100
@NP	certain nerve fiber types	45124
@NP	Novikova	45151
@NP	et al. , 2011	45160
@NP	et al.	45160
@NP	2011	45168
@NP	the use	45184
@NP	neonatal	45195
@NP	adult animals	45218
@NP	a cell source , culturing of OECs and fibroblast-like cells	45235
@NP	a cell source	45235
@NP	culturing of OECs and fibroblast-like cells	45250
@NP	culturing	45250
@NP	OECs and fibroblast-like cells	45263
@NP	OECs	45263
@NP	fibroblast-like cells	45272
@NP	separate pure populations	45318
@NP	differences in the methods used to assess axonal regeneration	45349
@NP	differences	45349
@NP	the methods used to assess axonal regeneration	45364
@NP	the methods	45364
@NP	axonal regeneration	45391
@NP	all potential alternative explanations	45415
@NP	The olfactory bulb fibroblast-like cells , when transplanted alone ,	45455
@NP	The olfactory bulb fibroblast-like cells	45455
@NP	less axonal regeneration	45532
@NP	any of the other cell types investigated	45562
@NP	any	45562
@NP	the other cell types investigated	45569
@NP	the other cell types	45569
@NP	There	45604
@NP	reports	45623
@NP	other fibroblast-like cells associated with the nervous system	45636
@NP	other fibroblast-like cells	45636
@NP	the nervous system	45680
@NP	CNS repair	45711
@NP	Meningeal fibroblasts	45741
@NP	axonal preservation/regeneration	45787
@NP	a crush injury	45826
@NP	the spinal cord -LRB- Franzen et al. , 1999 -RRB-	45844
@NP	the spinal cord	45844
@NP	Franzen	45861
@NP	et al. , 1999	45869
@NP	et al.	45869
@NP	1999	45877
@NP	regeneration of nigrostriatal dopaminergic axons -LRB- Teng et al. , 2008 -RRB-	45887
@NP	regeneration	45887
@NP	nigrostriatal dopaminergic axons -LRB- Teng et al. , 2008 -RRB-	45903
@NP	nigrostriatal dopaminergic axons	45903
@NP	Teng	45937
@NP	et al. , 2008	45942
@NP	et al.	45942
@NP	2008	45950
@NP	they	45960
@NP	the remyelination	45982
@NP	spinal axons	46031
@NP	OECs -LRB- Lakatos et al. , 2003 -RRB-	46070
@NP	OECs	46070
@NP	Lakatos	46076
@NP	et al. , 2003	46084
@NP	et al.	46084
@NP	2003	46092
@NP	there	46108
@NP	abundant evidence	46122
@NP	meningeal-fibroblasts	46145
@NP	important components of the glial scar that forms in the injured CNS	46171
@NP	important components	46171
@NP	the glial scar that forms in the injured CNS	46195
@NP	the glial scar	46195
@NP	the injured CNS	46224
@NP	these cells	46249
@NP	a source	46265
@NP	multiple molecular inhibitors	46277
@NP	axonal regeneration	46310
@NP	Shearer and Fawcett , 2001 ; Shearer et al. , 2001 ; Kawano et al. , 2012	46331
@NP	Shearer and Fawcett	46331
@NP	Shearer	46331
@NP	Fawcett	46343
@NP	2001 ; Shearer et al.	46352
@NP	2001	46352
@NP	Shearer et al.	46358
@NP	Shearer	46358
@NP	et al.	46366
@NP	2001 ; Kawano et al. , 2012	46374
@NP	2001	46374
@NP	Kawano et al. , 2012	46380
@NP	Kawano	46380
@NP	et al. , 2012	46387
@NP	et al.	46387
@NP	2012	46395
@NP	It	46402
@NP	the molecular and cellular environment	46422
@NP	pure populations of meningeal cells	46486
@NP	pure populations	46486
@NP	meningeal cells	46506
@NP	that produced by meningeal cells participating in the glial scar	46535
@NP	that	46535
@NP	meningeal cells participating in the glial scar	46552
@NP	meningeal cells	46552
@NP	the glial scar	46585
@NP	our observations	46605
@NP	the OB fibroblast-like cells at least	46635
@NP	the OB fibroblast-like cells	46635
@NP	more limited axonal regeneration	46682
@NP	other cell types	46720
@NP	Olfactory mucosa	46738
@NP	addition to the olfactory bulb	46758
@NP	addition	46758
@NP	the olfactory bulb	46770
@NP	the olfactory mucosa	46790
@NP	OECs	46820
@NP	the lamina propria	46832
@NP	The OECs from these two sources	46852
@NP	The OECs	46852
@NP	these two sources	46866
@NP	similar	46907
@NP	properties	46916
@NP	Ramer et al. , 2004 ; Richter et al. , 2005 ; Lu et al. , 2006	46928
@NP	Ramer	46928
@NP	et al. , 2004 ; Richter et al. , 2005 ; Lu et al. , 2006	46934
@NP	et al. , 2004	46934
@NP	et al.	46934
@NP	2004	46942
@NP	Richter et al. , 2005	46948
@NP	Richter	46948
@NP	et al. , 2005	46956
@NP	et al.	46956
@NP	2005	46964
@NP	Lu et al. , 2006	46970
@NP	Lu	46970
@NP	et al. , 2006	46973
@NP	et al.	46973
@NP	2006	46981
@NP	their in vivo properties	46997
@NP	their	46997
@NP	vivo properties	47006
@NP	Ramer et al. , 2004	47041
@NP	Ramer	47041
@NP	et al.	47047
@NP	2004	47055
@NP	recent transcriptional profiling	47065
@NP	notable molecular differences	47108
@NP	OB and OM OECs	47146
@NP	Guerout	47162
@NP	et al. , 2010	47170
@NP	et al.	47170
@NP	2010	47178
@NP	subpopulations of cells from the OB -LRB- Honore et al. , 2012 -RRB-	47201
@NP	subpopulations	47201
@NP	cells from the OB -LRB- Honore et al. , 2012 -RRB-	47219
@NP	cells	47219
@NP	the OB -LRB- Honore et al. , 2012 -RRB-	47230
@NP	the OB	47230
@NP	Honore	47238
@NP	et al. , 2012	47245
@NP	et al.	47245
@NP	2012	47253
@NP	The functional significance of these differences	47260
@NP	The functional significance	47260
@NP	these differences	47291
@NP	their implications for use of these cells in neural repair	47313
@NP	their implications	47313
@NP	use of these cells in neural repair	47336
@NP	use	47336
@NP	these cells in neural repair	47343
@NP	these cells	47343
@NP	neural repair	47358
@NP	The accessibility of olfactory mucosa	47414
@NP	The accessibility	47414
@NP	olfactory mucosa	47435
@NP	this tissue	47458
@NP	an attractive source of cells for autologous transplantation	47470
@NP	an attractive source	47470
@NP	cells for autologous transplantation	47494
@NP	cells	47494
@NP	autologous transplantation	47504
@NP	large numbers of purified cells from human biopsies	47545
@NP	large numbers	47545
@NP	purified cells from human biopsies	47562
@NP	purified cells	47562
@NP	human biopsies	47582
@NP	Choi et al. , 2008 ; Gorrie et al. , 2010	47615
@NP	Choi	47615
@NP	et al. , 2008 ; Gorrie et al. , 2010	47620
@NP	et al. , 2008	47620
@NP	et al.	47620
@NP	2008	47628
@NP	Gorrie et al. , 2010	47634
@NP	Gorrie	47634
@NP	et al. , 2010	47641
@NP	et al.	47641
@NP	2010	47649
@NP	This	47656
@NP	some groups	47669
@NP	transplantation of non-dissociated olfactory mucosal tissue	47696
@NP	transplantation	47696
@NP	non-dissociated olfactory mucosal tissue	47715
@NP	this tissue	47766
@NP	a diverse range of cell types -LRB- Lindsay et al. , 2010 -RRB-	47787
@NP	a diverse range	47787
@NP	cell types -LRB- Lindsay et al. , 2010 -RRB-	47806
@NP	cell types	47806
@NP	Lindsay	47818
@NP	et al. , 2010	47826
@NP	et al.	47826
@NP	2010	47834
@NP	the olfactory epithelium	47853
@NP	the olfactory mucosa as far as possible	47906
@NP	the olfactory mucosa	47906
@NP	preparation for transplantation	47953
@NP	preparation	47953
@NP	transplantation	47969
@NP	some adherent cells	47986
@NP	These OM tissue transplants	48030
@NP	the introduction	48078
@NP	many cell types	48098
@NP	the exception of OECs	48126
@NP	the exception	48126
@NP	OECs	48143
@NP	their effect	48197
@NP	spinal cord injuries	48233
@NP	this incomplete information	48263
@NP	autologous transplantation of olfactory mucosa	48292
@NP	autologous transplantation	48292
@NP	olfactory mucosa	48322
@NP	clinical trials -LRB- Lima et al. , 2010 ; Mackay-Sim and St John , 2011 -RRB-	48355
@NP	clinical trials	48355
@NP	Lima	48372
@NP	et al. , 2010 ; Mackay-Sim and St John , 2011	48377
@NP	et al.	48377
@NP	2010 ; Mackay-Sim and St John	48385
@NP	2010	48385
@NP	Mackay-Sim and St John	48391
@NP	Mackay-Sim	48391
@NP	St John	48406
@NP	2011	48415
@NP	a first attempt	48425
@NP	this diverse population of peripheral cells	48458
@NP	this diverse population	48458
@NP	peripheral cells	48485
@NP	glial cells	48523
@NP	respect	48540
@NP	axonal regeneration	48563
@NP	we	48584
@NP	transplants	48596
@NP	cells obtained from the whole olfactory mucosa in our comparison	48623
@NP	cells	48623
@NP	the whole olfactory mucosa in our comparison	48643
@NP	the whole olfactory mucosa	48643
@NP	our comparison	48673
@NP	our results	48704
@NP	the OM cell mixture	48726
@NP	substantial axonal regeneration , comparable to that of purified SCs and PNFBs	48756
@NP	substantial axonal regeneration	48756
@NP	that of purified SCs and PNFBs	48803
@NP	that	48803
@NP	purified SCs and PNFBs	48811
@NP	greater detail below	48860
@NP	greater detail	48860
@NP	OM cells	48882
@NP	a very significant adverse tissue response	48904
@NP	the transplant site	48950
@NP	a response	48971
@NP	that associated with any other of the cell types tested	49004
@NP	that	49004
@NP	any other of the cell types tested	49025
@NP	any other	49025
@NP	the cell types tested	49038
@NP	the cell types	49038
@NP	these cells	49076
@NP	axonal regeneration	49100
@NP	the host spinal cord would appear to limit their suitability for transplant	49155
@NP	the host	49155
@NP	spinal cord	49164
@NP	their suitability	49198
@NP	transplant	49220
@NP	repair	49240
@NP	Skin and PNFBs Fibroblasts from peripheral tissues	49248
@NP	Skin and PNFBs Fibroblasts	49248
@NP	peripheral tissues	49280
@NP	their ability to support axonal regeneration	49333
@NP	axonal regeneration	49358
@NP	SFs	49379
@NP	a growth supportive scaffold	49411
@NP	other regeneration stimulating treatments	49454
@NP	neurotrophins	49532
@NP	spinal cord injury sites	49549
@NP	e.g. , Murray and Fischer , 2001 ; Jones et al. , 2003 ; Lu and Tuszynski , 2008	49575
@NP	e.g.	49575
@NP	Murray	49581
@NP	Fischer , 2001 ; Jones et al. , 2003 ; Lu and Tuszynski , 2008	49592
@NP	Fischer , 2001	49592
@NP	Fischer	49592
@NP	2001	49601
@NP	Jones et al. , 2003	49607
@NP	Jones	49607
@NP	et al. , 2003	49613
@NP	et al.	49613
@NP	2003	49621
@NP	Lu and Tuszynski , 2008	49627
@NP	Lu and Tuszynski	49627
@NP	2008	49645
@NP	SFs acutely transplanted	49664
@NP	SFs	49664
@NP	wire knife lesions	49694
@NP	the cervical dorsolateral funiculus support ingrowth of rubrospinal axons	49716
@NP	the cervical dorsolateral funiculus support ingrowth	49716
@NP	rubrospinal axons	49772
@NP	dorsal column and CGRP positive fiber	49801
@NP	some extent	49842
@NP	cells	49887
@NP	nerve growth factor -LRB- Jones et al. , 2003 -RRB-	49920
@NP	nerve growth factor	49920
@NP	Jones	49941
@NP	et al. , 2003	49947
@NP	et al.	49947
@NP	2003	49955
@NP	The same group	49962
@NP	SFs	49995
@NP	a similar density	50007
@NP	axons	50041
@NP	adult rat OECs	50050
@NP	the lamina propria	50079
@NP	bone marrow	50105
@NP	mesenchymal stem cells	50117
@NP	wire knife lesions of the dorsal columns -LRB- Lu et al. , 2006 -RRB-	50163
@NP	wire knife lesions	50163
@NP	the dorsal columns -LRB- Lu et al. , 2006 -RRB-	50185
@NP	the dorsal columns	50185
@NP	Lu	50205
@NP	et al. , 2006	50208
@NP	et al.	50208
@NP	2006	50216
@NP	Our results	50223
@NP	previous evidence	50243
@NP	SF	50266
@NP	axonal regeneration	50281
@NP	this cell type	50320
@NP	significantly less regeneration	50344
@NP	purified populations of OECs obtained from the olfactory bulb	50381
@NP	purified populations	50381
@NP	OECs obtained from the olfactory bulb	50405
@NP	OECs	50405
@NP	the olfactory bulb	50424
@NP	PNFBs , in contrast ,	50444
@NP	PNFBs	50444
@NP	contrast	50454
@NP	a control cell	50489
@NP	various candidate cells studied for transplant mediated repair	50515
@NP	various candidate cells	50515
@NP	transplant	50551
@NP	repair	50571
@NP	The use of this cell type for this purpose	50579
@NP	The use	50579
@NP	this cell type for this purpose	50590
@NP	this cell type	50590
@NP	this purpose	50609
@NP	the assumption	50634
@NP	they	50654
@NP	a neutral cell type	50663
@NP	little or no repair	50688
@NP	properties	50718
@NP	e.g. , Keyvan-Foualadi and Raisman , 2005 ; Pearse et al. , 2007	50730
@NP	e.g.	50730
@NP	Keyvan-Foualadi and Raisman , 2005 ; Pearse et al.	50736
@NP	Keyvan-Foualadi and Raisman , 2005	50736
@NP	Keyvan-Foualadi and Raisman	50736
@NP	2005	50765
@NP	Pearse et al.	50771
@NP	Pearse	50771
@NP	et al.	50778
@NP	2007	50786
@NP	reports in the literature	50796
@NP	reports	50796
@NP	the literature	50807
@NP	this view	50852
@NP	example	50867
@NP	Keyvan-Fouladi and Raisman -LRB- 2003 , 2005 -RRB-	50876
@NP	Keyvan-Fouladi and Raisman	50876
@NP	2003	50904
@NP	2005	50910
@NP	transplants of PNFBs	50925
@NP	transplants	50925
@NP	PNFBs	50940
@NP	mixed olfactory cell transplants	50951
@NP	no neurofilament-positive staining or P0 labeling	51002
@NP	a marker for peripheral type myelination	51053
@NP	a marker	51053
@NP	peripheral type myelination	51066
@NP	the fibroblast	51107
@NP	transplants	51127
@NP	this	51152
@NP	olfactory cells , but not PNFBs	51158
@NP	olfactory cells	51158
@NP	PNFBs	51183
@NP	a partial restoration	51198
@NP	movements	51232
@NP	electrolytic lesions in the cervical dorsal columns	51248
@NP	electrolytic lesions	51248
@NP	the cervical dorsal columns	51272
@NP	They	51301
@NP	PNFBs	51332
@NP	pure SC populations prior to transplant	51341
@NP	pure SC populations	51341
@NP	transplant	51370
@NP	the reparative effect	51411
@NP	these cells -LRB- Keyvan-Fouladi and Raisman , 2005 -RRB-	51436
@NP	these cells	51436
@NP	Keyvan-Fouladi and Raisman	51449
@NP	2005	51477
@NP	One of the most surprising findings of the current study	51484
@NP	One	51484
@NP	the most surprising findings of the current study	51491
@NP	the most surprising findings	51491
@NP	the current study	51523
@NP	the observation	51555
@NP	the density	51576
@NP	neurofilament	51591
@NP	axons in transplants of fibroblasts	51616
@NP	axons	51616
@NP	transplants of fibroblasts	51625
@NP	transplants	51625
@NP	fibroblasts	51640
@NP	peripheral nerve in wire knife lesions of the dorsal columns	51657
@NP	peripheral nerve	51657
@NP	wire knife lesions of the dorsal columns	51677
@NP	wire knife lesions	51677
@NP	the dorsal columns	51699
@NP	that detected after SC transplantation	51737
@NP	that	51737
@NP	SC transplantation	51757
@NP	Origin	51777
@NP	fibers	51800
@NP	Our results	51807
@NP	the degree	51827
@NP	there	51847
@NP	differences	51857
@NP	the intrinsic growth	51872
@NP	properties of the several cell types and cell mixtures	51904
@NP	properties	51904
@NP	the several cell types and cell mixtures	51918
@NP	axonal regeneration	51989
@NP	we	52010
@NP	the density	52024
@NP	regenerating axons detected by immunolabeling for neurofilament proteins	52039
@NP	regenerating axons	52039
@NP	immunolabeling for neurofilament proteins	52070
@NP	immunolabeling	52070
@NP	neurofilament proteins	52089
@NP	the normal spinal cord	52116
@NP	these fibers	52140
@NP	axons	52166
@NP	axons	52203
@NP	neurons in the brain and primary afferent axons	52222
@NP	neurons	52222
@NP	the brain and primary afferent axons	52233
@NP	the brain	52233
@NP	primary afferent axons	52247
@NP	the dorsal root ganglia	52275
@NP	The latter	52300
@NP	the majority of axons in the dorsal columns	52319
@NP	the majority	52319
@NP	axons in the dorsal columns	52335
@NP	axons	52335
@NP	the dorsal columns	52344
@NP	the main origin of the neurofilament	52378
@NP	the main origin	52378
@NP	the neurofilament	52397
@NP	fibers	52423
@NP	the transplants	52437
@NP	The experiments where we used tract tracing	52454
@NP	The experiments	52454
@NP	we	52476
@NP	tract tracing	52484
@NP	tract	52484
@NP	at least a proportion of the axons	52512
@NP	at least a proportion	52512
@NP	the axons	52537
@NP	dorsal root ganglia	52562
@NP	neurofilament	52592
@NP	some	52624
@NP	the fine monoaminergic fibers	52632
@NP	the brain	52678
@NP	fine peptidergic primary afferent fibers	52694
@NP	Some of these fiber types	52736
@NP	Some	52736
@NP	these fiber types	52744
@NP	a greater propensity for regeneration -LRB- Hawthorne et al. , 2011 -RRB-	52767
@NP	a greater propensity	52767
@NP	regeneration -LRB- Hawthorne et al. , 2011 -RRB-	52792
@NP	regeneration	52792
@NP	Hawthorne	52806
@NP	et al. , 2011	52816
@NP	et al.	52816
@NP	2011	52824
@NP	we	52834
@NP	all fibers types	52866
@NP	a similar way	52899
@NP	neurofilament labeled axons	52916
@NP	neurofilament	52916
@NP	axons	52938
@NP	Andrews and Stelzner	52953
@NP	2007	52975
@NP	report	52981
@NP	SC transplants	52993
@NP	CGRP immunopositive fibers	53029
@NP	OEC transplants	53062
@NP	the OEC transplants	53095
@NP	this case	53118
@NP	a 50:50 mixture of OECs and fibroblast-like cells	53133
@NP	a 50:50 mixture	53133
@NP	OECs and fibroblast-like cells	53152
@NP	OECs	53152
@NP	fibroblast-like cells	53161
@NP	immunosuppressed hosts	53206
@NP	it	53237
@NP	purified OEC transplants	53257
@NP	Pearse et al. -LRB- 2007 -RRB- in contrast	53296
@NP	Pearse et al.	53296
@NP	Pearse	53296
@NP	et al.	53303
@NP	2007	53311
@NP	contrast	53320
@NP	neither SCs nor OECs	53341
@NP	SCs	53349
@NP	OECs	53357
@NP	a moderate contusion injury increase CGRP	53380
@NP	positive fibers within the graft-injury site	53422
@NP	positive fibers	53422
@NP	the graft-injury site	53445
@NP	control animals	53481
@NP	This issue	53498
@NP	facilitation of the sprouting of CGRP containing fibers	53536
@NP	facilitation	53536
@NP	the sprouting of CGRP containing fibers	53552
@NP	the sprouting	53552
@NP	CGRP containing fibers	53569
@NP	CGRP	53569
@NP	fibers	53585
@NP	an undesirable property	53599
@NP	the majority of these	53630
@NP	the majority	53630
@NP	these	53646
@NP	nociceptive primary afferent fibers	53656
@NP	mechanisms of pain	53722
@NP	mechanisms	53722
@NP	pain	53736
@NP	Myelination within the Graft and Recruitment of Nontransplanted CELLS	53742
@NP	Myelination	53742
@NP	the Graft and Recruitment of Nontransplanted CELLS	53761
@NP	the Graft and Recruitment	53761
@NP	Nontransplanted CELLS	53790
@NP	P0	53818
@NP	a marker of peripheral type myelin	53822
@NP	a marker	53822
@NP	peripheral type myelin	53834
@NP	neurofascin , a paranodal protein marker	53861
@NP	neurofascin	53861
@NP	a paranodal protein marker	53874
@NP	we	53902
@NP	evidence of myelination	53909
@NP	evidence	53909
@NP	myelination	53921
@NP	transplanted GFP-labeled OECs and SCs	53936
@NP	transplanted GFP-labeled OECs	53936
@NP	SCs	53970
@NP	we	53984
@NP	non-GFP labeled P0 IR	54001
@NP	non-GFP	54001
@NP	P0 IR	54017
@NP	nodal protein IR not associated with P0 staining	54034
@NP	nodal protein IR	54034
@NP	P0 staining	54071
@NP	The former	54084
@NP	P0 myelination	54109
@NP	endogenous SCs invading the graft	54141
@NP	endogenous SCs	54141
@NP	the graft	54165
@NP	the minority	54184
@NP	transplanted cells which did not express GFP	54200
@NP	transplanted cells	54200
@NP	GFP	54241
@NP	the infection rate	54255
@NP	90 %	54283
@NP	The identification of nodal staining without associated P0 labeling	54289
@NP	The identification	54289
@NP	nodal staining without associated P0 labeling	54311
@NP	nodal staining	54311
@NP	associated P0 labeling	54334
@NP	myelination	54366
@NP	endogenous CNS glial cells	54381
@NP	P0 IR , presumably from invading SCs ,	54409
@NP	P0 IR	54409
@NP	SCs	54441
@NP	grafts of PNFB-like cells	54463
@NP	grafts	54463
@NP	PNFB-like cells	54473
@NP	some myelination of regenerating fibers	54506
@NP	some myelination	54506
@NP	regenerating fibers	54526
@NP	transplants of cells with a nonmyelinating phenotype	54564
@NP	transplants	54564
@NP	cells with a nonmyelinating phenotype	54579
@NP	cells	54579
@NP	a nonmyelinating phenotype	54590
@NP	This	54618
@NP	the issue	54630
@NP	extent host cell types that infiltrate the graft site	54651
@NP	extent host cell types	54651
@NP	the graft site	54690
@NP	the outcome of transplants with different cell types	54715
@NP	the outcome	54715
@NP	transplants with different cell types	54730
@NP	transplants	54730
@NP	different cell types	54747
@NP	It	54769
@NP	SCs	54797
@NP	OEC transplants	54821
@NP	these	54846
@NP	peripheral derivation	54859
@NP	a response of oligodendrocyte precursor cells	54894
@NP	a response	54894
@NP	oligodendrocyte precursor cells	54908
@NP	injury -LRB- Zawadzka et al. , 2010 -RRB-	54943
@NP	injury	54943
@NP	Zawadzka	54951
@NP	et al. , 2010	54960
@NP	et al.	54960
@NP	2010	54968
@NP	an issue that remains to be clarified	54978
@NP	an issue	54978
@NP	It	55017
@NP	SCs	55049
@NP	an important role	55058
@NP	the regeneration supported by OECs -LRB- Richter et al. , 2005 -RRB-	55079
@NP	the regeneration	55079
@NP	OECs -LRB- Richter et al. , 2005 -RRB-	55109
@NP	OECs	55109
@NP	Richter	55115
@NP	et al. , 2005	55123
@NP	et al.	55123
@NP	2005	55131
@NP	it	55141
@NP	host cells recruited by the transplant	55166
@NP	host cells	55166
@NP	the transplant	55190
@NP	other properties such as the host	55229
@NP	other properties	55229
@NP	the host	55254
@NP	graft interaction	55263
@NP	Integration of Graft into the Host Tissue	55282
@NP	Integration	55282
@NP	Graft into the Host Tissue	55297
@NP	Graft	55297
@NP	the Host Tissue	55308
@NP	addition	55327
@NP	axonal regeneration , a further important factor	55350
@NP	axonal regeneration	55350
@NP	a further important factor	55371
@NP	the suitability of cells for spinal cord repair	55410
@NP	the suitability	55410
@NP	cells for spinal cord repair	55429
@NP	cells	55429
@NP	spinal cord repair	55439
@NP	their readiness to integrate within the host tissues	55465
@NP	the host tissues	55501
@NP	the current study	55522
@NP	we	55541
@NP	the ability of various cell types	55553
@NP	the ability	55553
@NP	various cell types	55568
@NP	the host spinal cord using two methods	55607
@NP	the host spinal cord	55607
@NP	two methods	55634
@NP	we	55654
@NP	the extent	55666
@NP	the glial scar associated with the transplanted dorsal column injury site	55680
@NP	the glial scar	55680
@NP	the transplanted dorsal column injury site	55711
@NP	we	55768
@NP	the reaction of host astrocytes to the transplanted cells	55780
@NP	the reaction	55780
@NP	host astrocytes to the transplanted cells	55796
@NP	host astrocytes	55796
@NP	the transplanted cells	55815
@NP	the complication of the response	55846
@NP	the complication	55846
@NP	the response	55866
@NP	injury	55882
@NP	injection of a small volume of cells	55893
@NP	injection	55893
@NP	a small volume of cells	55906
@NP	a small volume	55906
@NP	cells	55924
@NP	the normal spinal cord	55935
@NP	Toft	55959
@NP	et al. , 2012 ; Santos-Silva et al. , 2007	55964
@NP	et al.	55964
@NP	2012 ; Santos-Silva et al.	55972
@NP	2012	55972
@NP	Santos-Silva et al.	55978
@NP	Santos-Silva	55978
@NP	et al.	55991
@NP	2007	55999
@NP	both approaches	56010
@NP	astrocytic hypertrophy	56027
@NP	intermediate filament proteins -LRB- GFAP and nestin -RRB-	56078
@NP	intermediate filament proteins	56078
@NP	GFAP and nestin	56110
@NP	GFAP	56110
@NP	nestin	56119
@NP	reactive astrocytes -LRB- Frisen et al. , 1995 ; Ridet et al. , 1997 -RRB-	56153
@NP	reactive astrocytes	56153
@NP	Frisen	56174
@NP	et al. , 1995 ; Ridet et al. , 1997	56181
@NP	et al.	56181
@NP	1995 ; Ridet et al.	56189
@NP	1995	56189
@NP	Ridet et al.	56195
@NP	Ridet	56195
@NP	et al.	56201
@NP	1997	56209
@NP	These complimentary approaches	56216
@NP	results that are in close agreement and indicate marked differences	56256
@NP	results	56256
@NP	close agreement	56276
@NP	marked differences	56305
@NP	the response of host astrocytes	56327
@NP	the response	56327
@NP	host astrocytes	56343
@NP	the different cell types transplanted	56362
@NP	the different cell types	56362
@NP	Transplants of OECs and SCs	56401
@NP	Transplants	56401
@NP	OECs and SCs	56416
@NP	the least glial hypertrophy	56438
@NP	these two purified populations of glial cells	56482
@NP	these two purified populations	56482
@NP	glial cells	56516
@NP	a very different result	56559
@NP	transplants	56596
@NP	fibroblast-like cells	56619
@NP	PNFBs , SFs and olfactory bulb fibroblast-like cells	56642
@NP	PNFBs	56642
@NP	SFs	56649
@NP	olfactory bulb fibroblast-like cells	56657
@NP	Transplants of these cell types	56696
@NP	Transplants	56696
@NP	these cell types	56711
@NP	a more extensive glial hypertrophy	56749
@NP	the injury site	56797
@NP	a length of the cord double that seen for pure glial cell transplants	56827
@NP	a length	56827
@NP	the cord double that seen for pure glial cell transplants	56839
@NP	the cord double	56839
@NP	pure glial cell transplants	56869
@NP	addition	56901
@NP	injections of the cells into the normal cord	56911
@NP	injections	56911
@NP	the cells into the normal cord	56925
@NP	the cells	56925
@NP	the normal cord	56940
@NP	a reaction	56964
@NP	the host tissue	56978
@NP	the bolus of transplanted cells	57020
@NP	the bolus	57020
@NP	transplanted cells	57033
@NP	GFAP and nestin IR	57053
@NP	a radial pattern in host tissue	57107
@NP	a radial pattern	57107
@NP	host tissue	57127
@NP	the transplanted cells that was not seen for pure glial cell transplants	57151
@NP	the transplanted cells	57151
@NP	pure glial cell transplants	57196
@NP	olfactory bulb fibroblast-like cells to an equal quantity of OECs	57233
@NP	olfactory bulb fibroblast-like cells	57233
@NP	an equal quantity of OECs	57273
@NP	an equal quantity	57273
@NP	OECs	57294
@NP	the astrocytic hypertrophy	57309
@NP	the extent of the glial scar	57344
@NP	the extent	57344
@NP	the glial scar	57358
@NP	that for OECs and olfactory bulb fibroblast-like cells	57398
@NP	that	57398
@NP	OECs and olfactory bulb fibroblast-like cells	57407
@NP	OECs	57407
@NP	olfactory bulb fibroblast-like cells	57416
@NP	The most extensive scarring of all	57454
@NP	The most extensive scarring	57454
@NP	all	57485
@NP	transplants of the heterogeneous cell mixture obtained from the olfactory mucosa	57524
@NP	transplants	57524
@NP	the heterogeneous cell mixture obtained from the olfactory mucosa	57539
@NP	the heterogeneous cell mixture	57539
@NP	the olfactory mucosa	57584
@NP	The glial scar	57606
@NP	following injury to the CNS	57630
@NP	following injury	57630
@NP	the CNS	57650
@NP	complex cellular and molecular mechanisms	57667
@NP	the current view	57713
@NP	it	57738
@NP	the response	57786
@NP	injury	57802
@NP	the one hand	57813
@NP	it	57827
@NP	the glia limitans	57860
@NP	the barrier	57889
@NP	the CNS	57908
@NP	the injured region	57931
@NP	the other hand	57954
@NP	this wound healing response	57970
@NP	a chemical and physical barrier	58011
@NP	axonal regeneration	58046
@NP	this aspect	58076
@NP	structural repair	58091
@NP	Faulkner	58110
@NP	et al. , 2004 ; Sofroniew and Vinters , 2010	58119
@NP	et al.	58119
@NP	2004 ; Sofroniew and Vinters	58127
@NP	2004	58127
@NP	Sofroniew and Vinters	58133
@NP	2010	58156
@NP	The transplants of fibroblast-like and OM cells	58163
@NP	The transplants	58163
@NP	fibroblast-like and OM cells	58182
@NP	a response	58227
@NP	astrocytes	58241
@NP	the lesion boundary	58264
@NP	the host spinal cord	58293
@NP	we	58325
@NP	functional tests on transplanted animals	58346
@NP	functional tests	58346
@NP	transplanted animals	58366
@NP	we	58387
@NP	the exacerbation	58399
@NP	the scarring response	58419
@NP	these cells	58452
@NP	an undesirable property	58470
@NP	strategies	58513
@NP	spinal cord injury that seek to reconstruct the damaged injury site	58533
@NP	spinal cord injury	58533
@NP	the damaged injury site	58577
@NP	It	58602
@NP	differences in host/transplant interactions seen for different cells types	58622
@NP	differences	58622
@NP	host/transplant interactions seen for different cells types	58637
@NP	host/transplant interactions	58637
@NP	different cells types	58675
@NP	implications	58702
@NP	the penetration of regenerating axons into the graft in our study	58719
@NP	the penetration	58719
@NP	axons	58751
@NP	the graft in our study	58762
@NP	the graft	58762
@NP	our study	58775
@NP	the transplants	58793
@NP	axons	58836
@NP	the transplant	58881
@NP	the glial reaction	58903
@NP	It	58939
@NP	the greater reactivity	58967
@NP	it	58996
@NP	axons	59031
@NP	the graft	59046
@NP	This	59057
@NP	the current study	59089
@NP	tract-tracing	59115
@NP	none of the transplants	59141
@NP	none	59141
@NP	the transplants	59149
@NP	regeneration , that is , regeneration beyond the transplant	59184
@NP	regeneration	59184
@NP	regeneration beyond the transplant	59207
@NP	regeneration	59207
@NP	the transplant	59227
@NP	this lack of bridging regeneration both the relative ability of the cell	59251
@NP	this lack	59251
@NP	regeneration both the relative ability of the cell	59273
@NP	regeneration	59273
@NP	the relative ability of the cell	59291
@NP	the relative ability	59291
@NP	the cell	59315
@NP	regeneration and their ability	59347
@NP	regeneration	59347
@NP	their ability	59364
@NP	the host environment	59396
@NP	significance	59428
@NP	future studies	59445
@NP	combined treatments designed to allow such regeneration to occur	59466
@NP	combined treatments	59466
@NP	such regeneration	59504
@NP	there	59541
@NP	little difference	59551
@NP	the extent	59572
@NP	the glial scarring	59586
@NP	OEC and SC transplants in the wire knife injury	59621
@NP	OEC and SC transplants	59621
@NP	the wire knife injury	59647
@NP	the macroscopic level	59672
@NP	there	59695
@NP	well-established differences	59705
@NP	the interaction between these cells and host astrocytes	59737
@NP	the interaction	59737
@NP	these cells and host astrocytes	59761
@NP	the cellular and molecular levels	59796
@NP	In vitro , OECs	59831
@NP	In vitro	59831
@NP	OECs	59841
@NP	a reactive response in astrocytes and less chondroitin sulfate	59861
@NP	a reactive response	59861
@NP	astrocytes and less chondroitin sulfate	59884
@NP	astrocytes	59884
@NP	less chondroitin sulfate	59899
@NP	SCs	59953
@NP	addition	59961
@NP	OECs	59977
@NP	astrocytes in a co-culture	60001
@NP	astrocytes	60001
@NP	a co-culture	60015
@NP	SCs	60029
@NP	a distinct boundary	60046
@NP	Lakatos	60067
@NP	et al. , 2000 , 2003 ; Santos-Silva et al. , 2007	60075
@NP	et al.	60075
@NP	2000 , 2003 ; Santos-Silva et al.	60083
@NP	2000 , 2003	60083
@NP	2000	60083
@NP	2003	60089
@NP	Santos-Silva et al.	60095
@NP	Santos-Silva	60095
@NP	et al.	60108
@NP	2007	60116
@NP	This	60123
@NP	the current study	60143
@NP	other spinal cord injury models	60199
@NP	transplants of OECs and SCs	60237
@NP	transplants	60237
@NP	OECs and SCs	60252
@NP	a dorsal column crush model	60280
@NP	the SC/host interface	60315
@NP	a continuous astrocytic boundary	60357
@NP	the OEC/host interface	60391
@NP	openings	60424
@NP	the astrocyte layer -LRB- Andrews and Stelzner , 2007 -RRB-	60436
@NP	the astrocyte layer	60436
@NP	Andrews and Stelzner	60457
@NP	2007	60479
@NP	addition	60489
@NP	a moderate contusion injury model	60522
@NP	OECs	60557
@NP	less astrocytosis and lower levels of chondroitin sulfate proteoglycans	60571
@NP	less astrocytosis	60571
@NP	lower levels of chondroitin sulfate proteoglycans	60593
@NP	lower levels	60593
@NP	chondroitin sulfate proteoglycans	60609
@NP	SCs -LRB- Takami et al. , 2002 -RRB-	60648
@NP	SCs	60648
@NP	Takami	60653
@NP	et al. , 2002	60660
@NP	et al.	60660
@NP	2002	60668
@NP	These actions	60675
@NP	important implications	60698
@NP	the repair potential	60725
@NP	OECs -LRB- Raisman and Li , 2007 -RRB-	60749
@NP	OECs	60749
@NP	Raisman and Li , 2007	60755
@NP	Raisman	60755
@NP	Li , 2007	60767
@NP	Li	60767
@NP	2007	60771
@NP	some possible advantages over SCs	60788
@NP	some possible advantages	60788
@NP	SCs	60818
@NP	Implications for Clinical Translation of Cell Transplantation	60823
@NP	Implications	60823
@NP	Clinical Translation of Cell Transplantation	60840
@NP	Clinical Translation	60840
@NP	Cell Transplantation	60864
@NP	Our results	60885
@NP	pure populations	60907
@NP	glial cells	60927
@NP	a more diverse range	60949
@NP	cells types	60988
@NP	fibroblast-like cells not generally considered	61011
@NP	fibroblast-like cells	61011
@NP	unique regeneration promoting properties	61066
@NP	unique regeneration	61066
@NP	properties	61096
@NP	significant regeneration of axons	61120
@NP	significant regeneration	61120
@NP	axons	61148
@NP	transplantation	61160
@NP	dorsal column lesions	61181
@NP	none of the cell types	61213
@NP	none	61213
@NP	the cell types	61221
@NP	significant long distance axonal regeneration	61245
@NP	the emergent view	61303
@NP	cell transplants	61326
@NP	one element of a combined strategy	61364
@NP	one element	61364
@NP	a combined strategy	61379
@NP	axonal regeneration	61413
@NP	Murray and Fischer	61434
@NP	2001 ; Bunge , 2008 ; Kadoya et al. , 2009 ; Gros et al.	61454
@NP	2001	61454
@NP	Bunge , 2008 ; Kadoya et al. , 2009 ; Gros et al.	61460
@NP	Bunge , 2008	61460
@NP	Bunge	61460
@NP	2008	61467
@NP	Kadoya et al. , 2009	61473
@NP	Kadoya	61473
@NP	et al. , 2009	61480
@NP	et al.	61480
@NP	2009	61488
@NP	Gros et al.	61494
@NP	Gros	61494
@NP	et al.	61499
@NP	2010	61507
@NP	The study	61514
@NP	transplants of fibroblast-like cells	61548
@NP	transplants	61548
@NP	fibroblast-like cells	61563
@NP	transplants containing fibroblast-like cells	61589
@NP	transplants	61589
@NP	fibroblast-like cells	61612
@NP	a more marked host cell response than purified glial cell populations	61643
@NP	a more marked host cell response	61643
@NP	glial cell populations	61690
@NP	candidates for cell mediated repair	61728
@NP	candidates	61728
@NP	cell mediated repair	61743
@NP	an environment permissive for axonal regeneration	61777
@NP	an environment permissive	61777
@NP	axonal regeneration	61807
@NP	our study	61827
@NP	it	61851
@NP	account of how readily the cells integrate with the host spinal cord	61885
@NP	account	61885
@NP	the cells	61908
@NP	the host spinal cord	61933
@NP	This	61955
@NP	important implications for the choice of cells for clinical use	61964
@NP	important implications	61964
@NP	the choice of cells for clinical use	61991
@NP	the choice	61991
@NP	cells for clinical use	62005
@NP	cells	62005
@NP	clinical use	62015
@NP	some clinical programmes	62050
@NP	olfactory tissues	62085
@NP	e.g.	62103
@NP	olfactory mucosa -LRB- Lima et al. , 2006 ; Iwatsuki et al. , 2008 -RRB-	62108
@NP	olfactory mucosa	62108
@NP	Lima	62126
@NP	et al. , 2006 ; Iwatsuki et al. , 2008	62131
@NP	et al.	62131
@NP	2006 ; Iwatsuki et al.	62139
@NP	2006	62139
@NP	Iwatsuki et al.	62145
@NP	Iwatsuki	62145
@NP	et al.	62154
@NP	2008	62162
@NP	fetal tissue -LRB- Huang et al. , 2006 ; Liu et al. , 2010 -RRB-	62171
@NP	fetal tissue	62171
@NP	Huang	62185
@NP	et al. , 2006 ; Liu et al. , 2010	62191
@NP	et al.	62191
@NP	2006 ; Liu et al.	62199
@NP	2006	62199
@NP	Liu et al.	62205
@NP	Liu	62205
@NP	et al.	62209
@NP	2010	62217
@NP	cell cultures	62245
@NP	it	62264
@NP	the greater reactivity of the diverse cells types within these tissues	62284
@NP	the greater reactivity	62284
@NP	the diverse cells types within these tissues	62310
@NP	the diverse cells types	62310
@NP	these tissues	62341
@NP	summary	62386
@NP	our results	62395
@NP	the cells compared here	62424
@NP	the cells	62424
@NP	pure preparations of glial cells -LRB- OECs and SCs -RRB-	62449
@NP	pure preparations of glial cells	62449
@NP	pure preparations	62449
@NP	glial cells	62470
@NP	OECs and SCs	62483
@NP	OECs	62483
@NP	SCs	62492
@NP	an optimal combination of desirable properties	62505
@NP	an optimal combination	62505
@NP	desirable properties	62531
@NP	maximal support for axonal regeneration	62563
@NP	maximal support	62563
@NP	axonal regeneration	62583
@NP	a minimal glial reaction	62617
@NP	the transplant site	62649
@NP	This information	62670
@NP	the choice of cells for use	62712
@NP	the choice	62712
@NP	cells for use	62726
@NP	cells	62726
@NP	use	62736
@NP	future combinatorial therapies for spinal cord injury	62743
@NP	future combinatorial therapies	62743
@NP	spinal cord injury	62778
@NP	indeed purified cells	62801
@NP	transplant	62841
@NP	repair	62861
@NP	this in turn	62873
@NP	this	62873
@NP	turn	62881
@NP	implications	62890
@NP	the sourcing of cells and quality control of the culture process	62907
@NP	the sourcing	62907
@NP	cells and quality control	62923
@NP	the culture process	62952
@NP	a considerable volume of cells	62978
@NP	a considerable volume	62978
@NP	cells	63003
@NP	a human spinal cord injury	63034
@NP	It	63062
@NP	some of the stem cell and stem	63106
@NP	some	63106
@NP	the stem cell and stem	63114
@NP	cell-derived cell types	63137
@NP	use in spinal cord injury	63194
@NP	use	63194
@NP	spinal cord injury	63201
@NP	their regeneration supporting properties	63238
@NP	their regeneration	63238
@NP	properties	63268
@NP	cells	63305
@NP	their interaction with the host spinal cord	63336
@NP	their interaction	63336
@NP	the host spinal cord	63359
@NP	that of glial cells or that of fibroblast-like cells	63390
@NP	that of glial cells	63390
@NP	that	63390
@NP	glial cells	63398
@NP	that of fibroblast-like cells	63413
@NP	that	63413
@NP	fibroblast-like cells	63421
@VP	Injured Spinal Cord ANDREW TOFT ,1,2 * MERCEDES TOME ,1,2 SUSAN C.	99
@VP	have been investigated for their repair potential	672
@VP	been investigated for their repair potential	677
@VP	investigated for their repair potential	682
@VP	complicate determination of which cells are most effective	759
@VP	are most effective	799
@VP	supported axonal regeneration	1365
@VP	were least efficient and mixed cell populations	1466
@VP	were less effective than purified populations	1514
@VP	demonstrated that none of the cell types promoted regeneration beyond the lesion	1587
@VP	promoted regeneration beyond the lesion	1628
@VP	prevented cavity formation	1693
@VP	were associated with the least GFAP-IR	1849
@VP	associated with the least GFAP-IR	1854
@VP	surrounding transplants of OM	1973
@VP	was most extensive	2003
@VP	is not complicated by injury	2164
@VP	ascending and descending the spinal cord	2468
@VP	once damaged	2594
@VP	can not regenerate	2630
@VP	regenerate	2637
@VP	promoting axonal regeneration and spinal cord repair	2927
@VP	resulting in a proliferation of cell types with the potential to mediate repair	3093
@VP	to mediate repair	3155
@VP	mediate repair	3158
@VP	occurs	3429
@VP	found in the olfactory system where sensory neurons regenerate throughout life	3464
@VP	regenerate throughout life	3516
@VP	obtained from various tissues	3604
@VP	have any identified intrinsic growth promoting properties	3859
@VP	promoting properties	3896
@VP	supporting axonal regeneration within the transplant environment to some degree	3993
@VP	is not clear which cell type provides the best support for axonal regeneration	4170
@VP	provides the best support for axonal regeneration	4199
@VP	making any such comparison	4263
@VP	is the wide variation in study designs employed	4290
@VP	employed	4329
@VP	have been used	4363
@VP	been used	4368
@VP	used	4373
@VP	has been examined	4438
@VP	been examined	4442
@VP	examined	4447
@VP	to determine whether one cell type has a greater potential than another	4753
@VP	determine whether one cell type has a greater potential than another	4756
@VP	has a greater potential than another	4788
@VP	differentiated cells that would be suitable for autologous transplantation	4855
@VP	would be suitable for autologous transplantation	4881
@VP	be suitable for autologous transplantation	4887
@VP	may have an advantage -LRB- Li et al. , 2005a -RRB-	4985
@VP	have an advantage -LRB- Li et al. , 2005a -RRB-	4989
@VP	has been preferred	5123
@VP	been preferred	5127
@VP	preferred	5132
@VP	may contaminate glial cell preparations	5202
@VP	contaminate glial cell preparations	5206
@VP	have been included together with glial cells in mixed cell transplants	5255
@VP	been included together with glial cells in mixed cell transplants	5260
@VP	included together with glial cells in mixed cell transplants	5265
@VP	would be contained in tissue transplants	5342
@VP	be contained in tissue transplants	5348
@VP	contained in tissue transplants	5351
@VP	were tested	5438
@VP	tested	5443
@VP	promoting axonal regeneration	5462
@VP	mediated CNS repair should also integrate optimally with the host spinal cord	5524
@VP	should also integrate optimally with the host spinal cord	5544
@VP	integrate optimally with the host spinal cord	5556
@VP	react minimally with endogenous glial cells	5603
@VP	should not exacerbate the glial scar	5651
@VP	exacerbate the glial scar	5662
@VP	interact more favorably with astrocytes than SCs , both in vitro	5756
@VP	interact more favorably with astrocytes than SCs	5756
@VP	in vitro	5811
@VP	is known about other candidate cell types	5949
@VP	known about other candidate cell types	5952
@VP	integrate with the host spinal cord more favorably than others	6098
@VP	are capable of supporting substantial axonal regeneration	6213
@VP	supporting substantial axonal regeneration	6228
@VP	tested	6293
@VP	promote regeneration beyond the lesion	6300
@VP	induce marked astrocytosis in the host spinal cord at the transplant site	6401
@VP	includes cells that are potential contaminants of glial cell populations	6481
@VP	are potential contaminants of glial cell populations	6501
@VP	to integrate favorably within the host neuropil	6755
@VP	integrate favorably within the host neuropil	6758
@VP	were used for both cell preparation and transplantation	6877
@VP	used for both cell preparation and transplantation	6882
@VP	were performed in syngeneic adult male animals -LRB- 200 -- 250 g -RRB-	7050
@VP	performed in syngeneic adult male animals -LRB- 200 -- 250 g -RRB-	7055
@VP	approved by the Ethical Review Panel of the University of Glasgow	7143
@VP	were prepared as previously described by Tome et al. -LRB- 2009 -RRB-	7368
@VP	prepared as previously described by Tome et al. -LRB- 2009 -RRB-	7373
@VP	described by Tome et al. -LRB- 2009 -RRB-	7396
@VP	were removed from the heads of postnatal day 7 -LRB- P7 -RRB- rats	7454
@VP	removed from the heads of postnatal day 7 -LRB- P7 -RRB- rats	7459
@VP	was cut longitudinally	7521
@VP	cut longitudinally	7525
@VP	dissected with forceps	7563
@VP	was separated from the turbinate with forceps under the microscope	7689
@VP	separated from the turbinate with forceps under the microscope	7693
@VP	disrupted manually with a scalpel	7760
@VP	obtained from 7 to 9 animals	7806
@VP	to reduce cell clumping	8127
@VP	reduce cell clumping	8130
@VP	dissociated by pipetting gently several times	8167
@VP	pipetting gently several times	8182
@VP	plated in a 10 µg/cm2 collagen-coated T25 flask -LRB- Greiner Bio-one -RRB-	8217
@VP	were maintained at 37 °C in a 7 % CO2 incubator	8570
@VP	maintained at 37 °C in a 7 % CO2 incubator	8575
@VP	was changed every 2 -- 3 days	8631
@VP	changed every 2 -- 3 days	8635
@VP	Purified OECs and SCs	8659
@VP	described from P7 rat pups -LRB- Lakatos et al. , 2000 -RRB-	8722
@VP	maintained on PLL-coated flasks -LRB- 13.3 µg/mL ; Sigma -RRB-	8776
@VP	were obtained from olfactory bulbs of P7 rats using methods based on those	9546
@VP	obtained from olfactory bulbs of P7 rats using methods based on those	9551
@VP	using methods based on those	9592
@VP	used by Li et al. -LRB- 2003 -RRB-	9621
@VP	dissected	9672
@VP	enzymatically dissociated as described for the preparation of cell suspension	9686
@VP	described for the preparation of cell suspension	9715
@VP	centrifuged at 12,000 rpm	9839
@VP	placed into 25 cm3 tissue culture flasks containing DMEM-FBS	9869
@VP	containing DMEM-FBS	9910
@VP	were fed three times a week and passaged when confluent	9937
@VP	fed three times a week and passaged when confluent	9942
@VP	fed three times a week	9942
@VP	passaged when confluent	9969
@VP	assessed by lack of p75NTR expression and expression of thy1 .1	10093
@VP	smooth muscle actin -LRB- SMA -RRB- -LRB- Fig. 1 -RRB-	10160
@VP	described by Keyvan-Fouladi et al -LRB- 2003 , 2005 -RRB-	10302
@VP	are removed from the SC	10470
@VP	removed from the SC	10474
@VP	were allowed to overgrow	10514
@VP	allowed to overgrow	10519
@VP	to overgrow	10527
@VP	overgrow	10530
@VP	followed by trypsin -LRB- 0.25 % Sigma -RRB- for 15 min	10637
@VP	centrifuged at 12,000 rpm	10739
@VP	placed into 25 cm3 tissue culture flasks containing 10 % DMEM-FBS	10769
@VP	containing 10 % DMEM-FBS	10810
@VP	were fed three times a week and passaged when confluent	10841
@VP	fed three times a week and passaged when confluent	10846
@VP	fed three times a week	10846
@VP	passaged when confluent	10873
@VP	purified olfactory bulb cells	10924
@VP	using a protocol modified from Tuszynski et al. , 1996	11178
@VP	modified from Tuszynski	11195
@VP	measuring 10 3 10 mm3 in size	11256
@VP	were obtained from the abdominal region	11286
@VP	obtained from the abdominal region	11291
@VP	cleaned	11345
@VP	cut into 131mm3 pieces	11354
@VP	placed onto the surface of PLL-coated wells of a 24 well dish	11378
@VP	cultured in DMEMFBS	11444
@VP	grow out fromthe explant	11490
@VP	passaged and expanded in culture	11534
@VP	as the passaged cells	11714
@VP	immunolabeled with markers that characterize the various cell types	11741
@VP	characterize the various cell types	11773
@VP	trypsinized from the flask	11906
@VP	washed	11934
@VP	collected by centrifugation at 300g for 5 min	11945
@VP	were kept on ice until transplantation	11998
@VP	kept on ice until transplantation	12003
@VP	were plated onto 10 µg/cm2 collagen I-coated coverslips	12214
@VP	plated onto 10 µg/cm2 collagen I-coated coverslips	12219
@VP	was carried out on cells plated on PLL coated coverslips	12353
@VP	carried out on cells plated on PLL coated coverslips	12357
@VP	plated on PLL coated coverslips	12378
@VP	was used to label cells prepared at passage and at the time of transplantation	12449
@VP	used to label cells prepared at passage and at the time of transplantation	12453
@VP	prepared at passage and at the time of transplantation	12473
@VP	followed by the appropriate fluorochrome-conjugated secondary antibody	12951
@VP	fixed in methanol for 20 min at 220 C.	13026
@VP	were added followed by their appropriate secondary antibodies	13124
@VP	added followed by their appropriate secondary antibodies	13129
@VP	used at 1:100	13412
@VP	to dilute the antibody stocks and wash between incubations	13547
@VP	dilute the antibody stocks and wash between incubations	13550
@VP	containing 406-diamidine	13695
@VP	to visualize nuclei	13759
@VP	visualize nuclei	13762
@VP	was carried out on all cell cultures	14065
@VP	carried out on all cell cultures	14069
@VP	labeled nuclei counted per coverslip	14213
@VP	counted per coverslip	14228
@VP	were derived from 4 to 5 separate experiments	14272
@VP	derived from 4 to 5 separate experiments	14277
@VP	described previously	14509
@VP	exposed by laminectomy	14639
@VP	inserted over the left dorsal root entry zone	14682
@VP	protruded to form an arc encompassing the dorsal columns	14729
@VP	to form an arc encompassing the dorsal columns	14739
@VP	form an arc encompassing the dorsal columns	14742
@VP	encompassing the dorsal columns	14754
@VP	placed on the surface of the cord , cutting through the dorsal columns	14817
@VP	cutting through the dorsal columns	14852
@VP	was to be used to investigate regeneration	14975
@VP	to be used to investigate regeneration	14979
@VP	be used to investigate regeneration	14982
@VP	used to investigate regeneration	14985
@VP	to investigate regeneration	14990
@VP	investigate regeneration	14993
@VP	see below	15019
@VP	being transported along anastomosing afferent fibers in adjacent roots	15107
@VP	transported along anastomosing afferent fibers in adjacent roots	15113
@VP	anastomosing afferent fibers in adjacent roots	15131
@VP	described previously	15307
@VP	was gradually raised to the surface	15772
@VP	raised to the surface	15786
@VP	were observed overflowing from the lesion	15818
@VP	observed overflowing from the lesion	15823
@VP	overflowing from the lesion	15832
@VP	to close the dura	15947
@VP	close the dura	15950
@VP	were closed in layers and animals	15973
@VP	closed in layers and animals	15978
@VP	routinely received	16007
@VP	exposed by laminectomy at the T13/L1 vertebral junction	16424
@VP	inserted into the left	16671
@VP	right dorsal columns	16701
@VP	pointing medially	16865
@VP	ascending dorsal column axons	17048
@VP	was assessed using tract-tracing with BDA -LRB- 10,000 MW , product no	17078
@VP	assessed using tract-tracing with BDA -LRB- 10,000 MW , product no	17082
@VP	using tract-tracing with BDA -LRB- 10,000 MW , product no	17091
@VP	injected 2 weeks before perfusion	17164
@VP	see below	17199
@VP	were exposed at the level of the iliac crest under surgical anaesthesia	17244
@VP	exposed at the level of the iliac crest under surgical anaesthesia	17249
@VP	see above	17365
@VP	dye added -LRB- to detect spillage of the tracer -RRB-	17533
@VP	added -LRB- to detect spillage of the tracer -RRB-	17537
@VP	to detect spillage of the tracer	17544
@VP	detect spillage of the tracer	17547
@VP	were closed in layers and analgesia administered as above	17603
@VP	closed in layers and analgesia administered as above	17608
@VP	administered as above	17639
@VP	containing 0.1 % lidocaine	18006
@VP	freshly depolymerized 4 % paraformaldehyde in 0.1 M PF , pH 7.4	18045
@VP	encompassing the lesion/transplant or injection sites	18126
@VP	was removed and post-fixed overnight in the same fixative with 30 % sucrose	18180
@VP	removed and post-fixed overnight in the same fixative with 30 % sucrose	18184
@VP	removed	18184
@VP	post-fixed overnight in the same fixative with 30 % sucrose	18196
@VP	encompassing the lesion/injection sites	18271
@VP	cut on a freezing microtome	18316
@VP	incubated free-floating for 30 min	18348
@VP	then washed for 10 min in 0.3 M phosphatebuffered saline -LRB- PBS -RRB-	18398
@VP	phosphatebuffered saline -LRB- PBS -RRB-	18430
@VP	was to be detected	18926
@VP	to be detected	18930
@VP	be detected	18933
@VP	detected	18936
@VP	substituted in place of one of the antibodies in the primary antibody cocktail	19037
@VP	incubated in fluorophore	19144
@VP	conjugated species-specific donkey IgG secondary antibodies for 4 h	19170
@VP	were diluted in PBS with 0.3 % triton X-100	19274
@VP	diluted in PBS with 0.3 % triton X-100	19279
@VP	using VectaShield -LRB- Vector laboratories -RRB-	19364
@VP	stored at 220 °C	19408
@VP	using a Nikon Eclipse E600 epifluorescence microscope	19511
@VP	were noted	19668
@VP	noted	19673
@VP	Selected sections	19680
@VP	using a Bio-Rad MRC1024 confocal system	19819
@VP	using Confocal Assistant software , Todd Clark Brelje , University of Minnesota	19939
@VP	labeled axons	20094
@VP	entered the cell transplant in the lesion site	20108
@VP	passed rostrally of the dorsal column lesion	20158
@VP	selected for illustration	20211
@VP	were imported to Adobe Photoshop CS2 and formatted for publication	20237
@VP	imported to Adobe Photoshop CS2 and formatted for publication	20242
@VP	imported to Adobe Photoshop CS2	20242
@VP	formatted for publication	20278
@VP	differed when different cell preparations were grafted into the lesion site	20417
@VP	were grafted into the lesion site	20459
@VP	grafted into the lesion site	20464
@VP	defined the glial scar around the perimeter of the transplanted lesion	20601
@VP	showing the greatest distance between rostral and caudal lesion perimeters	20753
@VP	were exported to ImageJ software -LRB- NIH Image , Rasband , W.S. , ImageJ , U.	21024
@VP	exported to ImageJ software -LRB- NIH Image , Rasband , W.S. , ImageJ , U.	21029
@VP	were performed using GraphPad Prism v4 .03	21304
@VP	performed using GraphPad Prism v4 .03	21309
@VP	using GraphPad Prism v4 .03	21319
@VP	was used to test for significant differences between lesion lengths	21396
@VP	used to test for significant differences between lesion lengths	21400
@VP	to test for significant differences between lesion lengths	21405
@VP	test for significant differences between lesion lengths	21408
@VP	Regenerating Axons Regeneration into each cell transplant	21494
@VP	using ImageJ software	21685
@VP	was drawn using the `` Freehand selections '' tool	21824
@VP	drawn using the `` Freehand selections '' tool	21828
@VP	using the `` Freehand selections '' tool	21834
@VP	was multiplied by the number of sections within the image stack	21903
@VP	multiplied by the number of sections within the image stack	21907
@VP	stack	21961
@VP	stack to obtain a volume in µm3	22016
@VP	to obtain a volume in µm3	22022
@VP	obtain a volume in µm3	22025
@VP	to convert stacks of labeled axons into stacks of 1 pixel thick profiles	22167
@VP	convert stacks of labeled axons into stacks of 1 pixel thick profiles	22170
@VP	labeled axons into stacks of 1 pixel thick profiles	22188
@VP	stack was then obtained using the `` Analyze Particles '' function	22300
@VP	was then obtained using the `` Analyze Particles '' function	22306
@VP	obtained using the `` Analyze Particles '' function	22315
@VP	using the `` Analyze Particles '' function	22324
@VP	Analyze Particles	22336
@VP	are reported using one-way ANOVA with Tukey -- Kramer post hoc testing	22522
@VP	reported using one-way ANOVA with Tukey -- Kramer post hoc testing	22526
@VP	using one-way ANOVA with Tukey	22535
@VP	TABLE 1	22600
@VP	used for transplantation	22819
@VP	bar 10 µm -LRB- A -- C , G , I , L , and K -RRB-	23103
@VP	can be viewed in the online issue , which is available at wileyonlinelibrary.com	23444
@VP	be viewed in the online issue , which is available at wileyonlinelibrary.com	23448
@VP	viewed in the online issue , which is available at wileyonlinelibrary.com	23451
@VP	is available at wileyonlinelibrary.com	23485
@VP	assessed using anti-neurofilament	23579
@VP	using anti-neurofilament	23588
@VP	transplanted with each cell preparation	23743
@VP	depicts the glial scar delineating the lesion/graft site	23882
@VP	delineating the lesion/graft site	23905
@VP	To quantify regeneration in each transplant	23940
@VP	quantify regeneration in each transplant	23943
@VP	was assessed in confocal image stacks	24064
@VP	assessed in confocal image stacks	24068
@VP	show mean 6 SD	24203
@VP	showed significant differences between OECs and OBFB-L	24267
@VP	-LRB- A -- G -RRB- scale bar = 500 µm	24466
@VP	can be viewed in the online issue , which is available at wileyonlinelibrary.com	24676
@VP	be viewed in the online issue , which is available at wileyonlinelibrary.com	24680
@VP	viewed in the online issue , which is available at wileyonlinelibrary.com	24683
@VP	is available at wileyonlinelibrary.com	24717
@VP	assessed using tract tracing	24787
@VP	using tract tracing	24796
@VP	tracing	24808
@VP	transplanted with different cell preparations	24890
@VP	to label regenerating ascending dorsal column axons	25000
@VP	label regenerating ascending dorsal column axons	25003
@VP	regenerating ascending dorsal column axons	25009
@VP	ascending dorsal column axons	25022
@VP	supported regeneration of ascending dorsal column axons but regenerating axons	25092
@VP	ascending dorsal column axons but regenerating axons	25118
@VP	ascending dorsal column axons	25118
@VP	regenerating axons	25152
@VP	were confined to the transplant within the lesion site	25171
@VP	confined to the transplant within the lesion site	25176
@VP	is delineated with GFAP immunostaining for the astrocytic scar -LRB- blue -RRB-	25247
@VP	delineated with GFAP immunostaining for the astrocytic scar -LRB- blue -RRB-	25250
@VP	regenerating into the lesion site	25339
@VP	can be seen in red	25373
@VP	be seen in red	25377
@VP	seen in red	25380
@VP	boxed areas	25397
@VP	are shown in high power -LRB- 360 -RRB- insets in each panel	25409
@VP	shown in high power -LRB- 360 -RRB- insets in each panel	25413
@VP	bar A inset , 25 µm	25486
@VP	can be viewed in the online issue , which is available at wileyonlinelibrary.com	25520
@VP	be viewed in the online issue , which is available at wileyonlinelibrary.com	25524
@VP	viewed in the online issue , which is available at wileyonlinelibrary.com	25527
@VP	is available at wileyonlinelibrary.com	25561
@VP	assessed using GFAP immunolabeling	25781
@VP	using GFAP immunolabeling	25790
@VP	varied considerably with different cell preparations	25839
@VP	To quantify the mean lesion length	25893
@VP	quantify the mean lesion length	25896
@VP	showed the maximum rostro-caudal extent of the lesion	25963
@VP	was measured with the mean values 6 SD reported in H.	26017
@VP	measured with the mean values 6 SD reported in H.	26021
@VP	reported in H.	26056
@VP	contained a mixture of cells	26148
@VP	resulted in longer lesions	26201
@VP	bar = 500 µm	26700
@VP	= 500 µm	26704
@VP	to assess the induced glial reaction	26921
@VP	assess the induced glial reaction	26924
@VP	mingled throughout the injected area	27003
@VP	induce less interaction of this sort and tend to be closely	27051
@VP	induce less interaction of this sort	27051
@VP	tend to be closely	27092
@VP	to be closely	27097
@VP	be closely	27100
@VP	surrounded by the astrocytic tissue	27111
@VP	containing fibroblasts	27182
@VP	induced a more pronounced glial reaction	27205
@VP	radiated around the transplanted cell bolus	27363
@VP	injected with comparable volumes of culture medium	27420
@VP	seen above	27583
@VP	were mostly due to the transplanted cells	27594
@VP	bar A , 400 µm -LRB- applicable to A , D , G , J , M , and P -RRB-	27643
@VP	bar B , 100 µm -LRB- applicable to B&C , E&F , H&I , K&L , N&O , and Q&R -RRB-	27701
@VP	can be viewed in the online issue , which is available at wileyonlinelibrary.com	27779
@VP	be viewed in the online issue , which is available at wileyonlinelibrary.com	27783
@VP	viewed in the online issue , which is available at wileyonlinelibrary.com	27786
@VP	is available at wileyonlinelibrary.com	27820
@VP	are myelinated and express markers of nodal architecture	27889
@VP	are myelinated	27889
@VP	myelinated	27893
@VP	express markers of nodal architecture	27908
@VP	were assessed using immunostaining for P0 -LRB- peripheral - type myelin ,	28017
@VP	assessed using immunostaining for P0 -LRB- peripheral - type myelin ,	28022
@VP	using immunostaining for P0 -LRB- peripheral - type myelin ,	28031
@VP	detected throughout the transplants , enwrapped by P0 -LRB- green , arrows -RRB-	28137
@VP	enwrapped by P0 -LRB- green , arrows -RRB-	28174
@VP	suggesting normal paranodal architecture -LRB- arrows -RRB-	28426
@VP	bar A , 100 µm -LRB- applicable to A -- D -RRB-	28483
@VP	bar E , 20 µm -LRB- applicable to E , F -RRB-	28524
@VP	can be viewed in the online issue , which is available at wileyonlinelibrary.com	28573
@VP	be viewed in the online issue , which is available at wileyonlinelibrary.com	28577
@VP	viewed in the online issue , which is available at wileyonlinelibrary.com	28580
@VP	is available at wileyonlinelibrary.com	28614
@VP	was used to characterize the transplanted cells	28689
@VP	used to characterize the transplanted cells	28693
@VP	to characterize the transplanted cells	28698
@VP	characterize the transplanted cells	28701
@VP	are shown in Table 1	28759
@VP	shown in Table 1	28763
@VP	are shown in Figure 1	28816
@VP	shown in Figure 1	28820
@VP	were generally over 97 % pure as defined by expression of the low affinity nerve	28871
@VP	defined by expression of the low affinity nerve	28903
@VP	to be highly reactive to neuron specific class III b-tubulin -LRB- bIII -RRB-	29361
@VP	be highly reactive to neuron specific class III b-tubulin -LRB- bIII -RRB-	29364
@VP	reported not to cross react with b-tubulin found in glial cells	29433
@VP	to cross react with b-tubulin found in glial cells	29446
@VP	cross react with b-tubulin found in glial cells	29449
@VP	react with b-tubulin found in glial cells	29455
@VP	found in glial cells	29476
@VP	were found to express this marker	29554
@VP	found to express this marker	29559
@VP	to express this marker	29565
@VP	express this marker	29568
@VP	were over 96 % pure -LRB- p75NTR positive -RRB-	29612
@VP	about 50 % of cells in each case were TUJ-1 positive	29653
@VP	suggest that TUJ-1 is expressed by both OECs and SCs	29711
@VP	is expressed by both OECs and SCs	29730
@VP	expressed by both OECs and SCs	29733
@VP	is not specific to neurons	29814
@VP	is a component of the mitotic spindle in multiple cell types	29845
@VP	expressed high levels of fibronectin	29997
@VP	obtained from these tissues	30214
@VP	looked morphologically similar to one another	30242
@VP	expressing the various antigens	30313
@VP	differed	30345
@VP	isolated from the skin	30361
@VP	were used as a positive control for typical fibroblasts	30384
@VP	used as a positive control for typical fibroblasts	30389
@VP	also expressed SMA but only 3 % expressed nestin	30565
@VP	also expressed SMA	30565
@VP	only 3 % expressed nestin	30588
@VP	had a similar antigenic profile to SFs but with some quantitative differences	30620
@VP	isolated from the olfactory bulb	30738
@VP	expressed Thy1 .1	30917
@VP	suggest these cells are not typical fibroblasts	30951
@VP	are not typical fibroblasts	30971
@VP	generated from the olfactory mucosa	31009
@VP	is unlikely that after 10 days in culture any neurons would have survived	31177
@VP	would have survived	31231
@VP	have survived	31237
@VP	survived	31242
@VP	would remain in the culture	31287
@VP	remain in the culture	31293
@VP	not labeled with any of the panel of antibodies	31354
@VP	obtained from the transplant sites	31667
@VP	transplanted with the different cell types	31798
@VP	immunolabeled with the axonal marker neurofilament-200	31845
@VP	shown in red	31901
@VP	could be seen entering and growing within transplants of all of the cell types	31946
@VP	be seen entering and growing within transplants of all of the cell types	31952
@VP	seen entering and growing within transplants of all of the cell types	31955
@VP	entering and growing within transplants of all of the cell types	31960
@VP	investigated showing that each supports axonal regeneration to some degree	32025
@VP	showing that each supports axonal regeneration to some degree	32038
@VP	supports axonal regeneration to some degree	32056
@VP	summarized in the quantitative analysis in Figure 2H	32179
@VP	supported the greatest axonal density and therefore regeneration	32253
@VP	considered as cell types supporting axonal regeneration	32379
@VP	supporting axonal regeneration	32404
@VP	contained substantial numbers of axons	32436
@VP	tested	32567
@VP	were mixed with the OBFB-L cells	32585
@VP	mixed with the OBFB-L cells	32590
@VP	was increased	32632
@VP	increased	32636
@VP	was still less effective than OECs alone	32667
@VP	detected within the transplants	32807
@VP	regenerated beyond the lesion , tract tracing studies	32839
@VP	tracing studies	32876
@VP	were performed in a subset of animals	32892
@VP	performed in a subset of animals	32897
@VP	to label ascending dorsal column fibers	33003
@VP	label ascending dorsal column fibers	33006
@VP	ascending dorsal column fibers	33012
@VP	labeled fibers in animals transplanted with OECs , SCs , PNFB and OM	33060
@VP	transplanted with OECs , SCs , PNFB and OM	33086
@VP	are shown in Figure 3	33127
@VP	shown in Figure 3	33131
@VP	regenerating dorsal column fibers	33159
@VP	are among those regenerating in the transplants	33267
@VP	regenerating in the transplants	33283
@VP	extended beyond the transplanted lesion in any of the animals	33328
@VP	creates a gap that develops over several weeks into a fluid filled cavity	33475
@VP	develops over several weeks into a fluid filled cavity	33494
@VP	filled cavity	33535
@VP	extends rostro-caudally with time -LRB- Toft et al. , 2007 -RRB-	33606
@VP	filled the gap created by lesioning and prevented the development of cavities	33691
@VP	filled the gap created by lesioning	33691
@VP	created by lesioning	33706
@VP	lesioning	33717
@VP	prevented the development of cavities	33731
@VP	defined by GFAP immunolabeling of the glial scar	33859
@VP	transplanted with different cell types taken at the same magnification	34006
@VP	taken at the same magnification	34045
@VP	are shown in Figure 4	34077
@VP	shown in Figure 4	34081
@VP	was quantified	34147
@VP	quantified	34151
@VP	containing fibroblasts	34264
@VP	resulted in more extensive lesion environments -LRB- 1.5 -- 2.1 mm -RRB-	34287
@VP	produced the most extensive injury sites -LRB- 2.5 mm rostro-caudally -RRB-	34367
@VP	To further investigate the reaction of host astrocytes to transplanted cells	34497
@VP	further investigate the reaction of host astrocytes to transplanted cells	34500
@VP	were made into the normal spinal cord	34601
@VP	made into the normal spinal cord	34606
@VP	expressed in the processes of reactive astrocytes	34679
@VP	performed on tissue sections from the transplant site after 10 days	34730
@VP	immunolabeled with nestin -LRB- red -RRB- and GFAP -LRB- blue -RRB-	34889
@VP	produced a glial reaction , the extent of which varied with cell type	35076
@VP	varied with cell type	35123
@VP	produced relatively low amounts of astrocytic hypertrophy	35238
@VP	was similar in extent	35420
@VP	were largely excluded from the central cell bolus	35457
@VP	excluded from the central cell bolus	35470
@VP	was also very little mingling between astrocytes and the PNFB and OM grafts	35514
@VP	radiating outwards from the central cell bolus	35658
@VP	defined by nestin IR and this	35839
@VP	Transplanted Cells with Regenerating Axons In some transplants	35961
@VP	Regenerating Axons In some transplants	35985
@VP	engineered to express GFP to interact with axons	36065
@VP	to express GFP to interact with axons	36076
@VP	express GFP to interact with axons	36079
@VP	to interact with axons	36091
@VP	interact with axons	36094
@VP	interacted in and appeared to enwrap axons	36131
@VP	interacted in	36131
@VP	appeared to enwrap axons	36149
@VP	to enwrap axons	36158
@VP	enwrap axons	36161
@VP	Staining with anti-P0	36175
@VP	labeling around nerve fibers	36363
@VP	do not have a myelinating phenotype -LRB- Fig. 6C , D -RRB-	36531
@VP	have a myelinating phenotype -LRB- Fig. 6C , D -RRB-	36538
@VP	Included in the Study Cell transplantation	36612
@VP	differentiated cell types	36807
@VP	is one strategy for sourcing cells	36833
@VP	may be required for some stem cell sources	36958
@VP	be required for some stem cell sources	36962
@VP	required for some stem cell sources	36965
@VP	have been used previously in animal models of spinal cord injury repair	37177
@VP	been used previously in animal models of spinal cord injury repair	37182
@VP	used previously in animal models of spinal cord injury repair	37187
@VP	have never been directly compared in the same model	37253
@VP	been directly compared in the same model	37264
@VP	tested	37316
@VP	are well established to support axonal regeneration	37364
@VP	established to support axonal regeneration	37373
@VP	to support axonal regeneration	37385
@VP	support axonal regeneration	37388
@VP	employed	37749
@VP	been designed to minimize their presence -LRB- Barnett and Roskams , 2008 -RRB-	37772
@VP	designed to minimize their presence -LRB- Barnett and Roskams , 2008 -RRB-	37777
@VP	to minimize their presence -LRB- Barnett and Roskams , 2008 -RRB-	37786
@VP	minimize their presence -LRB- Barnett and Roskams , 2008 -RRB-	37789
@VP	have properties that will optimize regeneration	37906
@VP	will optimize regeneration	37927
@VP	optimize regeneration	37932
@VP	promote regeneration more effectively than if fibroblast-like cells are included	38004
@VP	are included	38072
@VP	included	38076
@VP	has rarely been directly tested	38100
@VP	been directly tested	38111
@VP	directly tested	38116
@VP	have been expressed	38151
@VP	been expressed	38156
@VP	expressed	38161
@VP	include a mixture of olfactory bulb OECs and fibroblastlike cells	38230
@VP	promoting axonal regeneration -LRB- Raisman and Li , 2007 -RRB-	38335
@VP	have chosen to transplant nondissociated tissue rather than cultured cells	38414
@VP	chosen to transplant nondissociated tissue rather than cultured cells	38419
@VP	chosen to transplant nondissociated tissue	38419
@VP	to transplant nondissociated tissue	38426
@VP	transplant nondissociated tissue	38429
@VP	cultured	38474
@VP	has been transplanted in some rat studies	38528
@VP	been transplanted in some rat studies	38532
@VP	transplanted in some rat studies	38537
@VP	containing many diverse cell types -LRB- Lindsay et al. , 2010 -RRB-	38785
@VP	may have when transplanted into the spinal cord has not yet been determined	38972
@VP	have when transplanted into the spinal cord has not yet been determined	38976
@VP	has not yet been determined	39020
@VP	been determined	39032
@VP	determined	39037
@VP	to clarify some of these issues by comparing key properties of different cells	39073
@VP	clarify some of these issues by comparing key properties of different cells	39076
@VP	comparing key properties of different cells	39108
@VP	transplanted under identical conditions	39157
@VP	to compare the ability of the cell transplants to support axonal regeneration	39233
@VP	compare the ability of the cell transplants to support axonal regeneration	39236
@VP	to support axonal regeneration	39280
@VP	support axonal regeneration	39283
@VP	transplanted into the gap created by a wire-knife injury	39377
@VP	created by a wire-knife injury	39403
@VP	can be unequivocally identified as regenerating axons	39455
@VP	be unequivocally identified as regenerating axons	39459
@VP	unequivocally identified as regenerating axons	39462
@VP	provide directly to growing axons	39650
@VP	see below	39816
@VP	therefore influence the number of fibers able to enter the graft	39831
@VP	to enter the graft	39877
@VP	enter the graft	39880
@VP	transplanting acutely	39900
@VP	affecting the numbers of axons within the graft	40107
@VP	tested	40251
@VP	distributed amongst the transplanted cells	40378
@VP	tested	40468
@VP	supported axonal regeneration	40476
@VP	purified populations of glial cells	40507
@VP	support a higher density than SCs , though this difference was not significant	40626
@VP	was not significant	40684
@VP	has been studied in detail	40751
@VP	been studied in detail	40755
@VP	studied in detail	40760
@VP	is well established that both cell types support axonal regeneration	40791
@VP	established that both cell types support axonal regeneration	40799
@VP	support axonal regeneration	40832
@VP	been surprisingly few direct comparisons under the same experimental conditions	40872
@VP	compared SCs	40974
@VP	were performed after 1 week	41081
@VP	performed after 1 week	41086
@VP	made using toluidine blue semithin sections from the injury / transplant site	41184
@VP	using toluidine blue semithin sections from the injury / transplant site	41189
@VP	supporting more than OEC transplants	41385
@VP	to distinguish between sparing and regeneration of fibers at the injury site	41473
@VP	distinguish between sparing and regeneration of fibers at the injury site	41476
@VP	remaining 3 weeks post-transplantation	41769
@VP	may have confounded the comparison of regeneration / sparing in this model	41846
@VP	have confounded the comparison of regeneration / sparing in this model	41850
@VP	confounded the comparison of regeneration / sparing in this model	41855
@VP	sparing in this model	41898
@VP	prepared from Fischer	42037
@VP	were associated with similar numbers of GAP-43 positive immunolabeling	42173
@VP	associated with similar numbers of GAP-43 positive immunolabeling	42178
@VP	were not quantified	42308
@VP	quantified	42317
@VP	involved in previous studies	42434
@VP	possibly more effectively than SC transplants	42619
@VP	studying OECs	42737
@VP	transplanted	43261
@VP	can extend -LRB- Raisman and Li , 2007 -RRB-	43334
@VP	extend -LRB- Raisman and Li , 2007 -RRB-	43338
@VP	exit or do	43610
@VP	enter	43630
@VP	obtained from the olfactory bulb	43876
@VP	supported regeneration within the transplant	43924
@VP	supported regeneration beyond the graft -LRB- Toft et al. , 2007 -RRB-	43977
@VP	promote the most axonal growth	44341
@VP	promote significantly less regeneration	44409
@VP	Adding OECs to the fibroblast -- like cells	44450
@VP	remains significantly less than that within transplants of purified OECs	44618
@VP	is maximized by purification of OECs obtained from the olfactory bulb	44743
@VP	maximized by purification of OECs obtained from the olfactory bulb	44746
@VP	obtained from the olfactory bulb	44780
@VP	are not clear	44877
@VP	may influence their pro-regenerative properties	44969
@VP	influence their pro-regenerative properties	44973
@VP	used to assess axonal regeneration	45376
@VP	to assess axonal regeneration	45381
@VP	assess axonal regeneration	45384
@VP	are all potential alternative explanations	45411
@VP	transplanted alone	45502
@VP	supported less axonal regeneration than any of the other cell types investigated	45522
@VP	investigated	45590
@VP	associated with the nervous system	45664
@VP	can enhance CNS repair when transplanted	45699
@VP	enhance CNS repair when transplanted	45703
@VP	transplanted	45727
@VP	co-transplanted with OECs -LRB- Lakatos et al. , 2003 -RRB-	46049
@VP	are important components of the glial scar that forms in the injured CNS	46167
@VP	forms in the injured CNS	46215
@VP	created by transplanting pure populations of meningeal cells	46461
@VP	transplanting pure populations of meningeal cells	46472
@VP	differs from that produced by meningeal cells participating in the glial scar	46522
@VP	produced by meningeal cells participating in the glial scar	46540
@VP	participating in the glial scar	46568
@VP	support more limited axonal regeneration than other cell types	46674
@VP	contains OECs within the lamina propria	46811
@VP	are not identical -LRB- Ramer et al. , 2004 -RRB-	47022
@VP	has , however , yet to be fully elucidated	47372
@VP	to be fully elucidated	47390
@VP	be fully elucidated	47393
@VP	fully elucidated	47396
@VP	makes this tissue an attractive source of cells for autologous transplantation	47452
@VP	obtaining large numbers of purified cells from human biopsies	47535
@VP	may be difficult -LRB- Choi et al. , 2008 ; Gorrie et al. , 2010 -RRB-	47597
@VP	be difficult -LRB- Choi et al. , 2008 ; Gorrie et al. , 2010 -RRB-	47601
@VP	to investigate transplantation of non-dissociated olfactory mucosal tissue	47681
@VP	investigate transplantation of non-dissociated olfactory mucosal tissue	47684
@VP	contains a diverse range of cell types -LRB- Lindsay et al. , 2010 -RRB-	47778
@VP	will inevitably remain	48006
@VP	remain	48022
@VP	transplanted into spinal cord injuries	48215
@VP	compares to purified glial cells with respect to support for axonal regeneration	48502
@VP	to purified glial cells with respect to support for axonal regeneration	48511
@VP	purified glial cells with respect to support for axonal regeneration	48514
@VP	to support for axonal regeneration	48548
@VP	support for axonal regeneration	48551
@VP	dissociated cells obtained from the whole olfactory mucosa in our comparison	48611
@VP	obtained from the whole olfactory mucosa in our comparison	48629
@VP	discussed in greater detail below	48847
@VP	induced a very significant adverse tissue response at the transplant site	48896
@VP	associated with any other of the cell types tested	49009
@VP	tested	49053
@VP	may support axonal regeneration	49088
@VP	support axonal regeneration	49092
@VP	would appear to limit their suitability for transplant	49176
@VP	appear to limit their suitability for transplant	49182
@VP	to limit their suitability for transplant	49189
@VP	limit their suitability for transplant	49192
@VP	mediated repair	49231
@VP	have not generally been noted for their ability to support axonal regeneration	49299
@VP	been noted for their ability to support axonal regeneration	49318
@VP	noted for their ability to support axonal regeneration	49323
@VP	to support axonal regeneration	49347
@VP	support axonal regeneration	49350
@VP	were engineered to produce nerve growth factor -LRB- Jones et al. , 2003 -RRB-	49893
@VP	engineered to produce nerve growth factor -LRB- Jones et al. , 2003 -RRB-	49898
@VP	to produce nerve growth factor -LRB- Jones et al. , 2003 -RRB-	49909
@VP	produce nerve growth factor -LRB- Jones et al. , 2003 -RRB-	49912
@VP	confirm previous evidence that SF can support axonal regeneration	50235
@VP	can support axonal regeneration	50269
@VP	support axonal regeneration	50273
@VP	obtained from the olfactory bulb	50410
@VP	studied for transplant mediated repair	50539
@VP	mediated repair	50562
@VP	have so far tended to confirm this view	50822
@VP	tended to confirm this view	50834
@VP	to confirm this view	50841
@VP	confirm this view	50844
@VP	compared transplants of PNFBs with mixed olfactory cell transplants	50916
@VP	was seen in the fibroblast only transplants	51095
@VP	seen in the fibroblast only transplants	51099
@VP	Paralleling this	51140
@VP	reaching movements after electrolytic lesions in the cervical dorsal columns	51223
@VP	reported that adding PNFBs to pure SC populations prior to transplant	51311
@VP	adding PNFBs to pure SC populations prior to transplant	51325
@VP	improved	51389
@VP	were equivalent to that detected after SC transplantation	51718
@VP	detected after SC transplantation	51742
@VP	supporting properties of the several cell types and cell mixtures	51893
@VP	tested	51959
@VP	assessing axonal regeneration	51979
@VP	detected by immunolabeling for neurofilament proteins	52058
@VP	make up the majority of axons in the dorsal columns	52311
@VP	labeled fibers within the transplants	52415
@VP	used tract tracing	52479
@VP	tracing	52490
@VP	originate from dorsal root ganglia	52547
@VP	descending from the brain or in fine peptidergic primary afferent fibers	52662
@VP	show a greater propensity for regeneration -LRB- Hawthorne et al. , 2011 -RRB-	52762
@VP	would behave in a similar way to neurofilament labeled axons	52883
@VP	behave in a similar way to neurofilament labeled axons	52889
@VP	labeled axons	52930
@VP	support regenerating CGRP immunopositive fibers while OEC transplants	53008
@VP	regenerating CGRP immunopositive fibers while OEC transplants	53016
@VP	do not	53078
@VP	in this case were a 50:50 mixture of OECs and fibroblast-like cells	53115
@VP	is not clear how purified OEC transplants would behave	53240
@VP	would behave	53282
@VP	behave	53288
@VP	containing fibers	53574
@VP	are nociceptive primary afferent fibers	53652
@VP	associated with mechanisms of pain	53706
@VP	saw evidence of myelination by transplanted GFP-labeled OECs and SCs	53905
@VP	labeled P0 IR	54009
@VP	not associated with P0 staining	54051
@VP	invading the graft	54156
@VP	did not express GFP	54225
@VP	express GFP	54233
@VP	was over 90 %	54274
@VP	suggests myelination by endogenous CNS glial cells	54357
@VP	invading SCs	54432
@VP	can occur even in transplants of cells with a nonmyelinating phenotype	54546
@VP	occur even in transplants of cells with a nonmyelinating phenotype	54550
@VP	infiltrate the graft site	54679
@VP	influence the outcome of transplants with different cell types	54705
@VP	is well established that SCs can be found within OEC transplants	54772
@VP	established that SCs can be found within OEC transplants	54780
@VP	can be found within OEC transplants	54801
@VP	be found within OEC transplants	54805
@VP	found within OEC transplants	54808
@VP	is an issue that remains to be clarified	54975
@VP	remains to be clarified	54992
@VP	to be clarified	55000
@VP	be clarified	55003
@VP	clarified	55006
@VP	supported by OECs -LRB- Richter et al. , 2005 -RRB-	55096
@VP	recruited by the transplant	55177
@VP	influence other properties such as the host -- graft interaction	55219
@VP	determining the suitability of cells for spinal cord repair	55398
@VP	may be their readiness to integrate within the host tissues	55458
@VP	be their readiness to integrate within the host tissues	55462
@VP	to integrate within the host tissues	55481
@VP	integrate within the host tissues	55484
@VP	to integrate within the host spinal cord using two methods	55587
@VP	integrate within the host spinal cord using two methods	55590
@VP	using two methods	55628
@VP	associated with the transplanted dorsal column injury site	55695
@VP	are in close agreement and indicate marked differences	56269
@VP	are in close agreement	56269
@VP	indicate marked differences	56296
@VP	transplanted	56387
@VP	produced the least glial hypertrophy	56429
@VP	results for these two purified populations of glial cells were closely similar	56470
@VP	were closely similar	56528
@VP	surrounding the injury site	56785
@VP	occupying a length of the cord double that seen for pure glial cell transplants	56817
@VP	seen for pure glial cell transplants	56860
@VP	extended well beyond the bolus of transplanted cells	56999
@VP	was not seen for pure glial cell transplants	57179
@VP	seen for pure glial cell transplants	57187
@VP	Adding	57225
@VP	was intermediate between that for OECs and olfactory bulb fibroblast-like cells	57373
@VP	obtained from the olfactory mucosa	57570
@VP	involves complex cellular and molecular mechanisms	57658
@VP	is that it can both positively and negatively influence the response to injury	57730
@VP	can both positively and negatively influence the response to injury	57741
@VP	positively and negatively influence the response to injury	57750
@VP	to re-establish the glia limitans	57844
@VP	re-establish the glia limitans	57847
@VP	reforming the barrier around the CNS and protecting the injured region	57879
@VP	reforming the barrier around the CNS	57879
@VP	protecting the injured region	57920
@VP	did not carry out functional tests on transplanted animals	58328
@VP	carry out functional tests on transplanted animals	58336
@VP	to treat spinal cord injury that seek to reconstruct the damaged injury site	58524
@VP	treat spinal cord injury that seek to reconstruct the damaged injury site	58527
@VP	seek to reconstruct the damaged injury site	58557
@VP	to reconstruct the damaged injury site	58562
@VP	reconstruct the damaged injury site	58565
@VP	seen for different cells types	58666
@VP	regenerating axons into the graft in our study	58738
@VP	were performed acutely	58809
@VP	performed acutely	58814
@VP	to enter the transplant before the glial reaction fully developed	58872
@VP	enter the transplant before the glial reaction fully developed	58875
@VP	developed	58928
@VP	makes it more difficult for regenerating axons to leave the graft	58990
@VP	regenerating axons to leave the graft	59018
@VP	to leave the graft	59037
@VP	leave the graft	59040
@VP	supported bridging regeneration , that is , regeneration beyond the transplant	59165
@VP	bridging regeneration , that is , regeneration beyond the transplant	59175
@VP	is , regeneration beyond the transplant	59203
@VP	bridging regeneration both the relative ability of the cell	59264
@VP	to support regeneration and their ability to integrate with the host environment	59336
@VP	support regeneration and their ability to integrate with the host environment	59339
@VP	to integrate with the host environment	59378
@VP	integrate with the host environment	59381
@VP	using combined treatments designed to allow such regeneration to occur	59460
@VP	designed to allow such regeneration to occur	59486
@VP	to allow such regeneration to occur	59495
@VP	allow such regeneration to occur	59498
@VP	to occur	59522
@VP	occur	59525
@VP	mingle freely with astrocytes in a co-culture	59982
@VP	was evident in the current study	60128
@VP	has also been observed in vivo in other spinal cord injury models	60165
@VP	been observed in vivo in other spinal cord injury models	60174
@VP	observed in vivo in other spinal cord injury models	60179
@VP	tended to form with a continuous astrocytic boundary	60337
@VP	to form with a continuous astrocytic boundary	60344
@VP	form with a continuous astrocytic boundary	60347
@VP	transplanted into a moderate contusion injury model	60504
@VP	suggesting some possible advantages over SCs	60777
@VP	not generally considered	61033
@VP	to have unique regeneration promoting properties	61058
@VP	have unique regeneration promoting properties	61061
@VP	promoting properties	61086
@VP	containing fibroblast-like cells	61601
@VP	provoke a more marked host cell response than purified glial cell populations	61635
@VP	than purified glial cell populations	61676
@VP	must provide an environment permissive for axonal regeneration	61764
@VP	provide an environment permissive for axonal regeneration	61769
@VP	to take account of how readily the cells integrate with the host spinal cord	61877
@VP	take account of how readily the cells integrate with the host spinal cord	61880
@VP	integrate with the host spinal cord	61918
@VP	has important implications for the choice of cells for clinical use	61960
@VP	noted previously	62032
@VP	purified	62236
@VP	will prove disadvantageous	62355
@VP	prove disadvantageous	62360
@VP	compared here	62434
@VP	possess an optimal combination of desirable properties	62497
@VP	evoking a minimal glial reaction around the transplant site	62609
@VP	are desirable for transplant mediated repair then	62823
@VP	mediated repair then	62852
@VP	may be required to treat a human spinal cord injury	63009
@VP	be required to treat a human spinal cord injury	63013
@VP	required to treat a human spinal cord injury	63016
@VP	to treat a human spinal cord injury	63025
@VP	treat a human spinal cord injury	63028
@VP	currently being investigated for use in spinal cord injury	63161
@VP	investigated for use in spinal cord injury	63177
@VP	supporting properties	63257
@VP	compare to differentiated cells	63279
@VP	to differentiated cells	63287
@VP	differentiated cells	63290
@VP	resembles that of glial cells or that of fibroblast-like cells	63380
